BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 037042
(1002 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 155 bits (391), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 180/627 (28%), Positives = 253/627 (40%), Gaps = 96/627 (15%)
Query: 46 VTCDVHSHRVTAL---NISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHT 102
++ DV R L ++S + S IP LG+ S+LQ L + N+ SG +I
Sbjct: 187 ISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTE 245
Query: 103 LKLLSFGDNQLSGEIPTNICSNLPF--FESLNLSKNMFHGGIPSALSN-CTYLRILRLSY 159
LKLL+ NQ G IP LP + L+L++N F G IP LS C L L LS
Sbjct: 246 LKLLNISSNQFVGPIPP-----LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG 300
Query: 160 NDFAGGIPKEIGNLTKLEELYLSFNGLQGAYDHGFLQIFVKNIFVQFSHNFSKCEIP-NE 218
N F G +P G+ + LE L LS N G E+P +
Sbjct: 301 NHFYGAVPPFFGSCSLLESLALSSNNFSG-------------------------ELPMDT 335
Query: 219 IGNLRNLEVLALGLNKLVGVIPAEIFNMSTIQGVXXXXXXXXXXXXXIPYVRLP--NLEE 276
+ +R L+VL L N+ G +P + N+S + P L+E
Sbjct: 336 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 395
Query: 277 LYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXXXXXXXXXXXX 336
LYL N F+G IP + N S+L L L N SG IPS+
Sbjct: 396 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL-------------------- 435
Query: 337 XXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCNVSGSIPEEIG 396
+ L + L N ++G + ++ + + I D +D ++G IP +
Sbjct: 436 ---------GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND--LTGEIPSGLS 484
Query: 397 NLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVCRLAKVYQLDLSN 456
N TNL L N L G IP +G+L+ L +L +N G+IP E+ + LDL+
Sbjct: 485 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 544
Query: 457 NKLSGSIPACF---------------------GDXXXXXXXXXXXXXXISVIPSTFWN-L 494
N +G+IPA D I S N L
Sbjct: 545 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 604
Query: 495 KDILYLNLSSNSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYNI 554
N++S G N ++ +D S N SG IP IG + L L L +N
Sbjct: 605 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 664
Query: 555 LQGSIPDSFGDLMXXXXXXXXXXXXXGSIPVSLEKLSYLKDLNLSFNKLEGEIPKGGSFG 614
+ GSIPD GDL G IP ++ L+ L +++LS N L G IP+ G F
Sbjct: 665 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 724
Query: 615 NFSAESFEGNKLLCGSPNLHVPPCKTS 641
F F N LCG P +P C S
Sbjct: 725 TFPPAKFLNNPGLCGYP---LPRCDPS 748
Score = 129 bits (325), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 169/553 (30%), Positives = 242/553 (43%), Gaps = 40/553 (7%)
Query: 26 PTNFFAKNWNSSISFCNWTGVTCDVHSHRVTALNISHLSLS---GTIPSRLGNLSSLQSL 82
P +W+S+ + C + GVTC +VT++++S L+ + S L +L+ L+SL
Sbjct: 22 PDKNLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 79
Query: 83 FLHSNQFSGSIPFSIFNIH-TLKLLSFGDNQLSGEIPT----NICSNLPFFESLNLSKNM 137
FL ++ +GS+ S F +L L N LSG + T CS L F LN+S N
Sbjct: 80 FLSNSHINGSV--SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF---LNVSSNT 134
Query: 138 --FHGGIPSALSNCTYLRILRLSYNDFAGGIPKEIG-----NLTKLEELYLSFNGLQGAY 190
F G + L L +L LS N +G +G +L+ L +S N + G
Sbjct: 135 LDFPGKVSGGLK-LNSLEVLDLSANSISGA--NVVGWVLSDGCGELKHLAISGNKISGDV 191
Query: 191 DHGFLQIFVKNIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVGVIPAEIFNMSTIQ 250
D + V F+ S N IP +G+ L+ L + NKL G I ST
Sbjct: 192 D---VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAI---STCT 244
Query: 251 GVXXXXXXXXXXXXXIPYVRLPNLEELYLWGNHFSGSIPNFIFNA-SKLSRLELQKNSFS 309
+ IP + L +L+ L L N F+G IP+F+ A L+ L+L N F
Sbjct: 245 ELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 304
Query: 310 GFIPSTFXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKS 369
G +P F + L+ +DLS N G L +S
Sbjct: 305 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM----RGLKVLDLSFNEFSGELP-ES 359
Query: 370 VGNLSHSLKIFDMSDCNVSGSI-PEEIGNLTN-LIGFYLGGNNLNGSIPITLGKLQKLQV 427
+ NLS SL D+S N SG I P N N L YL N G IP TL +L
Sbjct: 360 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 419
Query: 428 LYFPDNKLEGSIPDEVCRLAKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVI 487
L+ N L G+IP + L+K+ L L N L G IP I
Sbjct: 420 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 479
Query: 488 PSTFWNLKDILYLNLSSNSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQF 547
PS N ++ +++LS+N LTG +P IG L+ L + S N+FSG IP +G + L +
Sbjct: 480 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 539
Query: 548 LFLEYNILQGSIP 560
L L N+ G+IP
Sbjct: 540 LDLNTNLFNGTIP 552
Score = 99.0 bits (245), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 112/383 (29%), Positives = 155/383 (40%), Gaps = 56/383 (14%)
Query: 278 YLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXXXXXXXXXXXXX 337
+L +H +GS+ F +AS L+ L+L +NS SG P T
Sbjct: 80 FLSNSHINGSVSGFKCSAS-LTSLDLSRNSLSG--PVTTLTSLGSCSGLKFLNVSSNTLD 136
Query: 338 XXXXXXXXXNCKYLEFIDLSSNSIDG------ILSRKSVGNLSH---------------- 375
LE +DLS+NSI G +LS G L H
Sbjct: 137 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS-DGCGELKHLAISGNKISGDVDVSR 195
Query: 376 --SLKIFDMSDCNVSGSIPEEIGNLTNLIGFYLGGNNLNGSI------------------ 415
+L+ D+S N S IP +G+ + L + GN L+G
Sbjct: 196 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 254
Query: 416 ----PITLGKLQKLQVLYFPDNKLEGSIPDEVCRLAKVYQ-LDLSNNKLSGSIPACFGDX 470
PI L+ LQ L +NK G IPD + LDLS N G++P FG
Sbjct: 255 QFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 314
Query: 471 XXXXXXXXXXXXXISVIP-STFWNLKDILYLNLSSNSLTGPLPLEIGNLKV-LVKIDFSM 528
+P T ++ + L+LS N +G LP + NL L+ +D S
Sbjct: 315 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 374
Query: 529 NNFSG-VIPNAIGGIKD-LQFLFLEYNILQGSIPDSFGDLMXXXXXXXXXXXXXGSIPVS 586
NNFSG ++PN K+ LQ L+L+ N G IP + + G+IP S
Sbjct: 375 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 434
Query: 587 LEKLSYLKDLNLSFNKLEGEIPK 609
L LS L+DL L N LEGEIP+
Sbjct: 435 LGSLSKLRDLKLWLNMLEGEIPQ 457
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 154 bits (390), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 180/627 (28%), Positives = 253/627 (40%), Gaps = 96/627 (15%)
Query: 46 VTCDVHSHRVTAL---NISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHT 102
++ DV R L ++S + S IP LG+ S+LQ L + N+ SG +I
Sbjct: 190 ISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTE 248
Query: 103 LKLLSFGDNQLSGEIPTNICSNLPF--FESLNLSKNMFHGGIPSALSN-CTYLRILRLSY 159
LKLL+ NQ G IP LP + L+L++N F G IP LS C L L LS
Sbjct: 249 LKLLNISSNQFVGPIPP-----LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG 303
Query: 160 NDFAGGIPKEIGNLTKLEELYLSFNGLQGAYDHGFLQIFVKNIFVQFSHNFSKCEIP-NE 218
N F G +P G+ + LE L LS N G E+P +
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSG-------------------------ELPMDT 338
Query: 219 IGNLRNLEVLALGLNKLVGVIPAEIFNMSTIQGVXXXXXXXXXXXXXIPYVRLP--NLEE 276
+ +R L+VL L N+ G +P + N+S + P L+E
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398
Query: 277 LYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXXXXXXXXXXXX 336
LYL N F+G IP + N S+L L L N SG IPS+
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL-------------------- 438
Query: 337 XXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCNVSGSIPEEIG 396
+ L + L N ++G + ++ + + I D +D ++G IP +
Sbjct: 439 ---------GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND--LTGEIPSGLS 487
Query: 397 NLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVCRLAKVYQLDLSN 456
N TNL L N L G IP +G+L+ L +L +N G+IP E+ + LDL+
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 457 NKLSGSIPACF---------------------GDXXXXXXXXXXXXXXISVIPSTFWN-L 494
N +G+IPA D I S N L
Sbjct: 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 495 KDILYLNLSSNSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYNI 554
N++S G N ++ +D S N SG IP IG + L L L +N
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 555 LQGSIPDSFGDLMXXXXXXXXXXXXXGSIPVSLEKLSYLKDLNLSFNKLEGEIPKGGSFG 614
+ GSIPD GDL G IP ++ L+ L +++LS N L G IP+ G F
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 615 NFSAESFEGNKLLCGSPNLHVPPCKTS 641
F F N LCG P +P C S
Sbjct: 728 TFPPAKFLNNPGLCGYP---LPRCDPS 751
Score = 129 bits (325), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 169/553 (30%), Positives = 242/553 (43%), Gaps = 40/553 (7%)
Query: 26 PTNFFAKNWNSSISFCNWTGVTCDVHSHRVTALNISHLSLS---GTIPSRLGNLSSLQSL 82
P +W+S+ + C + GVTC +VT++++S L+ + S L +L+ L+SL
Sbjct: 25 PDKNLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82
Query: 83 FLHSNQFSGSIPFSIFNIH-TLKLLSFGDNQLSGEIPT----NICSNLPFFESLNLSKNM 137
FL ++ +GS+ S F +L L N LSG + T CS L F LN+S N
Sbjct: 83 FLSNSHINGSV--SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF---LNVSSNT 137
Query: 138 --FHGGIPSALSNCTYLRILRLSYNDFAGGIPKEIG-----NLTKLEELYLSFNGLQGAY 190
F G + L L +L LS N +G +G +L+ L +S N + G
Sbjct: 138 LDFPGKVSGGLK-LNSLEVLDLSANSISGA--NVVGWVLSDGCGELKHLAISGNKISGDV 194
Query: 191 DHGFLQIFVKNIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVGVIPAEIFNMSTIQ 250
D + V F+ S N IP +G+ L+ L + NKL G I ST
Sbjct: 195 D---VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAI---STCT 247
Query: 251 GVXXXXXXXXXXXXXIPYVRLPNLEELYLWGNHFSGSIPNFIFNA-SKLSRLELQKNSFS 309
+ IP + L +L+ L L N F+G IP+F+ A L+ L+L N F
Sbjct: 248 ELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307
Query: 310 GFIPSTFXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKS 369
G +P F + L+ +DLS N G L +S
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM----RGLKVLDLSFNEFSGELP-ES 362
Query: 370 VGNLSHSLKIFDMSDCNVSGSI-PEEIGNLTN-LIGFYLGGNNLNGSIPITLGKLQKLQV 427
+ NLS SL D+S N SG I P N N L YL N G IP TL +L
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 428 LYFPDNKLEGSIPDEVCRLAKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVI 487
L+ N L G+IP + L+K+ L L N L G IP I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 488 PSTFWNLKDILYLNLSSNSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQF 547
PS N ++ +++LS+N LTG +P IG L+ L + S N+FSG IP +G + L +
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542
Query: 548 LFLEYNILQGSIP 560
L L N+ G+IP
Sbjct: 543 LDLNTNLFNGTIP 555
Score = 98.6 bits (244), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 112/383 (29%), Positives = 155/383 (40%), Gaps = 56/383 (14%)
Query: 278 YLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXXXXXXXXXXXXX 337
+L +H +GS+ F +AS L+ L+L +NS SG P T
Sbjct: 83 FLSNSHINGSVSGFKCSAS-LTSLDLSRNSLSG--PVTTLTSLGSCSGLKFLNVSSNTLD 139
Query: 338 XXXXXXXXXNCKYLEFIDLSSNSIDG------ILSRKSVGNLSH---------------- 375
LE +DLS+NSI G +LS G L H
Sbjct: 140 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS-DGCGELKHLAISGNKISGDVDVSR 198
Query: 376 --SLKIFDMSDCNVSGSIPEEIGNLTNLIGFYLGGNNLNGSI------------------ 415
+L+ D+S N S IP +G+ + L + GN L+G
Sbjct: 199 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 416 ----PITLGKLQKLQVLYFPDNKLEGSIPDEVCRLAKVYQ-LDLSNNKLSGSIPACFGDX 470
PI L+ LQ L +NK G IPD + LDLS N G++P FG
Sbjct: 258 QFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 471 XXXXXXXXXXXXXISVIP-STFWNLKDILYLNLSSNSLTGPLPLEIGNLKV-LVKIDFSM 528
+P T ++ + L+LS N +G LP + NL L+ +D S
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 529 NNFSG-VIPNAIGGIKD-LQFLFLEYNILQGSIPDSFGDLMXXXXXXXXXXXXXGSIPVS 586
NNFSG ++PN K+ LQ L+L+ N G IP + + G+IP S
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 587 LEKLSYLKDLNLSFNKLEGEIPK 609
L LS L+DL L N LEGEIP+
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQ 460
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 144 bits (362), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 104/323 (32%), Positives = 159/323 (49%), Gaps = 26/323 (8%)
Query: 679 RQQPNDA--DMPQE-------ATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKARIQD 729
R++P D D+P E +RFS EL A+D FS N++GRGGFG VYK R+ D
Sbjct: 2 RKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD 61
Query: 730 GMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYM 788
G VAVK ++ + + F E E++ HRN++++ C + L YM
Sbjct: 62 GTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC----MTPTERLLVYPYM 117
Query: 789 PHGSLEKYLY---SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD 845
+GS+ L S LD +R I + A L YL+ +IH D+K +N+LL +
Sbjct: 118 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 177
Query: 846 NMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMET 905
A + DFG+ KL+ +D V TIG++A EY S G+ S DV+ +GVML+E
Sbjct: 178 EFEAVVGDFGLAKLMDYKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 236
Query: 906 FTGKKP---TNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFN 962
TG++ ++ + L WV ++K L D+Q K++ + +
Sbjct: 237 ITGQRAFDLARLANDDDVMLLDWVK-----GLLKEKKLEALVDVDLQGNYKDEEVEQLIQ 291
Query: 963 MAMECTVESPEKRINAKEIVTRL 985
+A+ CT SP +R E+V L
Sbjct: 292 VALLCTQSSPMERPKMSEVVRML 314
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 135 bits (340), Expect = 1e-31, Method: Composition-based stats.
Identities = 97/299 (32%), Positives = 150/299 (50%), Gaps = 17/299 (5%)
Query: 694 RRFSYLELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFK-SFDVE 752
+RFS EL A+D F N++GRGGFG VYK R+ DG VAVK ++ + + F E
Sbjct: 18 KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 753 CEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLY---SSNYILDIFQR 809
E++ HRN++++ C + L YM +GS+ L S LD +R
Sbjct: 78 VEMISMAVHRNLLRLRGFC----MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ 869
I + A L YL+ +IH D+K +N+LL + A + DFG+ KL+ +D V
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 870 TQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTN--EIFN-EGMTLKHWV 926
IG++A EY S G+ S DV+ +GVML+E TG++ + + N + + L WV
Sbjct: 194 A-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 927 NDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
++K L D+Q K++ + + +A+ CT SP +R E+V L
Sbjct: 253 K-----GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 118 bits (296), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 89/296 (30%), Positives = 149/296 (50%), Gaps = 18/296 (6%)
Query: 695 RFSYLELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECE 754
R ++L +AT+ F LIG G FG VYK ++DG +VA+K + + + F+ E E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 755 VMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSN---YILDIFQRLN 811
+ RH +++ +I C + L +YM +G+L+++LY S+ + QRL
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILI----YKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
I I A L YL+ + +IH D+K N+LL +N V ++DFGI+K T DQ
Sbjct: 144 ICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP-TNEIFNEGMTLKHW-VNDW 929
T+GY+ EY +GR++ DVY+FGV+L E + + E + L W V
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 930 LLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+ +IVD +L + + + + + A++C S E R + +++ +L
Sbjct: 261 NNGQLEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 115 bits (288), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 88/296 (29%), Positives = 148/296 (50%), Gaps = 18/296 (6%)
Query: 695 RFSYLELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECE 754
R ++L +AT+ F LIG G FG VYK ++DG +VA+K + + + F+ E E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 755 VMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSN---YILDIFQRLN 811
+ RH +++ +I C + L +YM +G+L+++LY S+ + QRL
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILI----YKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
I I A L YL+ + +IH D+K N+LL +N V ++DFGI+K T Q
Sbjct: 144 ICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP-TNEIFNEGMTLKHW-VNDW 929
T+GY+ EY +GR++ DVY+FGV+L E + + E + L W V
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 930 LLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+ +IVD +L + + + + + A++C S E R + +++ +L
Sbjct: 261 NNGQLEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 108 bits (269), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 83/263 (31%), Positives = 118/263 (44%), Gaps = 9/263 (3%)
Query: 380 FDMSDCNVSGS--IPEEIGNLTNLIGFYLGG-NNLNGSIPITLGKLQKLQVLYFPDNKLE 436
D+S N+ IP + NL L Y+GG NNL G IP + KL +L LY +
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 437 GSIPDEVCRLAKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKD 496
G+IPD + ++ + LD S N LSG++P IP ++ +
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 497 ILY-LNLSSNSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYNIL 555
+ + +S N LTG +P NL L +D S N G G K+ Q + L N L
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 556 QGSIPDSFGDLMXXXXXXXXXXXXXGSIPVSLEKLSYLKDLNLSFNKLEGEIPKGGSFGN 615
+ G G++P L +L +L LN+SFN L GEIP+GG+
Sbjct: 234 AFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 616 FSAESFEGNKLLCGSPNLHVPPC 638
F ++ NK LCGSP +P C
Sbjct: 293 FDVSAYANNKCLCGSP---LPAC 312
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 3/183 (1%)
Query: 58 LNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSGEI 117
L I+H ++SG IP L + +L +L N SG++P SI ++ L ++F N++SG I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 118 PTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYLRILRLSYNDFAGGIPKEIGNLTKLE 177
P + S F S+ +S+N G IP +N L + LS N G G+ +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 178 ELYLSFNGLQGAYDHGFLQIFVKNIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVG 237
+++L+ N L A+D G + + + +N +P + L+ L L + N L G
Sbjct: 225 KIHLAKNSL--AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 238 VIP 240
IP
Sbjct: 283 EIP 285
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 76/263 (28%), Positives = 112/263 (42%), Gaps = 41/263 (15%)
Query: 11 DLDALHALKTHITNDPTNFFAKNWNSSISFCN--WTGVTCDV--HSHRVTALNISHLSLS 66
D AL +K + N PT +W + CN W GV CD ++RV L++S L+L
Sbjct: 7 DKQALLQIKKDLGN-PTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 67 ---------------------------GTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFN 99
G IP + L+ L L++ SG+IP +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 100 IHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYL-RILRLS 158
I TL L F N LSG +P +I S+LP + N G IP + + + L + +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 159 YNDFAGGIPKEIGNLTKLEELYLSFNGLQGAYDHGFLQIFVKNI-FVQFSHNFSKCEIPN 217
N G IP NL L + LS N L+G D L KN + + N ++
Sbjct: 183 RNRLTGKIPPTFANL-NLAFVDLSRNMLEG--DASVLFGSDKNTQKIHLAKNSLAFDL-G 238
Query: 218 EIGNLRNLEVLALGLNKLVGVIP 240
++G +NL L L N++ G +P
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLP 261
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 79/326 (24%), Positives = 119/326 (36%), Gaps = 104/326 (31%)
Query: 142 IPSALSNCTYLRILRLS-YNDFAGGIPKEIGNLTKLEELYLSFNGLQGAYDHGFLQIFVK 200
IPS+L+N YL L + N+ G IP I LT+L LY++ + GA
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA----------- 116
Query: 201 NIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVGVIPAEIFNMSTIQGVXXXXXXXX 260
IP+ + ++ L L N L G +P I
Sbjct: 117 --------------IPDFLSQIKTLVTLDFSYNALSGTLPPSI----------------- 145
Query: 261 XXXXXIPYVRLPNLEELYLWGNHFSGSIPNFIFNASKL-SRLELQKNSFSGFIPSTFXXX 319
LPNL + GN SG+IP+ + SKL + + + +N +G IP TF
Sbjct: 146 --------SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197
Query: 320 XXXXXXXXXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGI--------------- 364
L F+DLS N ++G
Sbjct: 198 N------------------------------LAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 365 LSRKSVG------NLSHSLKIFDMSDCNVSGSIPEEIGNLTNLIGFYLGGNNLNGSIPIT 418
L++ S+ LS +L D+ + + G++P+ + L L + NNL G IP
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 419 LGKLQKLQVLYFPDNKLEGSIPDEVC 444
G LQ+ V + +NK P C
Sbjct: 288 -GNLQRFDVSAYANNKCLCGSPLPAC 312
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 49/188 (26%)
Query: 38 ISFCNWTGVTCDVHSH--RVTALNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPF 95
I+ N +G D S + L+ S+ +LSGT+P + +L +L + N+ SG+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 96 SIFNIHTL-KLLSFGDNQLSGEIPTNICS-NLPFFE------------------------ 129
S + L ++ N+L+G+IP + NL F +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 130 --------------------SLNLSKNMFHGGIPSALSNCTYLRILRLSYNDFAGGIPKE 169
L+L N +G +P L+ +L L +S+N+ G IP+
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 170 IGNLTKLE 177
GNL + +
Sbjct: 288 -GNLQRFD 294
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 105 bits (262), Expect = 1e-22, Method: Composition-based stats.
Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 49/290 (16%)
Query: 714 IGRGGFGSVYKAR------IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G FG V+ A +D M VAVK A K F E E++ +++H +I+K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYS---------------SNYILDIFQRLNI 812
C GD L + EYM HG L K+L + + L + Q L+I
Sbjct: 83 YGVCGDGD--PLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
+AS + YL S +H DL N L+G N++ + DFG+++ + D + T
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLL 931
I +M E + +T DV++FGV+L E FT GK+P ++ N +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV----------- 244
Query: 932 ISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEI 981
I I G +L R + C V+++ + C P++R+N KEI
Sbjct: 245 --IECITQGRVLERPRV-------CPKEVYDVMLGCWQREPQQRLNIKEI 285
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 102 bits (253), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L ++ +F + + P +
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-KVKEPGESP 180
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 241 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 100 bits (250), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 180
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 241 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 14 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 74 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 131
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 132 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 187
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 247
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 248 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 298
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 25 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 85 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 198
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 258
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 259 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 25 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 85 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 198
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 258
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 259 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 11 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 71 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 128
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 129 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 184
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 244
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 245 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 295
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 12 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 72 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 129
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 130 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 185
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 245
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 246 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 296
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 10 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 70 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 127
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 183
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 244 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 6 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 66 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 123
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 124 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 179
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 239
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 240 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 290
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 5 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 65 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 122
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 123 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 178
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 238
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 239 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 289
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 180
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 241 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 100 bits (249), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 156 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 211
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 272 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 100 bits (248), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 13 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 73 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 130
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 131 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 186
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 246
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 247 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 297
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 100 bits (248), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 87/300 (29%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 10 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL + +D + L +
Sbjct: 70 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQIC 127
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 183
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 244 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 99.4 bits (246), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 86/300 (28%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 10 FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +E++P+GSL +YL +D + L +
Sbjct: 70 SLQHDNIVKYKGVCYSAGRRNL--KLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQIC 127
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH DL N+L+ + + DFG+TK+L +D+ + + P +
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESP 183
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 244 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 98.6 bits (244), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 85/300 (28%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 708 FSENNL-----IGRGGFGSVYKAR---IQD--GMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R +QD G VAVK + F+ E E++K
Sbjct: 8 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
S++H NI+K C + L L +EY+P+GSL YL +D + L +
Sbjct: 68 SLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 125
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--AT 875
+EYL + IH +L N+L+ + + DFG+TK+L ++ ++ + + P +
Sbjct: 126 KGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYY-KVKEPGESP 181
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT----GKKPTNEIFNE-GMTLKHWVNDWL 930
I + A E +E + S DV++FGV+L E FT K P E G + + +
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 241
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
LI ++K + L R D C ++ + EC + +R + +++ R+ +I D
Sbjct: 242 LIELLK--NNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 292
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 97.1 bits (240), Expect = 5e-20, Method: Composition-based stats.
Identities = 83/291 (28%), Positives = 125/291 (42%), Gaps = 46/291 (15%)
Query: 714 IGRGGFGSVYKARI------QDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G FG V+ A QD + VAVK A K F E E++ +++H +I+K
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSN------------YILDIFQRLNIMID 815
C GD L + EYM HG L K+L + L Q L+I
Sbjct: 81 YGVCVEGD--PLI--MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
+A+ + YL S +H DL N L+G+N++ + DFG+++ + D + T
Sbjct: 137 IAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISI 934
I +M E + +T DV++ GV+L E FT GK+P ++ N + I
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------------I 240
Query: 935 MKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
I G +L R C V+ + + C P R N K I T L
Sbjct: 241 ECITQGRVLQR-------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 73/237 (30%), Positives = 113/237 (47%), Gaps = 21/237 (8%)
Query: 690 EATWRRFSYLELCQATDGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK----VFN 739
+ + FS+ EL T+ F E N +G GGFG VYK + + VAVK + +
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67
Query: 740 QQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYL-- 797
+ FD E +VM +H N+++++ S GD L YMP+GSL L
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV----YMPNGSLLDRLSC 123
Query: 798 YSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGIT 857
L R I A+ + +L+ + IH D+K +N+LL + A +SDFG+
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 180
Query: 858 KLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
+ + Q V ++ T YMA E G ++ D+Y+FGV+L+E TG +E
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 96.3 bits (238), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 73/237 (30%), Positives = 112/237 (47%), Gaps = 21/237 (8%)
Query: 690 EATWRRFSYLELCQATDGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK----VFN 739
+ + FS+ EL T+ F E N +G GGFG VYK + + VAVK + +
Sbjct: 3 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 61
Query: 740 QQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYL-- 797
+ FD E +VM +H N+++++ S GD L YMP+GSL L
Sbjct: 62 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV----YMPNGSLLDRLSC 117
Query: 798 YSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGIT 857
L R I A+ + +L+ + IH D+K +N+LL + A +SDFG+
Sbjct: 118 LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 174
Query: 858 KLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
+ + Q V + T YMA E G ++ D+Y+FGV+L+E TG +E
Sbjct: 175 RASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 230
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 95.9 bits (237), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 73/237 (30%), Positives = 112/237 (47%), Gaps = 21/237 (8%)
Query: 690 EATWRRFSYLELCQATDGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK----VFN 739
+ + FS+ EL T+ F E N +G GGFG VYK + + VAVK + +
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67
Query: 740 QQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYL-- 797
+ FD E +VM +H N+++++ S GD L YMP+GSL L
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV----YMPNGSLLDRLSC 123
Query: 798 YSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGIT 857
L R I A+ + +L+ + IH D+K +N+LL + A +SDFG+
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 180
Query: 858 KLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
+ + Q V + T YMA E G ++ D+Y+FGV+L+E TG +E
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 95.1 bits (235), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFK--SFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+V++A G +VAVK+ +Q A + F E +MK +RH NI+ +
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSS--NYILDIFQRLNIMIDVASALEYLYFGYST 829
+ + ++ EY+ GSL + L+ S LD +RL++ DVA + YL+ +
Sbjct: 104 T----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
P++H DLK N+L+ + DFG+++L + F+ T +MA E +
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
+ DVY+FGV+L E T ++P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 12/202 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFK--SFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+V++A G +VAVK+ +Q A + F E +MK +RH NI+ +
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSS--NYILDIFQRLNIMIDVASALEYLYFGYST 829
+ + ++ EY+ GSL + L+ S LD +RL++ DVA + YL+ +
Sbjct: 104 T----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
P++H +LK N+L+ + DFG+++L + F++ T +MA E +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
+ DVY+FGV+L E T ++P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 93.6 bits (231), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 85/296 (28%), Positives = 138/296 (46%), Gaps = 51/296 (17%)
Query: 711 NNLIGRGGFGSVYKARIQ-DG--MEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
++IG G FG V KARI+ DG M+ A+K + + + F E EV+ + H NII
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI---------------LDIFQRL 810
++ C + L+ LA+EY PHG+L +L S + L Q L
Sbjct: 80 NLLGACEHRGY--LY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
+ DVA ++YL IH DL N+L+G+N VA ++DFG+++ ++ +V +T
Sbjct: 136 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 189
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDW 929
+ +MA+E + +TN DV+++GV+L E + G P GMT
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYE-- 242
Query: 930 LLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
K+ G L + C V+++ +C E P +R + +I+ L
Sbjct: 243 ------KLPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 285
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 93.6 bits (231), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 85/296 (28%), Positives = 138/296 (46%), Gaps = 51/296 (17%)
Query: 711 NNLIGRGGFGSVYKARIQ-DG--MEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
++IG G FG V KARI+ DG M+ A+K + + + F E EV+ + H NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI---------------LDIFQRL 810
++ C + L+ LA+EY PHG+L +L S + L Q L
Sbjct: 90 NLLGACEHRGY--LY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
+ DVA ++YL IH DL N+L+G+N VA ++DFG+++ ++ +V +T
Sbjct: 146 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDW 929
+ +MA+E + +TN DV+++GV+L E + G P GMT
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYE-- 252
Query: 930 LLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
K+ G L + C V+++ +C E P +R + +I+ L
Sbjct: 253 ------KLPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 93.2 bits (230), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG G FG V+ + +VA+K ++ + + F E EVM + H ++++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-- 71
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ L E+M HG L YL + + L + +DV + YL VIH
Sbjct: 72 --LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIH 126
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+G+N V +SDFG+T+ + +DQ+ + T T + + + E S R S+
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 894 DVYNFGVMLMETFT-GKKP 911
DV++FGV++ E F+ GK P
Sbjct: 186 DVWSFGVLMWEVFSEGKIP 204
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 92.8 bits (229), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG G FG V+ + +VA+K + + + F E EVM + H ++++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC-- 71
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ L E+M HG L YL + + L + +DV + YL VIH
Sbjct: 72 --LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 126
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+G+N V +SDFG+T+ + +DQ+ + T T + + + E S R S+
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 894 DVYNFGVMLMETFT-GKKP 911
DV++FGV++ E F+ GK P
Sbjct: 186 DVWSFGVLMWEVFSEGKIP 204
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 714 IGRGGFGSVYKARI------QDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G FG V+ A QD M VAVK + A + F E E++ ++H++I++
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYS--------------SNYILDIFQRLNIM 813
C+ G + L + EYM HG L ++L S + L + Q L +
Sbjct: 86 FGVCTEG--RPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP 873
VA+ + YL +H DL N L+G +V + DFG+++ + D + +T
Sbjct: 142 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 874 ATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLI 932
I +M E + +T DV++FGV+L E FT GK+P W +
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQL 241
Query: 933 SIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
S + +D RE C V+ + C P++R + K++ RL
Sbjct: 242 SNTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 714 IGRGGFGSVYKARI------QDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G FG V+ A QD M VAVK + A + F E E++ ++H++I++
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYS--------------SNYILDIFQRLNIM 813
C+ G + L + EYM HG L ++L S + L + Q L +
Sbjct: 80 FGVCTEG--RPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP 873
VA+ + YL +H DL N L+G +V + DFG+++ + D + +T
Sbjct: 136 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 874 ATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLI 932
I +M E + +T DV++FGV+L E FT GK+P W +
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQL 235
Query: 933 SIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
S + +D RE C V+ + C P++R + K++ RL
Sbjct: 236 SNTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 714 IGRGGFGSVYKARI------QDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G FG V+ A QD M VAVK + A + F E E++ ++H++I++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYS--------------SNYILDIFQRLNIM 813
C+ G + L + EYM HG L ++L S + L + Q L +
Sbjct: 109 FGVCTEG--RPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP 873
VA+ + YL +H DL N L+G +V + DFG+++ + D + +T
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 874 ATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLI 932
I +M E + +T DV++FGV+L E FT GK+P W +
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQL 264
Query: 933 SIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
S + +D RE C V+ + C P++R + K++ RL
Sbjct: 265 SNTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG G FG V+ + +VA+K ++ + + F E EVM + H ++++ C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-- 69
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ L E+M HG L YL + + L + +DV + YL VIH
Sbjct: 70 --LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 124
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+G+N V +SDFG+T+ + +DQ+ + T T + + + E S R S+
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 894 DVYNFGVMLMETFT-GKKP 911
DV++FGV++ E F+ GK P
Sbjct: 184 DVWSFGVLMWEVFSEGKIP 202
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG G FG V+ + +VA+K ++ + + F E EVM + H ++++ C
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-- 74
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ L E+M HG L YL + + L + +DV + YL VIH
Sbjct: 75 --LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 129
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+G+N V +SDFG+T+ + +DQ+ + T T + + + E S R S+
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 894 DVYNFGVMLMETFT-GKKP 911
DV++FGV++ E F+ GK P
Sbjct: 189 DVWSFGVLMWEVFSEGKIP 207
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 91.7 bits (226), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG G FG V+ + +VA+K + + F E EVM + H ++++ C
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYGVC-- 91
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ L E+M HG L YL + + L + +DV + YL VIH
Sbjct: 92 --LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 146
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+G+N V +SDFG+T+ + +DQ+ + T T + + + E S R S+
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 894 DVYNFGVMLMETFT-GKKP 911
DV++FGV++ E F+ GK P
Sbjct: 206 DVWSFGVLMWEVFSEGKIP 224
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 91.7 bits (226), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/296 (28%), Positives = 138/296 (46%), Gaps = 51/296 (17%)
Query: 711 NNLIGRGGFGSVYKARIQ-DG--MEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
++IG G FG V KARI+ DG M+ A+K + + + F E EV+ + H NII
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI---------------LDIFQRL 810
++ C + L+ LA+EY PHG+L +L S + L Q L
Sbjct: 87 NLLGACEHRGY--LY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
+ DVA ++YL IH +L N+L+G+N VA ++DFG+++ ++ +V +T
Sbjct: 143 HFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 196
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDW 929
+ +MA+E + +TN DV+++GV+L E + G P GMT
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYE-- 249
Query: 930 LLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
K+ G L + C V+++ +C E P +R + +I+ L
Sbjct: 250 ------KLPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 292
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG G FG V+ + +VA+K ++ + + F E EVM + H ++++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-- 72
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ L E+M HG L YL + + L + +DV + YL VIH
Sbjct: 73 --LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 127
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+G+N V +SDFG+T+ + +DQ+ + T T + + + E S R S+
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 894 DVYNFGVMLMETFT-GKKP 911
DV++FGV++ E F+ GK P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 73/289 (25%), Positives = 136/289 (47%), Gaps = 37/289 (12%)
Query: 709 SENNLIGRGGFGSVYKARIQDG---MEVAVKVFNQQCGRAFKS---FDVECEVMKSIRHR 762
+ +IG G FG VYK ++ EV V + + G K F E +M H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ I +K + + EYM +G+L+K+L + + Q + ++ +A+ ++Y
Sbjct: 107 NIIRLEGV--ISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMA 880
L + +H DL N+L+ N+V +SDFG++++L +D T T + I + A
Sbjct: 163 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTA 218
Query: 881 LEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVD 939
E S + ++ DV++FG+++ E T G++P E+ N +MK ++
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------------EVMKAIN 264
Query: 940 GSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + C S ++ + M+C + +R +IV+ L K+
Sbjct: 265 ------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 88.6 bits (218), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 21/234 (8%)
Query: 693 WRRFSYLELCQATDGFSEN------NLIGRGGFGSVYKARIQDGMEVAVK----VFNQQC 742
+ FS+ EL T+ F E N G GGFG VYK + + VAVK + +
Sbjct: 3 FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 743 GRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYL--YSS 800
+ FD E +V +H N+++++ S GD L Y P+GSL L
Sbjct: 62 EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYV----YXPNGSLLDRLSCLDG 117
Query: 801 NYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL 860
L R I A+ + +L+ + IH D+K +N+LL + A +SDFG+ +
Sbjct: 118 TPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 174
Query: 861 TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
+ Q V ++ T Y A E G ++ D+Y+FGV+L+E TG +E
Sbjct: 175 EKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 227
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 87.8 bits (216), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 711 NNLIGRGGFGSVYKARIQDGMEVAVKVF----NQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+IG GGFG VY+A G EVAVK ++ + ++ E ++ ++H NII
Sbjct: 12 EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ C K L +E+ G L + L DI +N + +A + YL+
Sbjct: 71 LRGVC----LKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDE 124
Query: 827 YSTPVIHCDLKPSNVLL------GD--NMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
P+IH DLK SN+L+ GD N + ++DFG L RE T+ +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG----LAREWHRTTKMSAAGAYAW 180
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
MA E S DV+++GV+L E TG+ P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 86.7 bits (213), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 53 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 111
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 112 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 169 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 266
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 267 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 54 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 112
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 113 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 169
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 170 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 267
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 268 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 27 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 86 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 143 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 240
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 241 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 92 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 148
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 149 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 246
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 247 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 94 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 151 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 248
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 249 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 88
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 89 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 146 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 243
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 86.3 bits (212), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 90
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 91 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 147
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 148 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 245
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 93 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 150 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 247
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 248 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 94 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ + +T A + +MALE
Sbjct: 151 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 248
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 249 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA ++YL
Sbjct: 93 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT--IGYMALE 882
S +H DL N +L + ++DFG+ + + ++ +T A + +MALE
Sbjct: 150 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 247
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 248 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 71/287 (24%), Positives = 131/287 (45%), Gaps = 47/287 (16%)
Query: 708 FSENNLIGRGGFGSVYKARI--QDG--MEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
F+ ++G+G FGSV +A++ +DG ++VAVK+ + F E MK H
Sbjct: 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 762 RNIIKII--SCCSIGDFKALFKALALEYMPHGSLEKYLYSSN-----YILDIFQRLNIMI 814
++ K++ S S + + L +M HG L +L +S + L + + M+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 815 DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA 874
D+A +EYL S IH DL N +L ++M ++DFG+++ + D + +
Sbjct: 145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP-----TNEIFNEGMTLKHWVND 928
+ ++ALE ++ + + DV+ FGV + E T G+ P EI+N
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN----------- 250
Query: 929 WLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
++ G+ L + +CM V+++ +C P++R
Sbjct: 251 -------YLIGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQR 283
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 84.7 bits (208), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA +++L
Sbjct: 95 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK-LLTRE-DQFVTQTQTPATIGYMALE 882
S +H DL N +L + ++DFG+ + +L +E D +T + +MALE
Sbjct: 152 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 249
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 250 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 83.2 bits (204), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 73/318 (22%), Positives = 146/318 (45%), Gaps = 53/318 (16%)
Query: 687 MPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG- 743
+P+ +T + + AT+ S + ++G G FG V R++ E++V + + G
Sbjct: 15 VPRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 73
Query: 744 --RAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSN 801
+ + F E +M H NII++ + K+ + EYM +GSL+ +L +
Sbjct: 74 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHD 129
Query: 802 YILDIFQRLNIMIDVASALEYLY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL 860
+ Q + ++ +AS ++YL GY +H DL N+L+ N+V +SDFG++++L
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVL 185
Query: 861 ---------TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKK 910
TR + + +P I Y + ++ DV+++G++L E + G++
Sbjct: 186 EDDPEAAYTTRGGKIPIRWTSPEAIAYR--------KFTSASDVWSYGIVLWEVMSYGER 237
Query: 911 PTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVE 970
P E+ N+ ++K VD E + C + ++ + ++C +
Sbjct: 238 PYWEMSNQ--------------DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQK 277
Query: 971 SPEKRINAKEIVTRLLKI 988
R ++IV+ L K+
Sbjct: 278 DRNNRPKFEQIVSILDKL 295
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 83.2 bits (204), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 66/286 (23%), Positives = 136/286 (47%), Gaps = 36/286 (12%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+ ++G G FG V R++ E++V + + G + + F E +M H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY- 824
++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 110 RLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMALEY 883
GY +H DL N+L+ N+V +SDFG++++L + + T+ I + + E
Sbjct: 166 MGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ + ++ DV+++G++L E + G++P E+ N+ ++K VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVD--- 264
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 265 ---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 82.8 bits (203), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 67/289 (23%), Positives = 137/289 (47%), Gaps = 36/289 (12%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 107 NIIRLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 823 LY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMA 880
L GY +H DL N+L+ N+V +SDFG++++L + + T+ I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 881 LEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVD 939
E + + ++ DV+++G++L E + G++P E+ N+ ++K VD
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVD 264
Query: 940 GSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 265 ------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 82.8 bits (203), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 67/289 (23%), Positives = 137/289 (47%), Gaps = 36/289 (12%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 107 NIIRLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 823 LY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMA 880
L GY +H DL N+L+ N+V +SDFG++++L + + T+ I + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 881 LEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVD 939
E + + ++ DV+++G++L E + G++P E+ N+ ++K VD
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVD 264
Query: 940 GSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 265 ------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 82.8 bits (203), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ F++F E V++ RH NI+ +
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + A+ ++ SL K+L+ +FQ ++I A ++YL ++ +
Sbjct: 102 TKDNL-----AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNI 153
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH D+K +N+ L + + + DFG+ + +R Q ++ +MA E
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY++G++L E TG+ P + I N
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHINNR 243
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 82.8 bits (203), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 69/297 (23%), Positives = 136/297 (45%), Gaps = 52/297 (17%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 107 NIIRLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 823 LY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---------TREDQFVTQTQT 872
L GY +H DL N+L+ N+V +SDFG++++L TR + + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLL 931
P I Y + ++ DV+++G++L E + G++P E+ N+
Sbjct: 219 PEAIAYR--------KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------------- 257
Query: 932 ISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
++K VD E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 258 -DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 82.8 bits (203), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ ++ + EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 334 ---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVN 470
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 82.8 bits (203), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 67/289 (23%), Positives = 137/289 (47%), Gaps = 36/289 (12%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 45 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 105 NIIRLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 823 LY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMA 880
L GY +H DL N+L+ N+V +SDFG++++L + + T+ I + +
Sbjct: 161 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 881 LEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVD 939
E + + ++ DV+++G++L E + G++P E+ N+ ++K VD
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVD 262
Query: 940 GSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 263 ------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 82.8 bits (203), Expect = 1e-15, Method: Composition-based stats.
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVK-VFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G FG V + G +VAVK + N +AF + E VM +RH N+++++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLA---EASVMTQLRHSNLVQLLGVI- 68
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYS-SNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + L+ + EYM GSL YL S +L L +DV A+EYL
Sbjct: 69 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 123
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
+H DL NVL+ ++ VA +SDFG+TK + TQ + + A E E + ST
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 892 NGDVYNFGVMLMETFT-GKKPTNEI 915
DV++FG++L E ++ G+ P I
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRI 203
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 82.8 bits (203), Expect = 1e-15, Method: Composition-based stats.
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVK-VFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G FG V + G +VAVK + N +AF + E VM +RH N+++++
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLA---EASVMTQLRHSNLVQLLGVI- 83
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYS-SNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + L+ + EYM GSL YL S +L L +DV A+EYL
Sbjct: 84 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
+H DL NVL+ ++ VA +SDFG+TK + TQ + + A E E + ST
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 892 NGDVYNFGVMLMETFT-GKKPTNEI 915
DV++FG++L E ++ G+ P I
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRI 218
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 251 EPI-----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVN 387
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 36/287 (12%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 152
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA +++L
Sbjct: 153 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK-LLTRE-DQFVTQTQTPATIGYMALE 882
S +H DL N +L + ++DFG+ + + +E D +T + +MALE
Sbjct: 210 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGS 941
+ +T DV++FGV+L E T G P ++ +T+ +LL
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------YLL---------- 310
Query: 942 LLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 311 ----QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 40 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 98
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA +++L
Sbjct: 99 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 155
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK-LLTRE-DQFVTQTQTPATIGYMALE 882
S +H DL N +L + ++DFG+ + + +E D +T + +MALE
Sbjct: 156 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 253
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 254 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/286 (23%), Positives = 135/286 (47%), Gaps = 36/286 (12%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+ ++G G FG V R++ E++V + + G + + F E +M H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY- 824
++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 110 RLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMALEY 883
GY +H DL N+L+ N+V +SDFG+ ++L + + T+ I + + E
Sbjct: 166 MGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ + ++ DV+++G++L E + G++P E+ N+ ++K VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVD--- 264
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 265 ---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 251 EPI-----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVN 387
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA +++L
Sbjct: 94 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK-LLTRE-DQFVTQTQTPATIGYMALE 882
S +H DL N +L + ++DFG+ + + +E D +T + +MALE
Sbjct: 151 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 248
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 249 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA +++L
Sbjct: 95 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK-LLTRE-DQFVTQTQTPATIGYMALE 882
S +H DL N +L + ++DFG+ + + +E D +T + +MALE
Sbjct: 152 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 249
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 250 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/297 (23%), Positives = 136/297 (45%), Gaps = 52/297 (17%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 18 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 78 NIIRLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 823 LY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---------TREDQFVTQTQT 872
L GY +H DL N+L+ N+V +SDFG++++L TR + + +
Sbjct: 134 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLL 931
P I Y + ++ DV+++G++L E + G++P E+ N+
Sbjct: 190 PEAIAYR--------KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------------- 228
Query: 932 ISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
++K VD E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 229 -DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA +++L
Sbjct: 94 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK-LLTRE-DQFVTQTQTPATIGYMALE 882
S +H DL N +L + ++DFG+ + + +E D +T + +MALE
Sbjct: 151 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 248
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 249 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 34/286 (11%)
Query: 711 NNLIGRGGFGSVYKARIQDG----MEVAVKVFNQ--QCGRAFKSFDVECEVMKSIRHRNI 764
N +IGRG FG VY + D + AVK N+ G F E +MK H N+
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ ++ C + L + L YM HG L ++ + + + + + VA +++L
Sbjct: 92 LSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 148
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK-LLTRE-DQFVTQTQTPATIGYMALE 882
S +H DL N +L + ++DFG+ + + +E D +T + +MALE
Sbjct: 149 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ +T DV++FGV+L E T P N D ++
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------------------TFDITV 246
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+ + + E C ++ + ++C E R + E+V+R+ I
Sbjct: 247 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG+G FG V + G +VAVK ++F E VM +RH N+++++ +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI-V 256
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNY-ILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ L+ + EYM GSL YL S +L L +DV A+EYL +
Sbjct: 257 EEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL NVL+ ++ VA +SDFG+TK + TQ + + A E E + ST
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 893 GDVYNFGVMLMETFT-GKKPTNEI 915
DV++FG++L E ++ G+ P I
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRI 390
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 82.0 bits (201), Expect = 1e-15, Method: Composition-based stats.
Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VAVK+ ++ + F E + M + H ++K CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS- 73
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
K + EY+ +G L YL S L+ Q L + DV + +L S IH
Sbjct: 74 ---KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIH 127
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ ++ +SDFG+T+ + +DQ+V+ T + + A E + S+
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 894 DVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVA 952
DV+ FG+++ E F+ GK P + N + ++K+ G L R +
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEV-------------VLKVSQGHRLYRPHL---- 229
Query: 953 KEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLD 992
++ + C E PEKR +++++ + + + D
Sbjct: 230 ---ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 82.0 bits (201), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/294 (23%), Positives = 134/294 (45%), Gaps = 52/294 (17%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+ ++G G FG V R++ E++V + + G + + F E +M H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY- 824
++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 110 RLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---------TREDQFVTQTQTPAT 875
GY +H DL N+L+ N+V +SDFG+ ++L TR + + +P
Sbjct: 166 MGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISI 934
I Y + ++ DV+++G++L E + G++P E+ N+ +
Sbjct: 222 IAYR--------KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DV 259
Query: 935 MKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
+K VD E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 260 IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 82.0 bits (201), Expect = 2e-15, Method: Composition-based stats.
Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVK-VFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G FG V + G +VAVK + N +AF + E VM +RH N+++++
Sbjct: 20 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLA---EASVMTQLRHSNLVQLLGVI- 74
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYS-SNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + L+ + EYM GSL YL S +L L +DV A+EYL
Sbjct: 75 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 129
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
+H DL NVL+ ++ VA +SDFG+TK + TQ + + A E E ST
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 892 NGDVYNFGVMLMETFT-GKKPTNEI 915
DV++FG++L E ++ G+ P I
Sbjct: 185 KSDVWSFGILLWEIYSFGRVPYPRI 209
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 251 EPI-----YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVN 387
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + + ++F E +VMK +RH ++++ + S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 252 EPI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 363 SDVWSFGILLTELTTKGRVPYPGMVN 388
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 81.3 bits (199), Expect = 2e-15, Method: Composition-based stats.
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 40 LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + F + EYMP+G+L YL N + L + ++SA+EYL
Sbjct: 99 L---EPPF-YIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNF 151
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N V ++DFG+++L+T D + I + A E + S
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 211 KSDVWAFGVLLWEIATYGMSP 231
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/286 (22%), Positives = 136/286 (47%), Gaps = 36/286 (12%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+ ++G G FG V R++ E++V + + G + + F E +M H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY- 824
++ + K+ + EYM +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 110 RLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMALEY 883
G+ +H DL N+L+ N+V +SDFG++++L + + T+ I + + E
Sbjct: 166 MGF----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ + ++ DV+++G++L E + G++P E+ N+ ++K VD
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVD--- 264
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 265 ---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKIISCC 771
IGRG FG V+ R++ D VAVK + K+ F E ++K H NI+++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + ++ + +E + G +L + L + L ++ D A+ +EYL S
Sbjct: 182 T--QKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+ + V +SDFG+++ + + + A E + GR S+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 892 NGDVYNFGVMLMETFT-GKKPTNEIFNE 918
DV++FG++L ETF+ G P + N+
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQ 322
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 69/282 (24%), Positives = 128/282 (45%), Gaps = 28/282 (9%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VA+K+ ++ + F E +VM ++ H ++++ C+
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 74
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ +F + EYM +G L YL + Q L + DV A+EYL S +H
Sbjct: 75 -KQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ D V +SDFG+++ + +D++ + + + + E + S+
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 894 DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAK 953
D++ FGV++ E ++ K E F T +H I G L R + A
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL---AS 232
Query: 954 EQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
E+ V+ + C E ++R K +++ +L + D + G
Sbjct: 233 EK----VYTIMYSCWHEKADERPTFKILLSNILDVMDENLYG 270
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 58/293 (19%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIK 766
IG G FG V++AR + VAVK+ ++ ++ F E +M + NI+K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNY-----------------------I 803
++ C++G L EYM +G L ++L S +
Sbjct: 115 LLGVCAVGKPMCLL----FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 804 LDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE 863
L ++L I VA+ + YL +H DL N L+G+NMV ++DFG+++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 864 DQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTL 922
D + I +M E R +T DV+ +GV+L E F+ G +P + +E +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-- 285
Query: 923 KHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
I + DG++L+ E C ++N+ C + P R
Sbjct: 286 -----------IYYVRDGNILA-------CPENCPLELYNLMRLCWSKLPADR 320
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 28/277 (10%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VA+K+ ++ + F E +VM ++ H ++++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 89
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ +F + EYM +G L YL + Q L + DV A+EYL S +H
Sbjct: 90 -KQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ D V +SDFG+++ + +D++ + + + + E + S+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 894 DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAK 953
D++ FGV++ E ++ K E F T +H I G L R + A
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL---AS 247
Query: 954 EQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
E+ V+ + C E ++R K +++ +L + D
Sbjct: 248 EK----VYTIMYSCWHEKADERPTFKILLSNILDVMD 280
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 80.9 bits (198), Expect = 3e-15, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ +EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 80.9 bits (198), Expect = 4e-15, Method: Composition-based stats.
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK IRH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 80.5 bits (197), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKIISCC 771
IGRG FG V+ R++ D VAVK + K+ F E ++K H NI+++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + ++ + +E + G +L + L + L ++ D A+ +EYL S
Sbjct: 182 T--QKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+ + V +SDFG+++ + + + A E + GR S+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 892 NGDVYNFGVMLMETFT-GKKPTNEIFNE 918
DV++FG++L ETF+ G P + N+
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQ 322
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 80.5 bits (197), Expect = 5e-15, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 78 EPI-----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 189 SDVWSFGILLTELTTKGRVPYPGMVN 214
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 80.1 bits (196), Expect = 5e-15, Method: Composition-based stats.
Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 28/277 (10%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VA+K+ ++ + F E +VM ++ H ++++ C+
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 80
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ +F + EYM +G L YL + Q L + DV A+EYL S +H
Sbjct: 81 -KQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 134
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ D V +SDFG+++ + +D++ + + + + E + S+
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 894 DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAK 953
D++ FGV++ E ++ K E F T +H I G L R + A
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL---AS 238
Query: 954 EQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
E+ V+ + C E ++R K +++ +L + D
Sbjct: 239 EK----VYTIMYSCWHEKADERPTFKILLSNILDVMD 271
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 80.1 bits (196), Expect = 5e-15, Method: Composition-based stats.
Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 28/277 (10%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VA+K+ ++ + F E +VM ++ H ++++ C+
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 73
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ +F + EYM +G L YL + Q L + DV A+EYL S +H
Sbjct: 74 -KQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 127
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ D V +SDFG+++ + +D++ + + + + E + S+
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 894 DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAK 953
D++ FGV++ E ++ K E F T +H I G L R + A
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL---AS 231
Query: 954 EQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
E+ V+ + C E ++R K +++ +L + D
Sbjct: 232 EK----VYTIMYSCWHEKADERPTFKILLSNILDVMD 264
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 80.1 bits (196), Expect = 5e-15, Method: Composition-based stats.
Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 28/277 (10%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VA+K+ ++ + F E +VM ++ H ++++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 69
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ +F + EYM +G L YL + Q L + DV A+EYL S +H
Sbjct: 70 -KQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 123
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ D V +SDFG+++ + +D++ + + + + E + S+
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 894 DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAK 953
D++ FGV++ E ++ K E F T +H I G L R + A
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL---AS 227
Query: 954 EQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
E+ V+ + C E ++R K +++ +L + D
Sbjct: 228 EK----VYTIMYSCWHEKADERPTFKILLSNILDVMD 260
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 79.7 bits (195), Expect = 7e-15, Method: Composition-based stats.
Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 28/277 (10%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VA+K+ ++ + F E +VM ++ H ++++ C+
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 74
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ +F + EYM +G L YL + Q L + DV A+EYL S +H
Sbjct: 75 -KQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ D V +SDFG+++ + +D++ + + + + E + S+
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 894 DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAK 953
D++ FGV++ E ++ K E F T +H I G L R + A
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL---AS 232
Query: 954 EQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
E+ V+ + C E ++R K +++ +L + D
Sbjct: 233 EK----VYTIMYSCWHEKADERPTFKILLSNILDVMD 265
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 79.7 bits (195), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 135/297 (45%), Gaps = 52/297 (17%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + E M +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 107 NIIRLEGVVT----KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 823 LY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---------TREDQFVTQTQT 872
L GY +H DL N+L+ N+V +SDFG++++L TR + + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLL 931
P I Y + ++ DV+++G++L E + G++P E+ N+
Sbjct: 219 PEAIAYR--------KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------------- 257
Query: 932 ISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
++K VD E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 258 -DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 74 EPI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 185 SDVWSFGILLTELTTKGRVPYPGMVN 210
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 76 EPI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 187 SDVWSFGILLTELTTKGRVPYPGMVN 212
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 82 EPI-----YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 193 SDVWSFGILLTELTTKGRVPYPGMVN 218
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 75 EPI-----XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA-TIGYMALEYGSEGRVST 891
H DL+ +N+L+G+N+V ++DFG+ +L+ ED T Q I + A E GR +
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 892 NGDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 185 KSDVWSFGILLTELTTKGRVPYPGMVN 211
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 79.3 bits (194), Expect = 9e-15, Method: Composition-based stats.
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ +EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA-TIGYMALEYGSEGRVST 891
H DL+ +N+L+G+N+V ++DFG+ +L+ ED T Q I + A E GR +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 892 NGDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 79.3 bits (194), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 68/297 (22%), Positives = 135/297 (45%), Gaps = 52/297 (17%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 18 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + E M +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 78 NIIRLEGVVT----KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 823 LY-FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---------TREDQFVTQTQT 872
L GY +H DL N+L+ N+V +SDFG++++L TR + + +
Sbjct: 134 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLL 931
P I Y + ++ DV+++G++L E + G++P E+ N+
Sbjct: 190 PEAIAYR--------KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------------- 228
Query: 932 ISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
++K VD E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 229 -DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 79.0 bits (193), Expect = 1e-14, Method: Composition-based stats.
Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ +EYM G L +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 712 NLIGRGGFGSVYKARI--QDG--MEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHRNII 765
++G G FGSV + + +DG ++VAVK + R + F E MK H N+I
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 766 KIISCCSIGDFKALFKALA-LEYMPHGSLEKYLYSSNYI-----LDIFQRLNIMIDVASA 819
+++ C + + K + L +M +G L YL S + + L M+D+A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
+EYL + +H DL N +L D+M ++DFG++K + D + + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGM 920
A+E ++ ++ DV+ FGV + E T G P + N M
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 79.0 bits (193), Expect = 1e-14, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 774 GDFKALFKALALEYMPHGSLEKYLY-SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L + L + Q +++ +AS + Y+ +
Sbjct: 82 EPI-----YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 193 SDVWSFGILLTELTTKGRVPYPGMVN 218
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL+ + +
Sbjct: 74 TAPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ + +R Q +I +MA E +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 68/277 (24%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V + + +VA+K+ ++ + F E +VM ++ H ++++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT- 89
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIH 833
+ +F + EYM +G L YL + Q L + DV A+EYL S +H
Sbjct: 90 -KQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 834 CDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG 893
DL N L+ D V +SDFG+++ + +D+ + + + + E + S+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 894 DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAK 953
D++ FGV++ E ++ K E F T +H I G L R + A
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL---AS 247
Query: 954 EQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
E+ V+ + C E ++R K +++ +L + D
Sbjct: 248 EK----VYTIMYSCWHEKADERPTFKILLSNILDVMD 280
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + +E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 85 ----REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 133
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/288 (22%), Positives = 134/288 (46%), Gaps = 34/288 (11%)
Query: 708 FSENNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHR 762
S + ++G G FG V R++ E++V + + G + + F E +M H
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII++ + K+ + E M +GSL+ +L + + Q + ++ +AS ++Y
Sbjct: 107 NIIRLEGVVT----KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMAL 881
L +H DL N+L+ N+V +SDFG++++L + + T+ I + +
Sbjct: 163 LS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDG 940
E + + ++ DV+++G++L E + G++P E+ N+ ++K VD
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------DVIKAVD- 264
Query: 941 SLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + C + ++ + ++C + R ++IV+ L K+
Sbjct: 265 -----EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 78.2 bits (191), Expect = 2e-14, Method: Composition-based stats.
Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 688 PQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKA-RIQDG----MEVAVKVFNQQC 742
P +A R EL + ++G G FG+VYK + +G + VA+K+ N+
Sbjct: 27 PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 79
Query: 743 G-RAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSN 801
G +A F E +M S+ H ++++++ C + L + MPHG L +Y++
Sbjct: 80 GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-----LVTQLMPHGCLLEYVHEHK 134
Query: 802 YILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLT 861
+ LN + +A + YL ++H DL NVL+ ++DFG+ +LL
Sbjct: 135 DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 191
Query: 862 REDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLME--TFTGKK----PTNEI 915
+++ I +MALE + + DV+++GV + E TF GK PT EI
Sbjct: 192 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 78.2 bits (191), Expect = 2e-14, Method: Composition-based stats.
Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 688 PQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKA-RIQDG----MEVAVKVFNQQC 742
P +A R EL + ++G G FG+VYK + +G + VA+K+ N+
Sbjct: 4 PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 743 G-RAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSN 801
G +A F E +M S+ H ++++++ C + L + MPHG L +Y++
Sbjct: 57 GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-----LVTQLMPHGCLLEYVHEHK 111
Query: 802 YILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLT 861
+ LN + +A + YL ++H DL NVL+ ++DFG+ +LL
Sbjct: 112 DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 168
Query: 862 REDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLME--TFTGKK----PTNEI 915
+++ I +MALE + + DV+++GV + E TF GK PT EI
Sbjct: 169 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 20 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L++S ++ + ++I A ++YL ++ +
Sbjct: 78 TKPQL-----AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSI 129
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L ++ + DFG+ + +R Q +I +MA E
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLK 923
S DVY FG++L E TG+ P + I N ++
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 224
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL+ + +
Sbjct: 74 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ + +R Q +I +MA E +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL+ + +
Sbjct: 79 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ + +R Q +I +MA E +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 220
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL+ + +
Sbjct: 79 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ + +R Q +I +MA E +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 220
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N + L + ++SA+EYL
Sbjct: 78 ----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D F I + A E + + S
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 190 KSDVWAFGVLLWEIATYGMSP 210
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 18 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL+ + +
Sbjct: 76 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 127
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ + +R Q +I +MA E +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 217
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + +E+M +G+L YL N + L + ++SA+EYL
Sbjct: 80 ----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + +E+M +G+L YL N + L + ++SA+EYL
Sbjct: 80 ----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G+G FG V+ VA+K + ++F E +VMK +RH ++++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSS-NYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM G L +L L + Q +++ +AS + Y+ +
Sbjct: 85 EPI-----YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+G+N+V ++DFG+ +L+ ++++ + I + A E GR +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 893 GDVYNFGVMLME-TFTGKKPTNEIFN 917
DV++FG++L E T G+ P + N
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVN 221
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 43 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL+ + +
Sbjct: 101 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 152
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ + +R Q +I +MA E +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 242
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL+ + +
Sbjct: 102 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 153
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ + +R Q +I +MA E +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 243
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 85 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 133
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 93 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 141
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 142 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 199
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMSP 225
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 85 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 133
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 80 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 128
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 84 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 190
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP 216
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 80 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 128
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 82 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 130
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 188
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSP 214
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 82 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 130
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 188
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSP 214
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N ++ L + ++SA+EYL
Sbjct: 326 ----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 378
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH +L N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 892 NGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFV 951
DV+ FGV+L EI GM+ + I + ++ + L +D +
Sbjct: 438 KSDVWAFGVLLW----------EIATYGMS------PYPGIDLSQVYE---LLEKDYRME 478
Query: 952 AKEQCMSFVFNMAMECTVESPEKRINAKEI 981
E C V+ + C +P R + EI
Sbjct: 479 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 508
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVF-------NQQCGRAFKSFDVECEVMKSIRHRNII 765
IG+GGFG V+K R ++D VA+K + F+ F E +M ++ H NI+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
K+ + +E++P G L L + + +L +M+D+A +EY+
Sbjct: 87 KLYGLMHNP------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ- 139
Query: 826 GYSTPVIHCDLKPSNVLLGD-----NMVAHLSDFGITKLLTREDQFVT---QTQTPATIG 877
+ P++H DL+ N+ L + A ++DFG+++ + Q P TIG
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
E + D Y+F ++L TG+ P +E S KI
Sbjct: 200 ------AEEESYTEKADTYSFAMILYTILTGEGPFDE-----------------YSYGKI 236
Query: 938 VDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++ E ++ E C + N+ C P+KR + IV L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 283
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N ++ L + ++SA+EYL
Sbjct: 284 ----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 336
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH +L N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 337 IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 395
Query: 892 NGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFV 951
DV+ FGV+L EI GM+ + I + ++ + L +D +
Sbjct: 396 KSDVWAFGVLLW----------EIATYGMS------PYPGIDLSQVYE---LLEKDYRME 436
Query: 952 AKEQCMSFVFNMAMECTVESPEKRINAKEI 981
E C V+ + C +P R + EI
Sbjct: 437 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 466
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L++S ++ + ++I A ++YL ++ +
Sbjct: 90 TAPQL-----AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSI 141
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L ++ + DFG+ +R Q +I +MA E
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 76.6 bits (187), Expect = 6e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + +E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 81 ----REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 129
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D I + A E +
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 187
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSP 213
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQ-----DGMEVAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIKI 767
+G G FG V R G +VAVK + G E E+++++ H NI+K
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
C+ + L +E++P GSL++YL + +++ Q+L + + ++YL
Sbjct: 77 KGICTEDGGNGI--KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---G 131
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEYGSE 886
S +H DL NVL+ + DFG+TK + T ++ + + + + A E +
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 887 GRVSTNGDVYNFGVMLMETFT 907
+ DV++FGV L E T
Sbjct: 192 SKFYIASDVWSFGVTLHELLT 212
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 76.6 bits (187), Expect = 6e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 81 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 129
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAY 187
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSP 213
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 76.6 bits (187), Expect = 6e-14, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 82 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 130
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D + I + A E +
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAY 188
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSP 214
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 76.6 bits (187), Expect = 7e-14, Method: Composition-based stats.
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N + L + ++SA+EYL
Sbjct: 80 ----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 76.6 bits (187), Expect = 7e-14, Method: Composition-based stats.
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N + L + ++SA+EYL
Sbjct: 80 ----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 76.6 bits (187), Expect = 7e-14, Method: Composition-based stats.
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N + L + ++SA+EYL
Sbjct: 85 ----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 137
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 197 KSDVWAFGVLLWEIATYGMSP 217
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L++S ++ + ++I A ++YL ++ +
Sbjct: 90 TKPQL-----AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSI 141
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L ++ + DFG+ +R Q +I +MA E
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL ++ +
Sbjct: 74 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSI 125
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ +R Q +I +MA E +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 76.3 bits (186), Expect = 8e-14, Method: Composition-based stats.
Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 699 LELCQATDGFSENNL-----IGRGGFGSVYKARI-----QDGMEVAVKVFNQQCGRAFKS 748
L CQ F E +L +G+G FGSV R G VAVK +
Sbjct: 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 749 FDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
F E +++K++ H + I S G + + L +EY+P G L +L LD +
Sbjct: 71 FQREIQILKAL-HSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRARLDASR 128
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFV 867
L + +EYL S +H DL N+L+ ++DFG+ KLL + D +V
Sbjct: 129 LLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ + I + A E S+ S DV++FGV+L E FT
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 66/264 (25%), Positives = 122/264 (46%), Gaps = 32/264 (12%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ A +VAVK + + ++F E VMK+++H ++K+ + +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ E+M GSL +L S Q L +ID ++ + E + F I
Sbjct: 255 EPI-----YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ ++V ++DFG+ +++ ++++ + I + A E + G +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 893 GDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFV 951
DV++FG++LME T G+ P + N + I + G + R
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEV-------------IRALERGYRMPR------ 406
Query: 952 AKEQCMSFVFNMAMECTVESPEKR 975
E C ++N+ M C PE+R
Sbjct: 407 -PENCPEELYNIMMRCWKNRPEER 429
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQ-----DGMEVAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIKI 767
+G G FG V R G +VAVK + G E E+++++ H NI+K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
C+ + L +E++P GSL++YL + +++ Q+L + + ++YL
Sbjct: 89 KGICTEDGGNGI--KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---G 143
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEYGSE 886
S +H DL NVL+ + DFG+TK + T ++ + + + + A E +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 887 GRVSTNGDVYNFGVMLMETFT 907
+ DV++FGV L E T
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 76.3 bits (186), Expect = 8e-14, Method: Composition-based stats.
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 16/217 (7%)
Query: 702 CQATDGFSENNL-----IGRGGFGSVYKARI-----QDGMEVAVKVFNQQCGRAFKSFDV 751
CQ F E +L +G+G FGSV R G VAVK + F
Sbjct: 1 CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 752 ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
E +++K++ H + I S G + + L +EY+P G L +L LD + L
Sbjct: 61 EIQILKAL-HSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRARLDASRLLL 118
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQT 870
+ +EYL S +H DL N+L+ ++DFG+ KLL + D +V +
Sbjct: 119 YSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 175
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ I + A E S+ S DV++FGV+L E FT
Sbjct: 176 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 76.3 bits (186), Expect = 9e-14, Method: Composition-based stats.
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 713 LIGRGGFGSVYKARI----QDGMEVAVKVFNQ-QCGRAFKSFDVECEVMKSIRHRNIIKI 767
+IG G G V R+ Q + VA+K R + F E +M H NII++
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY-FG 826
+ G + EYM +GSL+ +L + + I Q + ++ V + + YL G
Sbjct: 116 EGVVTRGRLAMI----VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEYGS 885
Y +H DL NVL+ N+V +SDFG++++L + D T T I + A E +
Sbjct: 172 Y----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 886 EGRVSTNGDVYNFGVMLMETFT-GKKP 911
S+ DV++FGV++ E G++P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 76.3 bits (186), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 36 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL ++ +
Sbjct: 94 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSI 145
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ +R Q +I +MA E +
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 235
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 76.3 bits (186), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N + L + ++SA+EYL
Sbjct: 287 ----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH +L N L+G+N + ++DFG+++L+T D + I + A E + + S
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 892 NGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFV 951
DV+ FGV+L EI GM+ + I + ++ + L +D +
Sbjct: 399 KSDVWAFGVLLW----------EIATYGMS------PYPGIDLSQVYE---LLEKDYRME 439
Query: 952 AKEQCMSFVFNMAMECTVESPEKRINAKEI 981
E C V+ + C +P R + EI
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 75.9 bits (185), Expect = 1e-13, Method: Composition-based stats.
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 713 LIGRGGFGSVYKARI----QDGMEVAVKVFNQ-QCGRAFKSFDVECEVMKSIRHRNIIKI 767
+IG G G V R+ Q + VA+K R + F E +M H NII++
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY-FG 826
+ G + EYM +GSL+ +L + + I Q + ++ V + + YL G
Sbjct: 116 EGVVTRGRLAMI----VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEYGS 885
Y +H DL NVL+ N+V +SDFG++++L + D T T I + A E +
Sbjct: 172 Y----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 886 EGRVSTNGDVYNFGVMLMETFT-GKKP 911
S+ DV++FGV++ E G++P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 75.9 bits (185), Expect = 1e-13, Method: Composition-based stats.
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G FG VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 19 LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + E+M +G+L YL N + L + ++SA+EYL
Sbjct: 78 ----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D I + A E + + S
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 190 KSDVWAFGVLLWEIATYGMSP 210
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG+VYK + +VAVK+ N + ++F E V++ RH NI+ +
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ A+ ++ SL +L+ ++ + ++I A ++YL ++ +
Sbjct: 102 TKPQL-----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSI 153
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE---YGSEGR 888
IH DLK +N+ L +++ + DFG+ +R Q +I +MA E +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
S DVY FG++L E TG+ P + I N
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 243
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 46/288 (15%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVF-------NQQCGRAFKSFDVECEVMKSIRHRNII 765
IG+GGFG V+K R ++D VA+K + F+ F E +M ++ H NI+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
K+ + +E++P G L L + + +L +M+D+A +EY+
Sbjct: 87 KLYGLMHNP------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ- 139
Query: 826 GYSTPVIHCDLKPSNVLLGD-----NMVAHLSDFGITKLLTREDQFVT---QTQTPATIG 877
+ P++H DL+ N+ L + A ++DFG ++ + Q P TIG
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
E + D Y+F ++L TG+ P +E S KI
Sbjct: 200 ------AEEESYTEKADTYSFAMILYTILTGEGPFDE-----------------YSYGKI 236
Query: 938 VDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++ E ++ E C + N+ C P+KR + IV L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 75.9 bits (185), Expect = 1e-13, Method: Composition-based stats.
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEYLYFGYSTPV 831
+ + +E+M +G+L YL N + L + ++SA+EYL
Sbjct: 78 ----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVST 891
IH DL N L+G+N + ++DFG+++L+T D I + A E + + S
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV+ FGV+L E T G P
Sbjct: 190 KSDVWAFGVLLWEIATYGMSP 210
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 712 NLIGRGGFGSVYKA-RIQDG----MEVAVKVFNQQCGR-AFKSFDVECEVMKSIRHRNII 765
++G G FG+V+K I +G + V +KV + GR +F++ + S+ H +I+
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+++ C + L +Y+P GSL ++ L LN + +A + YL
Sbjct: 97 RLLGLCPGSSLQ-----LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE- 150
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
++H +L NVLL ++DFG+ LL +D+ + ++ I +MALE
Sbjct: 151 --EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 886 EGRVSTNGDVYNFGVMLMETFT-GKKP 911
G+ + DV+++GV + E T G +P
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMTFGAEP 235
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 75.5 bits (184), Expect = 1e-13, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G +G VY+ + + VAVK + + F E VMK I+H N+++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEYLYFG 826
+ + E+M +G+L YL N Q +N ++ ++SA+EYL
Sbjct: 85 ----REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE-- 133
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
IH DL N L+G+N + ++DFG+++L+T D I + A E +
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 191
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
+ S DV+ FGV+L E T G P
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSP 217
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 75.1 bits (183), Expect = 2e-13, Method: Composition-based stats.
Identities = 66/264 (25%), Positives = 122/264 (46%), Gaps = 32/264 (12%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ A +VAVK + + ++F E VMK+++H ++K+ + +
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ E+M GSL +L S Q L +ID ++ + E + F I
Sbjct: 82 EPI-----YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYI 133
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ ++V ++DFG+ +++ ++++ + I + A E + G +
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 893 GDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFV 951
DV++FG++LME T G+ P + N + I + G + R
Sbjct: 193 SDVWSFGILLMEIVTYGRIPYPGMSNPEV-------------IRALERGYRMPR------ 233
Query: 952 AKEQCMSFVFNMAMECTVESPEKR 975
E C ++N+ M C PE+R
Sbjct: 234 -PENCPEELYNIMMRCWKNRPEER 256
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/286 (22%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+IG G FG V R++ E+ V + + G + + F E +M H NII
Sbjct: 27 ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY- 824
+ + K+ + EYM +GSL+ +L ++ + Q + ++ +++ ++YL
Sbjct: 87 HLEGVVT----KSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSD 142
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMALEY 883
GY +H DL N+L+ N+V +SDFG++++L + + T+ I + A E
Sbjct: 143 MGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
+ + ++ DV+++G+++ E + G++P E+ N+ ++K V+
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQ--------------DVIKAVE--- 241
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
E + + C + ++ + ++C + R EIV L K+
Sbjct: 242 ---EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 74.7 bits (182), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 46/288 (15%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVF-------NQQCGRAFKSFDVECEVMKSIRHRNII 765
IG+GGFG V+K R ++D VA+K + F+ F E +M ++ H NI+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
K+ + +E++P G L L + + +L +M+D+A +EY+
Sbjct: 87 KLYGLMHNP------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ- 139
Query: 826 GYSTPVIHCDLKPSNVLLGD-----NMVAHLSDFGITKLLTREDQFVT---QTQTPATIG 877
+ P++H DL+ N+ L + A ++DF +++ + Q P TIG
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
E + D Y+F ++L TG+ P +E S KI
Sbjct: 200 ------AEEESYTEKADTYSFAMILYTILTGEGPFDE-----------------YSYGKI 236
Query: 938 VDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++ E ++ E C + N+ C P+KR + IV L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCG-RAFKSFDVECEVMKSIR 760
Q + +G GGFG V + QD G +VA+K Q+ + + + +E ++MK +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 761 HRNIIKIISCCSIGD-FKAL----FKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIM 813
H N++ S + D + L LA+EY G L KYL + + L ++
Sbjct: 71 HPNVV---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFVTQT 870
D++SAL YL+ +IH DLKP N++L ++ + D G K L DQ T
Sbjct: 128 SDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCT 181
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ T+ Y+A E + + + D ++FG + E TG +P
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIKIISCC 771
+G GGFG V + QD G +VA+K Q+ + + + +E ++MK + H N++ S
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV---SAR 79
Query: 772 SIGD-FKAL----FKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEYLY 824
+ D + L LA+EY G L KYL + + L ++ D++SAL YL+
Sbjct: 80 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 825 FGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
+IH DLKP N++L ++ + D G K L DQ T+ T+ Y+A
Sbjct: 140 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAP 193
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + + + D ++FG + E TG +P
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 223
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 37/289 (12%)
Query: 711 NNLIGRGGFGSVYKARIQ----DGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNII 765
N ++G G FG VY+ + + VAVK + C K F E +MK++ H +I+
Sbjct: 29 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
K+I G + + +E P+G L YL + L + + + + A+ YL
Sbjct: 89 KLI-----GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 142
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF-VTQTQTPATIGYMALEYG 884
S +H D+ N+L+ L DFG+++ + ED + + T+ P I +M+ E
Sbjct: 143 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESI 198
Query: 885 SEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLL 943
+ R +T DV+ F V + E + GK+P W+ + +I +++ G L
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLE--KGDRL 245
Query: 944 SREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLD 992
+ D+ C ++ + C P R E+V L + ++
Sbjct: 246 PKPDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 287
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 73.6 bits (179), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 37/289 (12%)
Query: 711 NNLIGRGGFGSVYKARIQ----DGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNII 765
N ++G G FG VY+ + + VAVK + C K F E +MK++ H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
K+I G + + +E P+G L YL + L + + + + A+ YL
Sbjct: 77 KLI-----GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF-VTQTQTPATIGYMALEYG 884
S +H D+ N+L+ L DFG+++ + ED + + T+ P I +M+ E
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESI 186
Query: 885 SEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLL 943
+ R +T DV+ F V + E + GK+P W+ + +I +++ G L
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLE--KGDRL 233
Query: 944 SREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLD 992
+ D+ C ++ + C P R E+V L + ++
Sbjct: 234 PKPDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 73.6 bits (179), Expect = 5e-13, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 713 LIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
++GRG FG V KA+ + +VA+K + R K+F VE + + H NI+K+ C
Sbjct: 16 VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC- 71
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI--LDIFQRLNIMIDVASALEYLYFGYSTP 830
+ L +EY GSL L+ + + ++ + + + YL+
Sbjct: 72 ---LNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 831 VIHCDLKPSNVLL-GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
+IH DLKP N+LL V + DFG T D T + +MA E
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEGSNY 181
Query: 890 STNGDVYNFGVMLMETFTGKKPTNEI 915
S DV+++G++L E T +KP +EI
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEI 207
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 73.6 bits (179), Expect = 5e-13, Method: Composition-based stats.
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 713 LIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
++GRG FG V KA+ + +VA+K + R K+F VE + + H NI+K+ C
Sbjct: 15 VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYI--LDIFQRLNIMIDVASALEYLYFGYSTP 830
+ L +EY GSL L+ + + ++ + + + YL+
Sbjct: 71 ---LNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 831 VIHCDLKPSNVLL-GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
+IH DLKP N+LL V + DFG T D T + +MA E
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 890 STNGDVYNFGVMLMETFTGKKPTNEI 915
S DV+++G++L E T +KP +EI
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEI 206
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 73.6 bits (179), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 37/289 (12%)
Query: 711 NNLIGRGGFGSVYKARIQ----DGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNII 765
N ++G G FG VY+ + + VAVK + C K F E +MK++ H +I+
Sbjct: 13 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
K+I G + + +E P+G L YL + L + + + + A+ YL
Sbjct: 73 KLI-----GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 126
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF-VTQTQTPATIGYMALEYG 884
S +H D+ N+L+ L DFG+++ + ED + + T+ P I +M+ E
Sbjct: 127 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESI 182
Query: 885 SEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLL 943
+ R +T DV+ F V + E + GK+P W+ + +I +++ G L
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLE--KGDRL 229
Query: 944 SREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLD 992
+ D+ C ++ + C P R E+V L + ++
Sbjct: 230 PKPDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 271
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 73.6 bits (179), Expect = 5e-13, Method: Composition-based stats.
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDGMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R G VAVK + F E +++K
Sbjct: 8 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
++ H + I S G + + L +EY+P G L +L LD + L +
Sbjct: 68 AL-HSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATI 876
+EYL S +H DL N+L+ ++DFG+ KLL + D +V + + I
Sbjct: 126 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 182
Query: 877 GYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ A E S+ S DV++FGV+L E FT
Sbjct: 183 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 73.6 bits (179), Expect = 5e-13, Method: Composition-based stats.
Identities = 75/304 (24%), Positives = 130/304 (42%), Gaps = 63/304 (20%)
Query: 708 FSENNLI-----GRGGFGSVYKA-----RIQDG-MEVAVKVFNQQCGRA-FKSFDVECEV 755
F NL+ G G FG V KA + + G VAVK+ + + + E V
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 756 MKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI------------ 803
+K + H ++IK+ CS D L L +EY +GSL +L S +
Sbjct: 80 LKQVNHPHVIKLYGACS-QDGPLL---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 804 -----------LDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS 852
L + ++ ++ ++YL ++H DL N+L+ + +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 853 DFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
DFG+++ + ED +V ++Q + +MA+E + +T DV++FGV+L E T G P
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 912 TNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVES 971
I E L +++K G + R D C ++ + ++C +
Sbjct: 253 YPGIPPE-----------RLFNLLKT--GHRMERPD-------NCSEEMYRLMLQCWKQE 292
Query: 972 PEKR 975
P+KR
Sbjct: 293 PDKR 296
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 73.2 bits (178), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ + H+NI++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 113 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 169 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 271
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 272 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ + H+NI++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 99 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 257
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 258 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 72.8 bits (177), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 90 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 146 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 202
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 248
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 249 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 86 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ ++++ + I + A E + G +
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 90 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 141
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ ++++ + I + A E + G +
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 201 SDVWSFGILLTEIVTHGRIP 220
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 80 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ ++++ + I + A E + G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 75 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 126
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ ++++ + I + A E + G +
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 186 SDVWSFGILLTEIVTHGRIP 205
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 85 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 136
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ ++++ + I + A E + G +
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 196 SDVWSFGILLTEIVTHGRIP 215
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VA+K + +SF E ++MK ++H ++++ + S
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSN-YILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ EYM GSL +L L + +++ VA+ + Y+ I
Sbjct: 76 EPI-----YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 127
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA-TIGYMALEYGSEGRVST 891
H DL+ +N+L+G+ ++ ++DFG+ +L+ ED T Q I + A E GR +
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 186 KSDVWSFGILLTELVTKGRVP 206
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 98 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 256
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 257 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 713 LIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCGR-AFKSFDVECEVMKSIRHRNIIK 766
++G G FG+V+K I +G + V +KV + GR +F++ + S+ H +I++
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
++ C + L +Y+P GSL ++ L LN + +A + YL
Sbjct: 80 LLGLCPGSSLQ-----LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
++H +L NVLL ++DFG+ LL +D+ + ++ I +MALE
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 887 GRVSTNGDVYNFGVMLMETFT-GKKP 911
G+ + DV+++GV + E T G +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 714 IGRGGFGSVY-----KARIQDGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKI 767
+G G FG V G VAVK CG +S + E ++++++ H +IIK
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
CC K+L L +EY+P GSL YL + + + Q L + + YL+
Sbjct: 82 KGCCEDQGEKSL--QLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH--- 134
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMALEYGSE 886
S IH +L NVLL ++ + + DFG+ K + + + + + + + A E E
Sbjct: 135 SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 887 GRVSTNGDVYNFGVMLMETFT 907
+ DV++FGV L E T
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 99 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 257
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 258 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 105 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 161 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 217
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 263
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 264 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 93 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 252
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 253 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 24 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 84 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 140 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 243
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 244 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 20 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 80 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 136 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 239
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 240 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 23 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 83 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 139 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 242
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 243 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 26 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 86 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 142 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 245
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 246 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 26 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 86 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 142 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 245
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 246 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 93 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 252
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 253 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 27 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 87 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + + +
Sbjct: 143 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 246
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 247 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 66/264 (25%), Positives = 117/264 (44%), Gaps = 42/264 (15%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ A +VAVK + + ++F E VMK+++H ++K+ + +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ E+M GSL +L S Q L +ID ++ + E + F I
Sbjct: 249 EPI-----YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYI 300
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ ++V ++DFG+ ++ + F + P I + G +
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAK---FPIKWTAPEAINF--------GSFTIK 349
Query: 893 GDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFV 951
DV++FG++LME T G+ P + N + I + G + R
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEV-------------IRALERGYRMPR------ 390
Query: 952 AKEQCMSFVFNMAMECTVESPEKR 975
E C ++N+ M C PE+R
Sbjct: 391 -PENCPEELYNIMMRCWKNRPEER 413
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G G+VY A + G EVA++ N Q + E VM+ ++ NI+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +EY+ GSL + + +D Q + + ALE+L+ S VI
Sbjct: 88 VGD--ELW--VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H D+K N+LLG + L+DFG +T E +++ T +MA E +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 893 GDVYNFGVMLMETFTGKKP 911
D+++ G+M +E G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 99 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 257
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 258 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 115 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 171 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 227
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 273
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 274 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 72.0 bits (175), Expect = 2e-12, Method: Composition-based stats.
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDGMEVAVKVFNQQCGRAFKSFDVECEVMK 757
F E +L +G+G FGSV R G VAVK + F E +++K
Sbjct: 4 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
++ H + I S G + + L +EY+P G L +L LD + L +
Sbjct: 64 AL-HSDFIVKYRGVSYGPGRPELR-LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATI 876
+EYL S +H DL N+L+ ++DFG+ KLL + D V + + I
Sbjct: 122 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 877 GYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ A E S+ S DV++FGV+L E FT
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 139 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 297
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 298 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 116 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 172 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 228
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 274
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 275 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/273 (25%), Positives = 109/273 (39%), Gaps = 40/273 (14%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVFNQQC---GRAFKSFDVECEVMKSIRHRNIIK 766
+G G FG V + A + VAVK A F E M S+ HRN+I+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEYLY 824
+ K + E P GSL L + +++L R + VA + YL
Sbjct: 80 LYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE 132
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMALEY 883
S IH DL N+LL + + DFG+ + L + +D +V Q + A E
Sbjct: 133 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSL 942
S D + FGV L E FT G++P W+ ++ +I+
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK-- 230
Query: 943 LSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
+ +E + E C ++N+ ++C PE R
Sbjct: 231 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 263
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + +E M G L+ +L S L + L++ D+A
Sbjct: 113 CIGV----SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 169 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 271
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 272 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + +E M G L+ +L S L + L++ D+A
Sbjct: 98 CIGV----SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 256
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 257 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 75/304 (24%), Positives = 129/304 (42%), Gaps = 63/304 (20%)
Query: 708 FSENNLI-----GRGGFGSVYKA-----RIQDG-MEVAVKVFNQQCGRA-FKSFDVECEV 755
F NL+ G G FG V KA + + G VAVK+ + + + E V
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 756 MKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI------------ 803
+K + H ++IK+ CS D L L +EY +GSL +L S +
Sbjct: 80 LKQVNHPHVIKLYGACS-QDGPLL---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 804 -----------LDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS 852
L + ++ ++ ++YL ++H DL N+L+ + +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKIS 192
Query: 853 DFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
DFG+++ + ED V ++Q + +MA+E + +T DV++FGV+L E T G P
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 912 TNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVES 971
I E L +++K G + R D C ++ + ++C +
Sbjct: 253 YPGIPPE-----------RLFNLLKT--GHRMERPD-------NCSEEMYRLMLQCWKQE 292
Query: 972 PEKR 975
P+KR
Sbjct: 293 PDKR 296
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G G+VY A + G EVA++ N Q + E VM+ ++ NI+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +EY+ GSL + + +D Q + + ALE+L+ S VI
Sbjct: 88 VGD--ELW--VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG---YMALEYGSEGRV 889
H D+K N+LLG + L+DFG +T E Q++ +G +MA E +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
D+++ G+M +E G+ P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 75/304 (24%), Positives = 129/304 (42%), Gaps = 63/304 (20%)
Query: 708 FSENNLI-----GRGGFGSVYKA-----RIQDG-MEVAVKVFNQQCGRA-FKSFDVECEV 755
F NL+ G G FG V KA + + G VAVK+ + + + E V
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 756 MKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI------------ 803
+K + H ++IK+ CS D L L +EY +GSL +L S +
Sbjct: 80 LKQVNHPHVIKLYGACS-QDGPLL---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 804 -----------LDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS 852
L + ++ ++ ++YL ++H DL N+L+ + +S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 853 DFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
DFG+++ + ED V ++Q + +MA+E + +T DV++FGV+L E T G P
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 912 TNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVES 971
I E L +++K G + R D C ++ + ++C +
Sbjct: 253 YPGIPPE-----------RLFNLLKT--GHRMERPD-------NCSEEMYRLMLQCWKQE 292
Query: 972 PEKR 975
P+KR
Sbjct: 293 PDKR 296
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+IG G FG V R++ E+ V + + G + + F E +M H NII
Sbjct: 34 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+ + K + EYM +GSL+ +L ++ + Q + ++ + S ++YL
Sbjct: 94 HLEGVVT----KCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS- 148
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMALEYG 884
+H DL N+L+ N+V +SDFG++++L + + T+ I + A E
Sbjct: 149 --DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 885 SEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ + ++ DV+++G+++ E + G++P ++ N+
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 241
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G G+VY A + G EVA++ N Q + E VM+ ++ NI+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +EY+ GSL + + +D Q + + ALE+L+ S VI
Sbjct: 88 VGD--ELW--VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG---YMALEYGSEGRV 889
H D+K N+LLG + L+DFG +T E Q++ +G +MA E +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
D+++ G+M +E G+ P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 52/214 (24%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 713 LIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNIIKI 767
+IG G FG V R++ +VAV + + G + + F E +M H N++ +
Sbjct: 50 VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY-FG 826
+ G K + + +E+M +G+L+ +L + + Q + ++ +A+ + YL G
Sbjct: 110 EGVVTRG--KPVM--IVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMG 165
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFV-TQTQTPATIGYMALEYGS 885
Y +H DL N+L+ N+V +SDFG+++++ + + V T T + + A E
Sbjct: 166 Y----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 886 EGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ ++ DV+++G+++ E + G++P ++ N+
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 255
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 71.2 bits (173), Expect = 2e-12, Method: Composition-based stats.
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 705 TDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRA---FKSFDVECEVMKSIR 760
+D + ++G GG V+ AR ++D +VAVKV R + F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H I+ + + +EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 821 EYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG--- 877
+ L F + +IH D+KP+N+++ + DFGI + + D + TQT A IG
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E V DVY+ G +L E TG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 71.2 bits (173), Expect = 2e-12, Method: Composition-based stats.
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 705 TDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRA---FKSFDVECEVMKSIR 760
+D + ++G GG V+ AR ++D +VAVKV R + F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H I+ + + +EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 821 EYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG--- 877
+ L F + +IH D+KP+N+++ + DFGI + + D + TQT A IG
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E V DVY+ G +L E TG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G G+VY A + G EVA++ N Q + E VM+ ++ NI+ +
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +EY+ GSL + + +D Q + + ALE+L+ S VI
Sbjct: 89 VGD--ELW--VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG---YMALEYGSEGRV 889
H D+K N+LLG + L+DFG +T E Q++ +G +MA E +
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
D+++ G+M +E G+ P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 714 IGRGGFGSVY-----KARIQDGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKI 767
+G G FG V G VAVK CG +S + E ++++++ H +IIK
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
CC K+L L +EY+P GSL YL + + + Q L + + YL+
Sbjct: 82 KGCCEDQGEKSL--QLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH--- 134
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMALEYGSE 886
+ IH +L NVLL ++ + + DFG+ K + + + + + + + A E E
Sbjct: 135 AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 887 GRVSTNGDVYNFGVMLMETFT 907
+ DV++FGV L E T
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + C + F +E ++ H+NI++
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 125 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 181 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 237
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 283
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 284 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 714 IGRGGFGSVY-----KARIQDGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKI 767
+G G FG V G VAVK + CG +S + E E+++++ H +I+K
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
CC K++ L +EY+P GSL YL + + + Q L + + YL+
Sbjct: 76 KGCCEDQGEKSV--QLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH--- 128
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMALEYGSE 886
+ IH L NVLL ++ + + DFG+ K + + + + + + + A E E
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 887 GRVSTNGDVYNFGVMLMETFT 907
+ DV++FGV L E T
Sbjct: 189 CKFYYASDVWSFGVTLYELLT 209
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 714 IGRGGFGSVY-----KARIQDGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKI 767
+G G FG V G VAVK + CG +S + E E+++++ H +I+K
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
CC K++ L +EY+P GSL YL + + + Q L + + YL+
Sbjct: 77 KGCCEDQGEKSV--QLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH--- 129
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMALEYGSE 886
+ IH L NVLL ++ + + DFG+ K + + + + + + + A E E
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 887 GRVSTNGDVYNFGVMLMETFT 907
+ DV++FGV L E T
Sbjct: 190 CKFYYASDVWSFGVTLYELLT 210
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+IG G FG V R++ E+ V + + G + + F E +M H NII
Sbjct: 13 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+ + K + EYM +GSL+ +L ++ + Q + ++ + S ++YL
Sbjct: 73 HLEGVVT----KCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS- 127
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMALEYG 884
+H DL N+L+ N+V +SDFG++++L + + T+ I + A E
Sbjct: 128 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 885 SEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ + ++ DV+++G+++ E + G++P ++ N+
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 220
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 69/299 (23%), Positives = 133/299 (44%), Gaps = 44/299 (14%)
Query: 704 ATDGFSENNLIGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVM 756
A + + + +G+G FG VY K ++D E VA+K N+ R F E VM
Sbjct: 45 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIF 807
K ++++++ S G + +E M G L+ YL S +N +L +
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 808 QRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFV 867
+ + + ++A + YL + +H DL N ++ ++ + DFG+T+ + D +
Sbjct: 161 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWV 926
+ + +M+ E +G +T DV++FGV+L E T ++P + NE +
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------ 271
Query: 927 NDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+ +++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 272 -------LRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 76/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 84 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ + + DFG+T+ + D + + +
Sbjct: 140 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 242
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P+ R EIV LLK +DL
Sbjct: 243 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLK-DDL---- 289
Query: 996 YPSY 999
+PS+
Sbjct: 290 HPSF 293
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 76/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 85 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ + + DFG+T+ + D + + +
Sbjct: 141 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 243
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P+ R EIV LLK +DL
Sbjct: 244 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLK-DDL---- 290
Query: 996 YPSY 999
+PS+
Sbjct: 291 HPSF 294
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 80 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ +++ + I + A E + G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 27 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 87 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + +
Sbjct: 143 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 246
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C +F + C +P+ R + EI++ +
Sbjct: 247 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 80 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ +++ + I + A E + G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 89 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 140
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ +++ + I + A E + G +
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 200 SDVWSFGILLTEIVTHGRIP 219
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 81 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 132
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ +++ + I + A E + G +
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 192 SDVWSFGILLTEIVTHGRIP 211
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 82 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 133
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ +++ + I + A E + G +
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 193 SDVWSFGILLTEIVTHGRIP 212
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 88 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 139
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ +++ + I + A E + G +
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 199 SDVWSFGILLTEIVTHGRIP 218
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 86 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +N+L+ D + ++DFG+ +L+ +++ + I + A E + G +
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 51/200 (25%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 76 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 127
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H +L+ +N+L+ D + ++DFG+ +L+ ++++ + I + A E + G +
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 187 SDVWSFGILLTEIVTHGRIP 206
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+IG G FG V R++ E+ V + + G + + F E +M H NII
Sbjct: 19 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+ + K + EYM +GSL+ +L ++ + Q + ++ + S ++YL
Sbjct: 79 HLEGVVT----KCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS- 133
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ-TPATIGYMALEYG 884
+H DL N+L+ N+V +SDFG++++L + + T+ I + A E
Sbjct: 134 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 885 SEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ + ++ DV+++G+++ E + G++P ++ N+
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 226
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 51/217 (23%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 711 NNLIGRGGFGSVYKARIQDGME----VAVKVFNQ-QCGRAFKSFDVECEVMKSIRHRNII 765
+IG G FG V + R++ + VA+K R + F E +M H NII
Sbjct: 21 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
++ + ++ + E+M +G+L+ +L ++ + Q + ++ +AS + YL
Sbjct: 81 RLEGVVT----NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA- 135
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT---PATIGYMALE 882
+H DL N+L+ N+V +SDFG+++ L T+T + I + A E
Sbjct: 136 --EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ + ++ D +++G+++ E + G++P ++ N+
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ 230
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 20 SEYELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLY--VIVEYASKGN 127
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 284
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 20 SEYELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLY--VIVEYASKGN 127
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 185 ARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 284
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 20 SEYELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACT--QDGPLY--VIVEYASKGN 127
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 284
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 20 SEYELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACT--QDGPLY--VIVEYASKGN 127
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 284
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 705 TDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRA---FKSFDVECEVMKSIR 760
+D + ++G GG V+ AR ++D +VAVKV R + F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H I+ + + +EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 821 EYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG--- 877
+ L F + +IH D+KP+N+L+ + DFGI + + D + QT A IG
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIA--DSGNSVXQTAAVIGTAQ 184
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E V DVY+ G +L E TG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 76/304 (25%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 82 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ + + DFG+T+ + D + +
Sbjct: 138 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 240
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P+ R EIV LLK +DL
Sbjct: 241 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLK-DDL---- 287
Query: 996 YPSY 999
+PS+
Sbjct: 288 HPSF 291
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 76/304 (25%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 85 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ + + DFG+T+ + D + +
Sbjct: 141 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 243
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P+ R EIV LLK +DL
Sbjct: 244 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLK-DDL---- 290
Query: 996 YPSY 999
+PS+
Sbjct: 291 HPSF 294
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 70.1 bits (170), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 37 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 94
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ C D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 95 DHPFFVKLYFC--FQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 149
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 150 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 69.7 bits (169), Expect = 7e-12, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 140/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 20 SEYELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 735 VKVFNQQCGRA-FKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 72 VKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLY--VIVEYASKGN 127
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 284
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 69.7 bits (169), Expect = 9e-12, Method: Composition-based stats.
Identities = 76/304 (25%), Positives = 131/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 85 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ + + DFG+T+ + D + +
Sbjct: 141 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 243
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P R EIV LLK +DL
Sbjct: 244 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVN-LLK-DDL---- 290
Query: 996 YPSY 999
+PS+
Sbjct: 291 HPSF 294
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 69.7 bits (169), Expect = 9e-12, Method: Composition-based stats.
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 714 IGRGGFGSVY-----KARIQDGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKI 767
+G G FG V G VAVK G +S + E ++++++ H +IIK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
CC D A L +EY+P GSL YL + + + Q L + + YL+
Sbjct: 99 KGCCE--DAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH--- 151
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMALEYGSE 886
+ IH DL NVLL ++ + + DFG+ K + + + + + + + A E E
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 887 GRVSTNGDVYNFGVMLMETFT 907
+ DV++FGV L E T
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 82/340 (24%), Positives = 136/340 (40%), Gaps = 71/340 (20%)
Query: 686 DMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVAVKV 737
++P++ W D + +G G FG V K + ++ + VAVK+
Sbjct: 23 ELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 738 FNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEK 795
+ E E+MK I +H+NII ++ C+ L+ + +EY G+L +
Sbjct: 75 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLY--VIVEYASKGNLRE 130
Query: 796 YLYSSN-----YILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLKPSN 840
YL + Y DI F+ L + +A +EYL S IH DL N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN 187
Query: 841 VLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGV 900
VL+ +N V ++DFG+ + + D T + +MA E + + DV++FGV
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 901 MLMETFT--GKK----PTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKE 954
++ E FT G P E+F L +E +
Sbjct: 248 LMWEIFTLGGSPYPGIPVEELFK-------------------------LLKEGHRMDKPA 282
Query: 955 QCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
C + ++ M +C P +R K++V L +I L N
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG+G G+VY A + G EVA++ N Q + E VM+ ++ NI+ +
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +EY+ GSL + + +D Q + + ALE+L+ S VI
Sbjct: 89 VGD--ELW--VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG---YMALEYGSEGRV 889
H ++K N+LLG + L+DFG +T E Q++ +G +MA E +
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
D+++ G+M +E G+ P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 82/343 (23%), Positives = 139/343 (40%), Gaps = 71/343 (20%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 66 SEYELPEDPKWEF--------PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA 117
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 118 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLY--VIVEYASKGN 173
Query: 793 LEKYLYSSN-----YILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 230
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290
Query: 898 FGVMLMETFT--GKK----PTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFV 951
FGV++ E FT G P E+F L +E +
Sbjct: 291 FGVLMWEIFTLGGSPYPGIPVEELFK-------------------------LLKEGHRMD 325
Query: 952 AKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
C + ++ M +C P +R K++V L +I L N
Sbjct: 326 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 7 SEYELPEDPKWEF--------PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA 58
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 59 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLY--VIVEYASKGN 114
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 115 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLT 171
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 172 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 231
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 232 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 271
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 272 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 309
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 12 SEYELPEDPKWEF--------PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA 63
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 64 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLY--VIVEYASKGN 119
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 120 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 176
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 177 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 236
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 237 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 276
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 277 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 314
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 9 SEYELPEDPKWEF--------PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA 60
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + +EY G+
Sbjct: 61 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLY--VIVEYASKGN 116
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 117 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 173
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 174 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 233
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 234 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 273
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 274 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 311
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/217 (23%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 711 NNLIGRGGFGSVYKARIQDGME----VAVKVFNQ-QCGRAFKSFDVECEVMKSIRHRNII 765
+IG G FG V + R++ + VA+K R + F E +M H NII
Sbjct: 19 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
++ + ++ + E+M +G+L+ +L ++ + Q + ++ +AS + YL
Sbjct: 79 RLEGVVT----NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA- 133
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT---PATIGYMALE 882
+H DL N+L+ N+V +SDFG+++ L T T + I + A E
Sbjct: 134 --EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ + ++ D +++G+++ E + G++P ++ N+
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ 228
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 82/346 (23%), Positives = 135/346 (39%), Gaps = 77/346 (22%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W EL + D +G G FG V K + +VA
Sbjct: 54 SEYELPEDPRW------ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA 105
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCC-------------SIGDFKAL 779
VK+ + E E+MK I +H+NII ++ C S G+ +
Sbjct: 106 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 165
Query: 780 FKA-----LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHC 834
+A L Y P + E+ L S + + +Q VA +EYL S IH
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ-------VARGMEYLA---SKKCIHR 215
Query: 835 DLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGD 894
DL NVL+ ++ V ++DFG+ + + D + T + +MA E + + D
Sbjct: 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 895 VYNFGVMLMETFT------GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDI 948
V++FGV+L E FT P E+F L +E
Sbjct: 276 VWSFGVLLWEIFTLGGSPYPGVPVEELFK-------------------------LLKEGH 310
Query: 949 QFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ C + ++ M +C P +R K++V L +I L N
Sbjct: 311 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ-----CGRAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G +V + V ++ +A K E VM S+ +
Sbjct: 42 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 102 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 157 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 248
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 75/304 (24%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 85 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H +L N ++ + + DFG+T+ + D + + +
Sbjct: 141 DGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 243
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P R EIV LLK +DL
Sbjct: 244 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVN-LLK-DDL---- 290
Query: 996 YPSY 999
+PS+
Sbjct: 291 HPSF 294
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 75/304 (24%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 86 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H +L N ++ + + DFG+T+ + D + + +
Sbjct: 142 DGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 244
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P R EIV LLK +DL
Sbjct: 245 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVN-LLK-DDL---- 291
Query: 996 YPSY 999
+PS+
Sbjct: 292 HPSF 295
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 82/338 (24%), Positives = 140/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 20 SEYELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ +A Y G+
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVA--YASKGN 127
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 284
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 90 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSA 144
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E S + D++ G ++ + G P
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 67/289 (23%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 18 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 78 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ ++ + DFG+T+ + D + +
Sbjct: 134 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 237
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C + + C +P+ R + EI++ +
Sbjct: 238 VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ-----CGRAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G +V + V ++ +A K E VM S+ +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 84 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ-----CGRAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G +V + V ++ +A K E VM S+ +
Sbjct: 27 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 87 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 142 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 233
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 67/289 (23%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVY----KARIQDGME--VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY K ++D E VA+K N+ R F E VMK ++++
Sbjct: 20 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYS------SNYIL---DIFQRLNIMIDVA 817
++ S G + +E M G L+ YL S +N +L + + + + ++A
Sbjct: 80 LLGVVSQGQPTLVI----MELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N + ++ + DFG+T+ + D + + +
Sbjct: 136 DGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M+ E +G +T DV++FGV+L E T ++P + NE + +
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------LRF 239
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
+++G LL + D C + + C +P+ R + EI++ +
Sbjct: 240 VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 90 DHPFFVKLYF--TFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 144
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGM 920
+ E +E + D++ G ++ + G P NEG+
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA-GNEGL 241
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 712 NLIGRGGFGSVYKA-RIQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNII 765
++G G FG+VYK I DG + VA+KV + +A K E VM + +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+++ C + L + MP+G L ++ + L LN + +A + YL
Sbjct: 83 RLLGICLTSTVQ-----LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE- 136
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
++H DL NVL+ ++DFG+ +LL ++ I +MALE
Sbjct: 137 --DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 886 EGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
R + DV+++GV + E T G KP + I
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 225
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 703 QATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQC---GRAFKSFDVECEVMKS 758
+ + F NL+G+G F VY+A I G+EVA+K+ +++ + E ++
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
++H +I+++ + ++ L LE +G + +YL + + + M + +
Sbjct: 68 LKHPSILELYNYFEDSNYVYL----VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIG 877
+ YL+ S ++H DL SN+LL NM ++DFG+ T+L ++ T TP
Sbjct: 124 GMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP---N 177
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E + DV++ G M G+ P
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 705 TDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRA---FKSFDVECEVMKSIR 760
+D + ++G GG V+ AR ++ +VAVKV R + F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H I+ + + + +EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 821 EYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG--- 877
+ L F + +IH D+KP+N+++ + DFGI + + D + TQT A IG
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E V DVY+ G +L E TG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 11/221 (4%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMK 757
LE D + ++G+G +G VY R + + + +A+K ++ R + E + K
Sbjct: 1 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
++H+NI++ + S F +F +E +P GSL L S L ++ I
Sbjct: 61 HLKHKNIVQYLGSFSENGFIKIF----MEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTK 115
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGD-NMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
LE L + + ++H D+K NVL+ + V +SDFG +K L + T+T T T+
Sbjct: 116 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFT-GTL 173
Query: 877 GYMALEYGSEGR--VSTNGDVYNFGVMLMETFTGKKPTNEI 915
YMA E +G D+++ G ++E TGK P E+
Sbjct: 174 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 214
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 68.2 bits (165), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 433 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 486
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 487 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 543
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 572
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 9 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 66
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 67 DHPFFVKLYF--TFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 121
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 122 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 10 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 67
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 68 DHPFFVKLYF--TFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 122
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 123 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 66 DHPFFVKLYF--TFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 120
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 121 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 7 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 64
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 65 DHPFFVKLYF--TFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 119
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 120 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 711 NNLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNII 765
+IG G FG V ++ E+ V + + G + + F E +M H N+I
Sbjct: 38 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+ + K+ + E+M +GSL+ +L ++ + Q + ++ +A+ ++YL
Sbjct: 98 HLEGVVT----KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA- 152
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA-----TIGYMA 880
+H DL N+L+ N+V +SDFG+++ L ED T T A I + A
Sbjct: 153 --DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTA 208
Query: 881 LEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
E + ++ DV+++G+++ E + G++P ++ N+
Sbjct: 209 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 247
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 81/340 (23%), Positives = 136/340 (40%), Gaps = 71/340 (20%)
Query: 686 DMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVAVKV 737
++P++ W D + +G G FG V K + ++ + VAVK+
Sbjct: 23 ELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 738 FNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEK 795
+ E E+MK I +H+NII ++ C+ L+ + +EY G+L +
Sbjct: 75 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLY--VIVEYASKGNLRE 130
Query: 796 YL-----------YSSNYILD---IFQRL-NIMIDVASALEYLYFGYSTPVIHCDLKPSN 840
YL Y N + + F+ L + +A +EYL S IH DL N
Sbjct: 131 YLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN 187
Query: 841 VLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGV 900
VL+ +N V ++DFG+ + + D T + +MA E + + DV++FGV
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 901 MLMETFT--GKK----PTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKE 954
++ E FT G P E+F L +E +
Sbjct: 248 LMWEIFTLGGSPYPGIPVEELFK-------------------------LLKEGHRMDKPA 282
Query: 955 QCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
C + ++ M +C P +R K++V L +I L N
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/289 (23%), Positives = 119/289 (41%), Gaps = 44/289 (15%)
Query: 714 IGRGGFGSVYKARIQ------DGMEVAVKVFNQQCGRAFK-SFDVECEVMKSIRHRNIIK 766
+G G FG VY+ ++ ++VAVK + + F +E ++ H+NI++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY------SSNYILDIFQRLNIMIDVASAL 820
I ++L + + LE M G L+ +L S L + L++ D+A
Sbjct: 113 CIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+YL + IH D+ N LL G VA + DFG+ + + R + +
Sbjct: 169 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+M E EG ++ D ++FGV+L E F+ G P N+ +++
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------EVLE 271
Query: 937 IVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
V R D + C V+ + +C PE R N I+ R+
Sbjct: 272 FVTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 75/304 (24%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 714 IGRGGFGSVYKARIQDGME------VAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNIIK 766
+G+G FG VY+ +D ++ VAVK N+ R F E VMK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD---------IFQRLNIMIDVA 817
++ S G + +E M HG L+ YL S + + + + + ++A
Sbjct: 85 LLGVVSKGQPTLV----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ YL + +H DL N ++ + + DFG+T+ + + + +
Sbjct: 141 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLME-TFTGKKPTNEIFNEGMTLKHWVNDWLLISIMK 936
+MA E +G +T+ D+++FGV+L E T ++P + NE ++K
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------------QVLK 243
Query: 937 IV-DGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFNG 995
V DG L + D C V ++ C +P+ R EIV LLK +DL
Sbjct: 244 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLK-DDL---- 290
Query: 996 YPSY 999
+PS+
Sbjct: 291 HPSF 294
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 434 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 487
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 488 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 544
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 573
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 711 NNLIGRGGFGSVYKA----RIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSIRHRNII 765
+ +IG+G FG VY + Q+ ++ A+K ++ + ++F E +M+ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+I I + L YM HG L +++ S + ++ + VA +EYL
Sbjct: 86 ALIG---IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA- 141
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA--TIGYMALEY 883
+H DL N +L ++ ++DFG+ + + + + Q A + + ALE
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 884 GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
R +T DV++FGV+L E T P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAP 227
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 16/226 (7%)
Query: 697 SYLELCQATDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF-----NQQCGRAFKSFD 750
+ L + + T+ F + ++G G FG+VYK I +G +V + V +A K
Sbjct: 41 ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEIL 99
Query: 751 VECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
E VM S+ + ++ +++ C + L + MP G L Y+ + L
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLL 154
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
N + +A + YL ++H DL NVL+ ++DFG+ KLL E++
Sbjct: 155 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 211
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
I +MALE + DV+++GV + E T G KP + I
Sbjct: 212 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 257
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 712 NLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV------ECEVMKSIRHRNI 764
+ +G G FG V Q G +VAVK+ N+Q +S DV E + +K RH +I
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 765 IKIISCCSI-GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
IK+ S DF + +EY+ G L Y+ + ++ R + + SA++Y
Sbjct: 74 IKLYQVISTPTDF-----FMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYC 127
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ V+H DLKP NVLL +M A ++DFG++ +++ + T +P Y A E
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP---NYAAPEV 181
Query: 884 GSEGRVSTNG--DVYNFGVMLMETFTGKKPTNE 914
S GR+ D+++ GV+L G P ++
Sbjct: 182 IS-GRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 67.4 bits (163), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ-----CGRAFKSFDVECEVMKSIRH 761
F + ++ G FG+VYK I +G +V + V ++ +A K E VM S+ +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 84 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 78 PHVCRLLGICLTSTVQ-----LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 705 TDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRA---FKSFDVECEVMKSIR 760
+D + ++G GG V+ AR ++ +VAVKV R + F E + ++
Sbjct: 28 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H I+ + + +EY+ +L +++ + + I + +A A
Sbjct: 88 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 821 EYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG--- 877
+ L F + +IH D+KP+N+++ + DFGI + + D + TQT A IG
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 201
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E V DVY+ G +L E TG+ P
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 705 TDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRA---FKSFDVECEVMKSIR 760
+D + ++G GG V+ AR ++ +VAVKV R + F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H I+ + + +EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 821 EYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG--- 877
+ L F + +IH D+KP+N+++ + DFGI + + D + TQT A IG
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E V DVY+ G +L E TG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 81/338 (23%), Positives = 140/338 (41%), Gaps = 61/338 (18%)
Query: 683 NDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVY--------KARIQDGMEVA 734
++ ++P++ W D + +G G FG V K + ++ + VA
Sbjct: 20 SEYELPEDPKWEF--------PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 735 VKVFNQQCG-RAFKSFDVECEVMKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGS 792
VK+ + E E+MK I +H+NII ++ C+ L+ + + Y G+
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLY--VIVGYASKGN 127
Query: 793 LEKYLYSS-----NYILDI---------FQRL-NIMIDVASALEYLYFGYSTPVIHCDLK 837
L +YL + Y DI F+ L + +A +EYL S IH DL
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184
Query: 838 PSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN 897
NVL+ +N V ++DFG+ + + D + T + +MA E + + DV++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 898 FGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQC 956
FGV++ E FT G P I E + K++ +E + C
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVE--------------ELFKLL------KEGHRMDKPANC 284
Query: 957 MSFVFNMAMECTVESPEKRINAKEIVTRLLKINDLDFN 994
+ ++ M +C P +R K++V L +I L N
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 79 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 80 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 81 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 78 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 77 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 11/221 (4%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMK 757
LE D + ++G+G +G VY R + + + +A+K ++ R + E + K
Sbjct: 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 758 SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
++H+NI++ + S F +F +E +P GSL L S L ++ I
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIF----MEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTK 129
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGD-NMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
LE L + + ++H D+K NVL+ + V +SDFG +K L + T+T T T+
Sbjct: 130 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFT-GTL 187
Query: 877 GYMALEYGSEGR--VSTNGDVYNFGVMLMETFTGKKPTNEI 915
YMA E +G D+++ G ++E TGK P E+
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 72/275 (26%), Positives = 112/275 (40%), Gaps = 44/275 (16%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNI 764
+G G FG V + A + VAVK V +Q A F E M S+ HRN+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIREVNAMHSLDHRNL 77
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEY 822
I++ K + E P GSL L + +++L R + VA + Y
Sbjct: 78 IRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 130
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMAL 881
L S IH DL N+LL + + DFG+ + L + +D +V Q + A
Sbjct: 131 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDG 940
E S D + FGV L E FT G++P W+ ++ +I+
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK 230
Query: 941 SLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
+ +E + E C ++N+ ++C PE R
Sbjct: 231 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 263
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 72/275 (26%), Positives = 112/275 (40%), Gaps = 44/275 (16%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNI 764
+G G FG V + A + VAVK V +Q A F E M S+ HRN+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIREVNAMHSLDHRNL 73
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEY 822
I++ K + E P GSL L + +++L R + VA + Y
Sbjct: 74 IRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 126
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMAL 881
L S IH DL N+LL + + DFG+ + L + +D +V Q + A
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDG 940
E S D + FGV L E FT G++P W+ ++ +I+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK 226
Query: 941 SLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
+ +E + E C ++N+ ++C PE R
Sbjct: 227 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 72/275 (26%), Positives = 112/275 (40%), Gaps = 44/275 (16%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNI 764
+G G FG V + A + VAVK V +Q A F E M S+ HRN+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIREVNAMHSLDHRNL 83
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEY 822
I++ K + E P GSL L + +++L R + VA + Y
Sbjct: 84 IRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 136
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMAL 881
L S IH DL N+LL + + DFG+ + L + +D +V Q + A
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDG 940
E S D + FGV L E FT G++P W+ ++ +I+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK 236
Query: 941 SLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
+ +E + E C ++N+ ++C PE R
Sbjct: 237 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 67.4 bits (163), Expect = 4e-11, Method: Composition-based stats.
Identities = 72/275 (26%), Positives = 112/275 (40%), Gaps = 44/275 (16%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNI 764
+G G FG V + A + VAVK V +Q A F E M S+ HRN+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIREVNAMHSLDHRNL 73
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEY 822
I++ K + E P GSL L + +++L R + VA + Y
Sbjct: 74 IRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 126
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMAL 881
L S IH DL N+LL + + DFG+ + L + +D +V Q + A
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDG 940
E S D + FGV L E FT G++P W+ ++ +I+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK 226
Query: 941 SLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
+ +E + E C ++N+ ++C PE R
Sbjct: 227 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 90 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 144
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGM 920
+ E +E + D++ G ++ + G P NEG+
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEGL 241
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ-----CGRAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G +V + V ++ +A K E VM S+ +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 84 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG KLL E++ I +MAL
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 35 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 92
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 93 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 147
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 148 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 90
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 91 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 145
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 146 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 90 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 144
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 90 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 144
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 14 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 71
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 72 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 126
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 127 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 90
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 91 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 145
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 146 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 88 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 142
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 89
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 90 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 144
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 67.0 bits (162), Expect = 5e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 75 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 128
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 129 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPEC 185
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 88 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 142
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 86
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 87 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 141
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 88 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 142
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F +V AR + E A+K+ ++ K V E +VM +
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 86
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 87 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 141
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
F E LIG GGFG V+KA+ + DG +K +A + E + + + H NI+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 767 IISCCSIGDF--------------KALFKALALEYMPHGSLEKYLYSSN-YILDIFQRLN 811
C D+ K LF + +E+ G+LE+++ LD L
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLF--IQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
+ + ++Y++ S +I+ DLKPSN+ L D + DFG+ L + + + +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXR 180
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLME 904
+ T+ YM+ E S D+Y G++L E
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRA--FKSFDVECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 71 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 124
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDY 177
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 178 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 712 NLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV------ECEVMKSIRHRNI 764
+ +G G FG V Q G +VAVK+ N+Q +S DV E + +K RH +I
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 765 IKIISCCSI-GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
IK+ S DF + +EY+ G L Y+ + ++ R + + SA++Y
Sbjct: 74 IKLYQVISTPTDF-----FMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYC 127
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ V+H DLKP NVLL +M A ++DFG++ +++ + +P Y A E
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSP---NYAAPEV 181
Query: 884 GSEGRVSTNG--DVYNFGVMLMETFTGKKPTNE 914
S GR+ D+++ GV+L G P ++
Sbjct: 182 IS-GRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSIRHRNIIKII 768
+G G FGSV Y+ R + ++VA+KV Q +A + E ++M + + I+++I
Sbjct: 18 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
C +AL L +E G L K+L + + ++ V+ ++YL
Sbjct: 77 GVCQA---EALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---E 128
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT-QTQTPATIGYMALEYGSEG 887
+H DL NVLL + A +SDFG++K L +D + T ++ + + A E +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 888 RVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
+ S+ DV+++GV + E + G+KP ++
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRA--FKSFDVECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 81 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 134
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 135 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L Y P + E+ L S + +
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 148 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 197
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
+ T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 255
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 256 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 292
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 293 QLVEDLDRIVALTSN 307
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L Y P + E+ L S + +
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 145 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 194
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
+ T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 252
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 253 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 289
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 290 QLVEDLDRIVALTSN 304
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L Y P + E+ L S + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 156 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
+ T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 263
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 264 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 301 QLVEDLDRIVALTSN 315
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L Y P + E+ L S + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 156 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
+ T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 263
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 264 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 301 QLVEDLDRIVALTSN 315
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L Y P + E+ L S + +
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 149 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 198
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
+ T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 256
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 257 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 293
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 294 QLVEDLDRIVALTSN 308
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 9 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 69 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 122
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 123 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 179
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 208
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 91 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 144
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 145 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 91 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 144
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 145 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 75 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 128
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 129 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 185
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 29 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 89 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 142
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 143 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 199
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 228
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 710 ENNLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFK-SFDVECEVMKSIRHRNI 764
E+ +G G FG+V K Q V + N+ A K E VM+ + + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+++I C + L +E G L KYL + ++ D + ++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-----MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE 124
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQTQTPATIGYMALEY 883
+ +H DL NVLL A +SDFG++K L E+ + QT + + A E
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 884 GSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ + S+ DV++FGV++ E F+ G+KP
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 210
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G + K L + D + + ++A+
Sbjct: 71 RHPNILRLY-----GYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELAN 124
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 177
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 178 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 66.2 bits (160), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRA--FKSFDVECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 71 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 124
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 177
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 178 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRA--FKSFDVECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 69 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 122
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 175
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 176 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 66.2 bits (160), Expect = 8e-11, Method: Composition-based stats.
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G G V+ +VAVK +Q + +F E +MK ++H+ ++++ + +
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL-EYLYFGYSTPVI 832
+ EYM +GSL +L + + I +N ++D+A+ + E + F I
Sbjct: 80 EPI-----YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA-TIGYMALEYGSEGRVST 891
H DL+ +N+L+ D + ++DFG+ +L+ ED T + I + A E + G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 892 NGDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 66.2 bits (160), Expect = 8e-11, Method: Composition-based stats.
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 92 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 145
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATI 876
AL Y + S VIH D+KP N+LLG ++DFG + +R D T+
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTL 196
Query: 877 GYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
Y+ E EGR+ D+++ GV+ E GK P
Sbjct: 197 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 66.2 bits (160), Expect = 8e-11, Method: Composition-based stats.
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 69 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 122
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATI 876
AL Y + S VIH D+KP N+LLG ++DFG + +R D T+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTL 173
Query: 877 GYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
Y+ E EGR+ D+++ GV+ E GK P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ-----CGRAFKSFDVECEVMKSIRH 761
F + ++ G FG+VYK I +G +V + V ++ +A K E VM S+ +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 84 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T+ T+ Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLDY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 77 PHVCRLLGICLTSTVQ-----LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 67 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 120
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATI 876
AL Y + S VIH D+KP N+LLG ++DFG + +R D T+
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC------GTL 171
Query: 877 GYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
Y+ E EGR+ D+++ GV+ E GK P
Sbjct: 172 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 14 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 74 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 129 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 220
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 79 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 23 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 83 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 137
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 138 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 229
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 80 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 77 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 71 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 77 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 80 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 80 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRN 763
FS+ IG G FG+VY AR +++ VA+K + +Q ++ E ++ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS----A 819
I+ C + L +EY L S++ +L++ ++ +++A+ A
Sbjct: 116 TIQYRGCY----LREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
L+ L + +S +IH D+K N+LL + + L DFG ++ + FV TP +
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG---TPYWMAPE 220
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ EG+ DV++ G+ +E K P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 47/229 (20%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVA---VKVFNQQCGRAFKSFDVECEVMKSIRHRN 763
F E LIG GGFG V+KA+ + DG VK N++ R E + + + H N
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER-------EVKALAKLDHVN 66
Query: 764 IIKIISCCSIGDF---------------------------KALFKALALEYMPHGSLEKY 796
I+ C D+ K LF + +E+ G+LE++
Sbjct: 67 IVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLF--IQMEFCDKGTLEQW 124
Query: 797 LYSSN-YILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG 855
+ LD L + + ++Y++ S +IH DLKPSN+ L D + DFG
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 856 ITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLME 904
+ L + + +T++ T+ YM+ E S D+Y G++L E
Sbjct: 182 LVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSIRHRNIIKIIS 769
+G+G FG+VY AR Q +A+KV F Q +A + E E+ +RH NI+++
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY- 78
Query: 770 CCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
G F + L LEY P G++ + L + D + + ++A+AL Y + S
Sbjct: 79 ----GYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---S 130
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
VIH D+KP N+LLG N ++DFG + +R D T+ Y+ E E
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC------GTLDYLPPEM-IE 183
Query: 887 GRVSTNG-DVYNFGVMLMETFTGKKP 911
GR+ D+++ GV+ E G P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 66/295 (22%), Positives = 123/295 (41%), Gaps = 50/295 (16%)
Query: 714 IGRGGFGSVYKARI------QDGMEVAVKVFNQQC-GRAFKSFDVECEVMKSIRHRNIIK 766
+G FG VYK + + VA+K + G + F E + ++H N++
Sbjct: 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQR---------------LN 811
++ + K ++ Y HG L ++L + D+ ++
Sbjct: 94 LLGVVT----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
++ +A+ +EYL S V+H DL NVL+ D + +SD G+ + + D +
Sbjct: 150 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWL 930
+ I +MA E G+ S + D++++GV+L E F+ G +P N+
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------------ 254
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
D + R + C ++V+ + +EC E P +R K+I +RL
Sbjct: 255 --------DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 66/295 (22%), Positives = 123/295 (41%), Gaps = 50/295 (16%)
Query: 714 IGRGGFGSVYKARI------QDGMEVAVKVFNQQC-GRAFKSFDVECEVMKSIRHRNIIK 766
+G FG VYK + + VA+K + G + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQR---------------LN 811
++ + K ++ Y HG L ++L + D+ ++
Sbjct: 77 LLGVVT----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
++ +A+ +EYL S V+H DL NVL+ D + +SD G+ + + D +
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWL 930
+ I +MA E G+ S + D++++GV+L E F+ G +P N+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------------ 237
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
D + R + C ++V+ + +EC E P +R K+I +RL
Sbjct: 238 --------DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSIRHRNIIKII 768
+G G FGSV Y+ R + ++VA+KV Q +A + E ++M + + I+++I
Sbjct: 344 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
C +AL L +E G L K+L + + ++ V+ ++YL
Sbjct: 403 GVCQA---EALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---E 454
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT-QTQTPATIGYMALEYGSEG 887
+H +L NVLL + A +SDFG++K L +D + T ++ + + A E +
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 888 RVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
+ S+ DV+++GV + E + G+KP ++
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRN 763
FS+ IG G FG+VY AR +++ VA+K + +Q ++ E ++ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS----A 819
I+ C + L +EY L S++ +L++ ++ +++A+ A
Sbjct: 77 TIQYRGCY----LREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
L+ L + +S +IH D+K N+LL + + L DFG ++ + FV TP +
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG---TPYWMAPE 181
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ EG+ DV++ G+ +E K P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 67 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 120
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS----RRTTLSGTLDY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 174 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 79 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG KLL E++ I +MAL
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 79 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG KLL E++ I +MAL
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L ++ MP G L Y+ + LN + +A +
Sbjct: 81 PHVCRLLGICLTSTVQ-----LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG KLL E++ I +MAL
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 49/200 (24%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ + +VAVK + ++F E +MK+++H ++++ + +
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT- 78
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL-NIMIDVASALEYLYFGYSTPVI 832
+ + EYM GSL +L S + +L + +A + Y+ I
Sbjct: 79 ---REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 132
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +NVL+ ++++ ++DFG+ +++ ++++ + I + A E + G +
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 893 GDVYNFGVMLMETFT-GKKP 911
DV++FG++L E T GK P
Sbjct: 192 SDVWSFGILLYEIVTYGKIP 211
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV-----ECEVMKSI 759
+ F ++G G F + AR + E A+K+ ++ K V E +VM +
Sbjct: 30 EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRL 87
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H +K+ + D + L+ L Y +G L KY+ + R ++ SA
Sbjct: 88 DHPFFVKLY--FTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSA 142
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LEYL+ +IH DLKP N+LL ++M ++DFG K+L+ E + T Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ E +E + D++ G ++ + G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 65.5 bits (158), Expect = 2e-10, Method: Composition-based stats.
Identities = 72/275 (26%), Positives = 111/275 (40%), Gaps = 44/275 (16%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNI 764
+G G FG V + A + VAVK V +Q A F E M S+ HRN+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIREVNAMHSLDHRNL 73
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEY 822
I++ K + E P GSL L + +++L R + VA + Y
Sbjct: 74 IRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 126
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMAL 881
L S IH DL N+LL + + DFG+ + L + +D V Q + A
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDG 940
E S D + FGV L E FT G++P W+ ++ +I+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK 226
Query: 941 SLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
+ +E + E C ++N+ ++C PE R
Sbjct: 227 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 65.5 bits (158), Expect = 2e-10, Method: Composition-based stats.
Identities = 72/275 (26%), Positives = 111/275 (40%), Gaps = 44/275 (16%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNI 764
+G G FG V + A + VAVK V +Q A F E M S+ HRN+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIREVNAMHSLDHRNL 83
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEY 822
I++ K + E P GSL L + +++L R + VA + Y
Sbjct: 84 IRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 136
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-EDQFVTQTQTPATIGYMAL 881
L S IH DL N+LL + + DFG+ + L + +D V Q + A
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDG 940
E S D + FGV L E FT G++P W+ ++ +I+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK 236
Query: 941 SLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKR 975
+ +E + E C ++N+ ++C PE R
Sbjct: 237 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 67 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 120
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 174 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L Y P + E+ L S + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 156 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
+ T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 263
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 264 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 301 QLVEDLDRIVALTSN 315
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLDY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L Y P + E+ L S + +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 141 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
+ T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 248
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 249 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 286 QLVEDLDRIVALTSN 300
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 23/212 (10%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q G+AFK + E ++M+ + H NI++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFK--NRELQIMRKLDHCNIVR 77
Query: 767 I-ISCCSIGDFK-ALFKALALEYMP---HGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
+ S G+ K ++ L L+Y+P + Y + + I+ +L M + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYR 189
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 220
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q G+AFK + E ++M+ + H NI++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFK--NRELQIMRKLDHCNIVR 77
Query: 767 I-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 190
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 220
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 70 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 123
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 176
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 177 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 83 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 136
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 189
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 190 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 65 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 118
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 171
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 172 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 69 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 122
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 175
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 176 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 92 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 145
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 198
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 199 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G + K L + D + + ++A+
Sbjct: 71 RHPNILRLY-----GYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELAN 124
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + + T+ Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLXGTLDY 177
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 178 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 714 IGRGGFGSVYKARIQD---GMEVAVKVF---NQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G GG +VY A +D ++VA+K ++ K F+ E + H+NI+ +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
I D + L +EY+ +L +Y+ S+ L + +N + +++ +
Sbjct: 77 IDV----DEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKH---AH 128
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEG 887
++H D+KP N+L+ N + DFGI K L+ E T+ Y + E
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 888 RVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKH 924
D+Y+ G++L E G+ P N + +KH
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/218 (22%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 712 NLIGRGGFGSVYKARIQ--DGMEVAVKVFNQQCG---RAFKSFDVECEVMKSIRHRNIIK 766
+IG G FG V ++ E+ V + + G + + F E +M H N+I
Sbjct: 13 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ + K+ + E+M +GSL+ +L ++ + Q + ++ +A+ ++YL
Sbjct: 73 LEGVVT----KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA-- 126
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSE 886
+H L N+L+ N+V +SDFG+++ L ED T T A G + + + +
Sbjct: 127 -DMNYVHRALAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAP 183
Query: 887 GRV-----STNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ ++ DV+++G+++ E + G++P ++ N+
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 221
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q G+AFK + E ++M+ + H NI++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFK--NRELQIMRKLDHCNIVR 77
Query: 767 I-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 190
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 220
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 708 FSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQC-GRAFKSFDVECEVMKSIRHRNII 765
+ + IG GGF V A I G VA+K+ ++ G E E +K++RH++I
Sbjct: 12 YELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHIC 71
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
++ + +F + LEY P G L Y+ S + + + R+ + + SA+ Y++
Sbjct: 72 QLYHVLETAN--KIF--MVLEYCPGGELFDYIISQDRLSEEETRV-VFRQIVSAVAYVH- 125
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY-G 884
S H DLKP N+L + L DFG+ + QT ++ Y A E
Sbjct: 126 --SQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQT-CCGSLAYAAPELIQ 182
Query: 885 SEGRVSTNGDVYNFGVMLMETFTGKKPTNE-----IFNEGMTLKHWVNDWL 930
+ + + DV++ G++L G P ++ ++ + M K+ V WL
Sbjct: 183 GKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWL 233
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSIRHRNIIKIIS 769
+G+G FG+VY AR Q +A+KV F Q +A + E E+ +RH NI+++
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY- 78
Query: 770 CCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
G F + L LEY P G++ + L + D + + ++A+AL Y + S
Sbjct: 79 ----GYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---S 130
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
VIH D+KP N+LLG N ++DFG + +T T+ Y+ E EGR
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEM-IEGR 185
Query: 889 VSTNG-DVYNFGVMLMETFTGKKP 911
+ D+++ GV+ E G P
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPP 209
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVAVK+ + Q + + E +MK + H NI+K+
Sbjct: 15 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + ++ + R + SA++Y + +
Sbjct: 75 --IETEKTLY--LVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF--- 126
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE-YGSEGRV 889
++H DLK N+LL +M ++DFG + T ++ T +P Y A E + +
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP---YAAPELFQGKKYD 183
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLP 205
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRA--FKSFDVECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 69 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 122
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATI 876
AL Y + S VIH D+KP N+LLG ++DFG + +R T+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC------GTL 173
Query: 877 GYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
Y+ E EGR+ D+++ GV+ E GK P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFNQQ-CGRAFKSFDV--ECEVMKSIRH 761
D F IG+G FG V + D ++ A+K N+Q C + +V E ++M+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ + S D + +F + ++ + G L +L + + + +L I ++ AL+
Sbjct: 75 PFLVNL--WYSFQDEEDMF--MVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CELVMALD 129
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL + +IH D+KP N+LL ++ H++DF I +L RE Q T T YMA
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAP 183
Query: 882 EYGSEGR---VSTNGDVYNFGVMLMETFTGKKP 911
E S + S D ++ GV E G++P
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 63 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 116
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 169
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 170 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRA--FKSFDVECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A E E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 68 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 121
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG +++FG + +T T+ Y
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDY 174
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 175 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 71 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 124
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + +T T+ Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDY 177
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR D+++ GV+ E GK P
Sbjct: 178 LPPEX-IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 79 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG KLL E++ I +MAL
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++G G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 77 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG KLL E++ I +MAL
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 77/315 (24%), Positives = 123/315 (39%), Gaps = 69/315 (21%)
Query: 714 IGRGGFGSVY--------KARIQDGMEVAVKVFNQQCG-RAFKSFDVECEVMKSI-RHRN 763
+G G FG V K + +VAVK+ + E E+MK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 IIKIISCC-------------SIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILD 805
II ++ C S G+ + +A L + P + E+ L S + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+Q VA +EYL S IH DL NVL+ ++ V ++DFG+ + + D
Sbjct: 156 AYQ-------VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDX 205
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT--GKK----PTNEIFNEG 919
T + +MA E + + DV++FGV+L E FT G P E+F
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 263
Query: 920 MTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAK 979
L +E + C + ++ M +C P +R K
Sbjct: 264 -----------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 300
Query: 980 EIVTRLLKINDLDFN 994
++V L +I L N
Sbjct: 301 QLVEDLDRIVALTSN 315
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDG-MEVAVKVFNQQCGRAFK-SFDVECEV 755
F NNL +G G FG V +A +D ++VAVK+ K + E ++
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 756 MKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI 814
M + +H NI+ ++ C+ G + EY +G L +L + +L+ I
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVIT----EYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 815 DVASALEYLYFG----------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED 864
AS + L+F S IH D+ NVLL + VA + DFG+ + + +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 865 QFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
++ + + +MA E + + DV+++G++L E F+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 711 NNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRHRNIIK 766
++++G+G +V++ R + G A+KVFN + DV E EV+K + H+NI+K
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY--SSNYILDIFQRLNIMIDVASALEYLY 824
+ + + K L +E+ P GSL L S+ Y L + L ++ DV + +L
Sbjct: 72 LFAIEE--ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL- 128
Query: 825 FGYSTPVIHCDLKPSNVL--LGDN--MVAHLSDFGITKLLTREDQFVTQTQT-----PAT 875
++H ++KP N++ +G++ V L+DFG + L ++QFV+ T P
Sbjct: 129 --RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
L + + D+++ GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 63.9 bits (154), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGR--AFKSFDVECEVMKSIR 760
Q + F +G G +GSVYKA +++ G+ A K VE ++ + I+
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKA------------IHKETGQIVAIKQVPVESDLQEIIK 73
Query: 761 HRNIIKIISCCS---IGDFKALFK----ALALEYMPHGSLEKYLYSSNYILDIFQRLNIM 813
+I++ C S + + + FK + +EY GS+ + N L + I+
Sbjct: 74 EISIMQ--QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATIL 131
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP 873
LEYL+F IH D+K N+LL A L+DFG+ LT D +
Sbjct: 132 QSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVI 186
Query: 874 ATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
T +MA E E + D+++ G+ +E GK P +I
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 711 NNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRHRNIIK 766
++++G+G +V++ R + G A+KVFN + DV E EV+K + H+NI+K
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLY--SSNYILDIFQRLNIMIDVASALEYLY 824
+ + + K L +E+ P GSL L S+ Y L + L ++ DV + +L
Sbjct: 72 LFAIEE--ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL- 128
Query: 825 FGYSTPVIHCDLKPSNVL--LGDN--MVAHLSDFGITKLLTREDQFVTQTQT-----PAT 875
++H ++KP N++ +G++ V L+DFG + L ++QFV T P
Sbjct: 129 --RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
L + + D+++ GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 712 NLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV------ECEVMKSIRHRNI 764
+ +G G FG V + + G +VAVK+ N+Q +S DV E + +K RH +I
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
IK+ S +F + +EY+ G L Y+ N LD + + + S ++Y +
Sbjct: 79 IKLYQVISTP--SDIF--MVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYG 884
V+H DLKP NVLL +M A ++DFG++ +++ + +P Y A E
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSP---NYAAPEVI 187
Query: 885 SEGRVSTNG--DVYNFGVMLMETFTGKKPTNE 914
S GR+ D+++ GV+L G P ++
Sbjct: 188 S-GRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 63.5 bits (153), Expect = 5e-10, Method: Composition-based stats.
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDG----MEVAVKVFNQQCG-RAFKSFDVECEVMKSIRH 761
F + ++ G FG+VYK I +G + VA+K + +A K E VM S+ +
Sbjct: 17 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ +++ C + L + MP G L Y+ + LN + +A +
Sbjct: 77 PHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL ++H DL NVL+ ++DFG+ KLL E++ I +MAL
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEI 915
E + DV+++GV + E T G KP + I
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR + G EVAVK+ + Q + + E +MK + H NI+K+
Sbjct: 23 IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y + Y
Sbjct: 83 --IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY--- 134
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE-YGSEGRV 889
++H DLK N+LL +M ++DFG + T ++ T +P Y A E + +
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPP---YAAPELFQGKKYD 191
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHR 762
Q ++ +IG G FG V++A++ + EVA+K Q + FK + E ++M+ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFK--NRELQIMRIVKHP 92
Query: 763 NIIKIIS-CCSIGDFK-ALFKALALEYMPHGSLEKYLYSSNY--ILDIFQRLNIMIDVAS 818
N++ + + S GD K +F L LEY+P Y S +Y + L I + +
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L L + +S + H D+KP N+LL + V L DFG K+L + V+ +
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI---CSRY 206
Query: 878 YMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
Y A E +G+ +TN D+++ G ++ E G+
Sbjct: 207 YRAPELIFGATN-YTTNIDIWSTGCVMAELMQGQ 239
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 63.2 bits (152), Expect = 7e-10, Method: Composition-based stats.
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 68 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 121
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATI 876
AL Y + S VIH D+KP N+LLG ++DFG + +R T+
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC------GTL 172
Query: 877 GYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
Y+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 63.2 bits (152), Expect = 7e-10, Method: Composition-based stats.
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 69 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 122
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATI 876
AL Y + S VIH D+KP N+LLG ++DFG + +R T+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC------GTL 173
Query: 877 GYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
Y+ E EGR+ D+++ GV+ E GK P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 63.2 bits (152), Expect = 7e-10, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 69 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 122
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG +++FG + +T T+ Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDY 175
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 176 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 63.2 bits (152), Expect = 7e-10, Method: Composition-based stats.
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG--ITKLLTREDQFVTQTQTPATI 876
AL Y + S VIH D+KP N+LLG ++DFG + +R T+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC------GTL 170
Query: 877 GYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
Y+ E EGR+ D+++ GV+ E GK P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 63.2 bits (152), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVAVK+ + Q + + E +MK + H NI+K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y + +
Sbjct: 82 --IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE-YGSEGRV 889
++H DLK N+LL +M ++DFG + T ++ T +P Y A E + +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP---YAAPELFQGKKYD 190
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 63.2 bits (152), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVAVK+ + Q + + E +MK + H NI+K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y + +
Sbjct: 82 --IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE-YGSEGRV 889
++H DLK N+LL +M ++DFG + T ++ T +P Y A E + +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP---YAAPELFQGKKYD 190
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR Q +A+KV F Q +A + E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + + T+ Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+G G FG V+ + +VAVK + ++F E +MK+++H ++++ + +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT- 77
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL-NIMIDVASALEYLYFGYSTPVI 832
K + E+M GSL +L S + +L + +A + Y+ I
Sbjct: 78 ---KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 131
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H DL+ +NVL+ ++++ ++DFG+ +++ ++++ + I + A E + G +
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 893 GDVYNFGVMLMETFT-GKKP 911
+V++FG++L E T GK P
Sbjct: 191 SNVWSFGILLYEIVTYGKIP 210
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 62.8 bits (151), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
+G+G +G V++ Q G VAVK+F+ R KS+ E E+ ++ RH NI+ I+
Sbjct: 45 VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY---FGYS 828
+ L Y GSL YL + LD L I++ +AS L +L+ FG
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 829 -TPVI-HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--ATIGYMALE-- 882
P I H DLK N+L+ N ++D G+ + ++ + P T YMA E
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 883 --------YGSEGRVSTNGDVYNFGVMLME 904
+ S RV D++ FG++L E
Sbjct: 219 DETIQVDCFDSYKRV----DIWAFGLVLWE 244
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 62.8 bits (151), Expect = 1e-09, Method: Composition-based stats.
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEK-YLYSSNYILDIFQRL 810
I+ C G+ ++ E++P+ L K +L + I FQ
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ-- 152
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 153 -----VAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
+G+G +G V++ Q G VAVK+F+ R KS+ E E+ ++ RH NI+ I+
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY---FGYS 828
+ L Y GSL YL + LD L I++ +AS L +L+ FG
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 829 -TPVI-HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--ATIGYMALE-- 882
P I H DLK N+L+ N ++D G+ + ++ + P T YMA E
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 883 --------YGSEGRVSTNGDVYNFGVMLME 904
+ S RV D++ FG++L E
Sbjct: 190 DETIQVDCFDSYKRV----DIWAFGLVLWE 215
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQDGMEV-AVKV-FNQQCGRAFKSFDV--ECEVMKSI 759
A + F +G+G FG+VY AR ++ + A+KV F Q +A + E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNIIKIISCCSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
RH NI+++ G F + L LEY P G++ + L + D + + ++A+
Sbjct: 66 RHPNILRLY-----GYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
AL Y + S VIH D+KP N+LLG ++DFG + + T+ Y
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
+ E EGR+ D+++ GV+ E GK P
Sbjct: 173 LPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
+G+G +G V++ Q G VAVK+F+ R KS+ E E+ ++ RH NI+ I+
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY---FGYS 828
+ L Y GSL YL + LD L I++ +AS L +L+ FG
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 829 -TPVI-HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--ATIGYMALE-- 882
P I H DLK N+L+ N ++D G+ + ++ + P T YMA E
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 883 --------YGSEGRVSTNGDVYNFGVMLME 904
+ S RV D++ FG++L E
Sbjct: 190 DETIQVDCFDSYKRV----DIWAFGLVLWE 215
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEK-YLYSSNYILDIFQRL 810
I+ C G+ ++ E++P+ L K +L + I FQ
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ-- 152
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 153 -----VAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 712 NLIGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRAFK-SFDVECEVMKSI-RHRN 763
++G G FG V A + ++VAVK+ ++ + + + E ++M + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 764 IIKIISCCSI-GDFKALFKALALEYMPHGSLEKYL-------------YSSNYILDIFQR 809
I+ ++ C++ G +F EY +G L YL Y + L+ +
Sbjct: 111 IVNLLGACTLSGPIYLIF-----EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 810 LNIMI---------DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL 860
LN++ VA +E+L F +H DL NVL+ V + DFG+ + +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 861 TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ +V + + +MA E EG + DV+++G++L E F+
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVAV++ + Q + + E +MK + H NI+K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y + +
Sbjct: 82 --IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE-YGSEGRV 889
++H DLK N+LL +M ++DFG + T ++ T +P Y A E + +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP---YAAPELFQGKKYD 190
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 712 NLIGRGGFGSVYKARIQDGMEVAVK----VFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
++G+G FG K ++ EV V F+++ R F E +VM+ + H N++K
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPNVLKF 72
Query: 768 ISCCSIGDFKALFKALAL----EYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
I L+K L EY+ G+L + S + QR++ D+AS + YL
Sbjct: 73 IG--------VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED---QFVTQTQTP------A 874
+ S +IH DL N L+ +N ++DFG+ +L+ E + + + P
Sbjct: 125 H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 875 TIG---YMALEYGSEGRVSTNGDVYNFGVMLME 904
+G +MA E + DV++FG++L E
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G FG VYKA+ ++ G A KV + + + VE E++ + H I+K++
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-Y 77
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
D K + +E+ P G+++ + + L Q I + LE L F +S +I
Sbjct: 78 YHDGKLW---IMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRII 131
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGIT----KLLTREDQFVTQTQTPATIG--YMALEYGSE 886
H DLK NVL+ L+DFG++ K L + D F+ TP + + E +
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG---TPYWMAPEVVMCETMKD 188
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
D+++ G+ L+E + P +E+
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHEL 217
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G FG VYKA+ ++ G A KV + + + VE E++ + H I+K++
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-Y 85
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
D K + +E+ P G+++ + + L Q I + LE L F +S +I
Sbjct: 86 YHDGKLW---IMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRII 139
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGIT----KLLTREDQFVTQTQTPATIG--YMALEYGSE 886
H DLK NVL+ L+DFG++ K L + D F+ TP + + E +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG---TPYWMAPEVVMCETMKD 196
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
D+++ G+ L+E + P +E+
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHEL 225
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 17/153 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
IG+G FG V++ + + G EVAVK+F+ R +S+ E E+ +++ RH NI+ I+
Sbjct: 50 IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 772 SI--GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF---- 825
+ G + L+ L +Y HGSL YL + Y + + + + + AS L +L+
Sbjct: 106 NKDNGTWTQLW--LVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 826 GYSTPVI-HCDLKPSNVLLGDNMVAHLSDFGIT 857
P I H DLK N+L+ N ++D G+
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVF-NQQCGRAFKSFDV-ECEVMKSI 759
Q+ + + L+G G +G V K R +D G VA+K F + K + E +++K +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
RH N++ ++ C K L E++ H ILD + +D
Sbjct: 82 RHENLVNLLEVCK----KKKRWYLVFEFVDHT-----------ILDDLELFPNGLDYQVV 126
Query: 820 LEYLY-------FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-----EDQFV 867
+YL+ F +S +IH D+KP N+L+ + V L DFG + L +D+
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ + ++YG DV+ G ++ E F G+
Sbjct: 187 TRWYRAPELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 27/216 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSIRHR-NII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
I+ C G+ ++ E++P+ + LY L + +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 189
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 190 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ +MA E + + DV++FGV+L E F+
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + M VA+K N + F E M+ H +I+K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L Y LD+ + +++AL YL S
Sbjct: 78 GVITENPVWIIMELCTL-----GELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 129
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 232
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 233 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 84/314 (26%), Positives = 127/314 (40%), Gaps = 53/314 (16%)
Query: 712 NLIGRGGFGSVYKARIQDGMEVAVKVF---NQQCGRAFKSFDVECEVMKS--IRHRNIIK 766
LIGRG +G+VYK + D VAVKVF N+Q +F E + + + H NI +
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ------NFINEKNIYRVPLMEHDNIAR 71
Query: 767 IISCCSIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
I +GD + L +EY P+GSL KYL S + D + V L
Sbjct: 72 FI----VGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLA 125
Query: 822 YLYFG------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLT--------REDQFV 867
YL+ Y + H DL NVL+ ++ +SDFG++ LT ED
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN-- 183
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNG--------DVYNFGVMLMETF---TGKKPTNEIF 916
TI YMA E EG V+ D+Y G++ E F T P +
Sbjct: 184 AAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 917 NEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSF--VFNMAMECTVESPEK 974
M + V + M+++ R KE ++ + +C + E
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 975 RINAKEIVTRLLKI 988
R+ A+ R+ ++
Sbjct: 303 RLTAQXAEERMAEL 316
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDG-MEVAVKVFNQQCGRAFK-SFDVECEV 755
F NNL +G G FG V +A +D ++VAVK+ K + E ++
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 756 MKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI 814
M + +H NI+ ++ C+ G + EY +G L +L + +L+ I
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVIT----EYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 815 DVASALEYLYFG----------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED 864
S + L+F S IH D+ NVLL + VA + DFG+ + + +
Sbjct: 159 STLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 865 QFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
++ + + +MA E + + DV+++G++L E F+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 61.6 bits (148), Expect = 2e-09, Method: Composition-based stats.
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
I+ C G+ ++ E++P+ + LY L + +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD--FLTLEHLIC 154
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 155 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVAV++ + Q + + E +MK + H NI+K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y + +
Sbjct: 82 --IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLT---REDQFVTQTQTPATIGYMALEYGSEG 887
++H DLK N+LL +M ++DFG + T + D+F A + +Y
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD--- 190
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 191 --GPEVDVWSLGVILYTLVSGSLP 212
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G FG VYKA+ ++ + A KV + + + + VE +++ S H NI+K++
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ + +E+ G+++ + L Q I + L+ L + + +I
Sbjct: 105 YENNLWIL----IEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKII 157
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGI----TKLLTREDQFVTQTQTPATIG--YMALEYGSE 886
H DLK N+L + L+DFG+ T+ + R D F+ TP + + E +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG---TPYWMAPEVVMCETSKD 214
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
DV++ G+ L+E + P +E+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHEL 243
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G FG VYKA+ ++ + A KV + + + + VE +++ S H NI+K++
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ + +E+ G+++ + L Q I + L+ L + + +I
Sbjct: 105 YENNLWIL----IEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKII 157
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGI----TKLLTREDQFVTQTQTPATIG--YMALEYGSE 886
H DLK N+L + L+DFG+ T+ + R D F+ TP + + E +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIG---TPYWMAPEVVMCETSKD 214
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
DV++ G+ L+E + P +E+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHEL 243
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+G G FG VYKA+ ++ + A KV + + + + VE +++ S H NI+K++
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+ + +E+ G+++ + L Q I + L+ L + + +I
Sbjct: 105 YENNLWIL----IEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKII 157
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGI----TKLLTREDQFVTQTQTPATIG--YMALEYGSE 886
H DLK N+L + L+DFG+ T+ + R D F+ TP + + E +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIG---TPYWMAPEVVMCETSKD 214
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
DV++ G+ L+E + P +E+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHEL 243
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 76
Query: 766 KI-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 77 RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYR 189
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 220
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVAVK+ + Q + + E +MK + H NI+K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y + +
Sbjct: 82 --IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLT---REDQFVTQTQTPATIGYMALEYGSEG 887
++H DLK N+LL +M ++DFG + T + D F A + +Y
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD--- 190
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 191 --GPEVDVWSLGVILYTLVSGSLP 212
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 46/244 (18%)
Query: 688 PQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVA---VKVFNQQCG 743
PQ+A Y L F IGRG F VY+A + DG+ VA V++F+
Sbjct: 18 PQKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA 73
Query: 744 RAFKSFDVECEVMKSIRHRNIIK-------------IISCCSIGDFKALFKALALEYMPH 790
+A E +++K + H N+IK ++ GD + K H
Sbjct: 74 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK--------H 125
Query: 791 GSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAH 850
+K L + F + + SALE+++ S V+H D+KP+NV + V
Sbjct: 126 FKKQKRLIPERTVWKYF------VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176
Query: 851 LSDFGITKLLTREDQFVTQTQTPATIG---YMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
L D G+ + + + T + +G YM+ E E + D+++ G +L E
Sbjct: 177 LGDLGLGRFFSSK-----TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 908 GKKP 911
+ P
Sbjct: 232 LQSP 235
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 60.8 bits (146), Expect = 3e-09, Method: Composition-based stats.
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
I+ C G+ ++ E++P+ + LY L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 152
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 60.8 bits (146), Expect = 3e-09, Method: Composition-based stats.
Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 766 KIISCCS--------------IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
++ C+ G+ ++ E++P+ + LY L + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 144 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 60.8 bits (146), Expect = 3e-09, Method: Composition-based stats.
Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 766 KIISCCS--------------IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
++ C+ G+ ++ E++P+ + LY L + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 144 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 76
Query: 766 KI-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYR 189
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 220
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 76
Query: 766 KI-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYR 189
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 220
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 77
Query: 766 KI-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 78 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 138 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYR 190
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 191 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 221
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + + VA+K N + F E M+ H +I+K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L Y LD+ + +++AL YL S
Sbjct: 78 GVITENPVWIIMELCTL-----GELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 129
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 232
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 233 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + + VA+K N + F E M+ H +I+K+I
Sbjct: 46 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L Y LD+ + +++AL YL S
Sbjct: 106 GVITENPVWIIMELCTL-----GELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 157
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 260
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 261 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 26 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 81
Query: 767 I-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 82 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 142 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYRA 194
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 195 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 224
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 95
Query: 766 KIIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 96 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYR 208
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 209 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 239
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 89
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 90 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYRA 202
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 203 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 232
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 89
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 90 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYRA 202
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 203 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 232
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 111
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYRA 224
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 225 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 254
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 84
Query: 766 KIIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 85 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---CSRYYR 197
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 198 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 228
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 76
Query: 766 KI-ISCCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYR 189
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 220
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 27 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 82
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 83 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 143 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 195
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 196 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 225
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 60 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 115
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 228
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 229 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 258
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 685 ADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQC 742
A+MP+ R+F+ D F +G+G FG+VY AR Q+ +A+KV F Q
Sbjct: 4 AEMPK----RKFT-------IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 52
Query: 743 GRAFKSFDV--ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSS 800
+ + E E+ +RH NI+++ + D K ++ L LE+ P G L K L
Sbjct: 53 EKEGVEHQLRREIEIQSHLRHPNILRMYN--YFHDRKRIY--LMLEFAPRGELYKELQKH 108
Query: 801 NYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG 855
D + M ++A AL Y + VIH D+KP N+L+G ++DFG
Sbjct: 109 GR-FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 159
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 685 ADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQC 742
A+MP+ R+F+ D F +G+G FG+VY AR Q+ +A+KV F Q
Sbjct: 5 AEMPK----RKFT-------IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 53
Query: 743 GRAFKSFDV--ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSS 800
+ + E E+ +RH NI+++ + D K ++ L LE+ P G L K L
Sbjct: 54 EKEGVEHQLRREIEIQSHLRHPNILRMYN--YFHDRKRIY--LMLEFAPRGELYKELQKH 109
Query: 801 NYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG 855
D + M ++A AL Y + VIH D+KP N+L+G ++DFG
Sbjct: 110 GR-FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 160
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + + VA+K N + F E M+ H +I+K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L Y LD+ + +++AL YL S
Sbjct: 83 GVITENPVWIIMELCTL-----GELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 237
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 238 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 58 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 113
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 174 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 226
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 227 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 256
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + + VA+K N + F E M+ H +I+K+I
Sbjct: 21 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L Y LD+ + +++AL YL S
Sbjct: 81 GVITENPVWIIMELCTL-----GELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 132
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 192 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 235
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 236 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 707 GFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI+
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIV 89
Query: 766 KIIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++ S G+ K ++ L L+Y+P + ++ + L + M + +L
Sbjct: 90 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 822 YLY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
Y++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYR 202
Query: 880 ALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
A E +G+ S+ DV++ G +L E G+
Sbjct: 203 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ 233
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 50 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 105
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 166 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 218
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 219 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 248
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + + VA+K N + F E M+ H +I+K+I
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L Y LD+ + +++AL YL S
Sbjct: 75 GVITENPVWIIMELCTL-----GELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 229
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 230 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + + VA+K N + F E M+ H +I+K+I
Sbjct: 20 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L Y LD+ + +++AL YL S
Sbjct: 80 GVITENPVWIIMELCTL-----GELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 131
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 190
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 191 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 234
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 235 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 156
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 269
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 270 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 299
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 60.1 bits (144), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
+++ +IG G FG VY+A++ D E VA+K Q + FK + E ++M+ + H NI++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVR 111
Query: 767 IIS-CCSIGDFK-ALFKALALEYMPHG--SLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+ S G+ K ++ L L+Y+P + ++ + L + M + +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 823 LY-FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMA 880
++ FG + H D+KP N+LL D V L DFG K L R + V+ + Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---CSRYYRA 224
Query: 881 LE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
E +G+ S+ DV++ G +L E G+
Sbjct: 225 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ 254
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 60.1 bits (144), Expect = 7e-09, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 720 GSVYKARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFK 777
G ++K R Q G ++ VKV + R + F+ EC ++ H N++ ++ C
Sbjct: 24 GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ--SPP 80
Query: 778 ALFKALALEYMPHGSLEKYLYS-SNYILDIFQRLNIMIDVASALEYLYFGYSTPVI--HC 834
A L +MP+GSL L+ +N+++D Q + +D+A + +L+ P+I H
Sbjct: 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA 138
Query: 835 DLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGD 894
L +V++ ++M A +S + Q + PA + AL+ E + D
Sbjct: 139 -LNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 895 VYNFGVMLMETFTGKKPTNEIFNEGMTLK 923
+++F V+L E T + P ++ N + +K
Sbjct: 194 MWSFAVLLWELVTREVPFADLSNMEIGMK 222
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 59.7 bits (143), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
F++ IG+G FG V+K +V A K D+E + + I +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVV----------AIKIIDLEEAEDEIEDIQQEITV 74
Query: 768 ISCCSIGDFKALFKA--------LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
+S C + + + +EY+ GS L + + D FQ ++ ++
Sbjct: 75 LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKG 132
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
L+YL+ S IH D+K +NVLL + L+DFG+ LT D + + T +M
Sbjct: 133 LDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 187
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
A E + + D+++ G+ +E G+ P +++
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 59.7 bits (143), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVA+K+ + Q + + E +MK + H NI+K+
Sbjct: 20 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y +
Sbjct: 80 --IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKR 131
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE-YGSEGRV 889
++H DLK N+LL +M ++DFG + T + T +P Y A E + +
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPP---YAAPELFQGKKYD 188
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLP 210
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
I+ C G+ ++ E++P+ + LY L + +
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ V +
Sbjct: 144 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
I+ C G+ ++ E++P+ + LY L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 152
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ V +
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 59.3 bits (142), Expect = 9e-09, Method: Composition-based stats.
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 766 KIISCCS--------------IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
++ C+ G+ ++ E++P+ + LY L + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ V +
Sbjct: 144 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDG-MEVAVKV-FNQQCGR--AFKSFDVECEVMKSIRH 761
D F +G+G FG+VY AR + VA+KV F Q + E E+ + H
Sbjct: 23 DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ + D + ++ L LEY P G L K L S D + IM ++A AL
Sbjct: 83 PNILRLYN--YFYDRRRIY--LILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALM 137
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
Y + VIH D+KP N+LLG ++DFG + +T T+ Y+
Sbjct: 138 YCH---GKKVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMC-GTLDYLPP 190
Query: 882 EYGSEGRVSTNG-DVYNFGVMLMETFTGKKP 911
E EGR+ D++ GV+ E G P
Sbjct: 191 EM-IEGRMHNEKVDLWCIGVLCYELLVGNPP 220
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + M VA+K N + F E M+ H +I+K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L + LD+ + +++AL YL S
Sbjct: 458 GVITENPVWIIMELCTL-----GELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + + ++ I +MA E + R
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 612
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 685 ADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKV-FNQQC 742
A+MP+ R+F+ D F +G+G FG+VY AR Q+ +A+KV F Q
Sbjct: 4 AEMPK----RKFT-------IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 52
Query: 743 GRAFKSFDV--ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSS 800
+ + E E+ +RH NI+++ + D K ++ L LE+ P G L K L
Sbjct: 53 EKEGVEHQLRREIEIQSHLRHPNILRMYN--YFHDRKRIY--LMLEFAPRGELYKELQKH 108
Query: 801 NYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG 855
D + M ++A AL Y + VIH D+KP N+L+G ++DFG
Sbjct: 109 GR-FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 159
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
I+ C G+ ++ E++P+ + LY L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 152
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ V +
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
IG+G FG V++ + + G EVAVK+F+ R +S+ E E+ +++ RH NI+ I+
Sbjct: 12 IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 772 SI--GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF---- 825
+ G + L+ L +Y HGSL YL + Y + + + + + AS L +L+
Sbjct: 68 NKDNGTWTQLW--LVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 826 GYSTPVI-HCDLKPSNVLLGDNMVAHLSDFGI 856
P I H DLK N+L+ N ++D G+
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 155
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
IG+G FG V++ + + G EVAVK+F+ R +S+ E E+ +++ RH NI+ I+
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 772 SI--GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF---- 825
+ G + L+ L +Y HGSL YL + Y + + + + + AS L +L+
Sbjct: 67 NKDNGTWTQLW--LVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 826 GYSTPVI-HCDLKPSNVLLGDNMVAHLSDFGI 856
P I H DLK N+L+ N ++D G+
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
IG+G FG V++ + + G EVAVK+F+ R +S+ E E+ +++ RH NI+ I+
Sbjct: 37 IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 772 SI--GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF---- 825
+ G + L+ L +Y HGSL YL + Y + + + + + AS L +L+
Sbjct: 93 NKDNGTWTQLW--LVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 826 GYSTPVI-HCDLKPSNVLLGDNMVAHLSDFGI 856
P I H DLK N+L+ N ++D G+
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 180
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
IG+G FG V++ + + G EVAVK+F+ R +S+ E E+ +++ RH NI+ I+
Sbjct: 17 IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 772 SI--GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF---- 825
+ G + L+ L +Y HGSL YL + Y + + + + + AS L +L+
Sbjct: 73 NKDNGTWTQLW--LVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 826 GYSTPVI-HCDLKPSNVLLGDNMVAHLSDFGI 856
P I H DLK N+L+ N ++D G+
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 160
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 17/152 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
IG+G FG V++ + + G EVAVK+F+ R +S+ E E+ +++ RH NI+ I+
Sbjct: 14 IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 772 SI--GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF---- 825
+ G + L+ L +Y HGSL YL + Y + + + + + AS L +L+
Sbjct: 70 NKDNGTWTQLW--LVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 826 GYSTPVI-HCDLKPSNVLLGDNMVAHLSDFGI 856
P I H DLK N+L+ N ++D G+
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 157
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 58.9 bits (141), Expect = 2e-08, Method: Composition-based stats.
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 766 K--------------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
I+ C G+ ++ E++P+ + E LY L + +
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPED-LYKD--FLTLEHLIC 152
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ 871
VA +E+L S IH DL N+LL + V + DFG+ + + ++ V +
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 58.9 bits (141), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRA-FKSFDVECEVMKSIRHRNIIKIISCC 771
+G G FG V+ + G+E +K N+ + + + E EV+KS+ H NIIKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 772 SIGDFKALFKALA-------LEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
D+ ++ + LE + S Y+ ++ +++ +AL Y
Sbjct: 89 -FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAYF- 140
Query: 825 FGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
+S V+H DLKP N+L D + + DFG+ +L ++ T T YMA
Sbjct: 141 --HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAP 195
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E V+ D+++ GV++ TG P
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVMYFLLTGCLP 224
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + M VA+K N + F E M+ H +I+K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L + LD+ + +++AL YL S
Sbjct: 78 GVITENPVWIIMELCTL-----GELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 129
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ N L DFG+++ + + ++ I +MA E + R
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESINFRR 188
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 232
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 233 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDG-MEVAVKVFNQQCGRAFK-SFDVECEV 755
F NNL +G G FG V +A +D ++VAVK+ K + E ++
Sbjct: 35 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 756 MKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI---------LD 805
M + +H NI+ ++ C+ G + EY +G L +L L+
Sbjct: 95 MSHLGQHENIVNLLGACTHGGPVLVIT----EYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+ L+ VA + +L S IH D+ NVLL + VA + DFG+ + + +
Sbjct: 151 LRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
++ + + +MA E + + DV+++G++L E F+
Sbjct: 208 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
VA +E+L S IH DL N+LL +N V + DFG+ + + + +V + T
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISI 934
+ +MA E + ST DV+++GV+L E F+ G P G+ +
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYP-----GVQMDE---------- 309
Query: 935 MKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRL 985
D RE ++ A E ++ + ++C P++R E+V +L
Sbjct: 310 ----DFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVA+K+ + Q + + E +MK + H NI+K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L +EY G + YL + + + R + SA++Y +
Sbjct: 83 --IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKR 134
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLT---REDQFVTQTQTPATIGYMALEYGSEG 887
++H DLK N+LL +M ++DFG + T + D F A + +Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD--- 191
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 192 --GPEVDVWSLGVILYTLVSGSLP 213
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 698 YLELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMK 757
Y + + F++ IG+G FG V+K I + + V A K D+E +
Sbjct: 19 YFQSMDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDE 68
Query: 758 SIRHRNIIKIISCCSIGDFKALFKA--------LALEYMPHGSLEKYLYSSNYILDIFQR 809
+ I ++S C + + + +EY+ GS L LD Q
Sbjct: 69 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQI 126
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ 869
I+ ++ L+YL+ S IH D+K +NVLL ++ L+DFG+ LT D + +
Sbjct: 127 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKR 181
Query: 870 TQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
T +MA E + + D+++ G+ +E G+ P +E+
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 26/295 (8%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI--RHRNIIKIISCC 771
+G+G +G V++ + G VAVK+F+ R +S+ E E+ ++ RH NI+ I+
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVKIFSS---RDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY---FGYS 828
+ L Y HGSL +L L+ L + + A L +L+ FG
Sbjct: 72 MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 829 -TPVI-HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP--ATIGYMALEYG 884
P I H D K NVL+ N+ ++D G+ + ++ ++ P T YMA E
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 885 SEGRVSTN-------GDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWV--NDWLLISIM 935
E ++ T+ D++ FG++L E + N I + + V ND +
Sbjct: 190 DE-QIRTDCFESYKWTDIWAFGLVLWE-IARRTIVNGIVEDYRPPFYDVVPNDPSFEDMK 247
Query: 936 KIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
K+V + +A + +S + M EC +P R+ A I L KI++
Sbjct: 248 KVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISN 302
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
F++ IG+G FG V+K I + + V A K D+E + + I +
Sbjct: 24 FTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITV 73
Query: 768 ISCCSIGDFKALFKA--------LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
+S C + + + +EY+ GS L LD Q I+ ++
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 131
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
L+YL+ S IH D+K +NVLL ++ L+DFG+ LT D + + T +M
Sbjct: 132 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWM 186
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
A E + + D+++ G+ +E G+ P +E+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDG-MEVAVKVFNQQCGRAFK-SFDVECEV 755
F NNL +G G FG V +A +D ++VAVK+ K + E ++
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 756 MKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI---------LD 805
M + +H NI+ ++ C+ G + EY +G L +L L+
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVIT----EYCCYGDLLNFLRRKAEADLDKEDGRPLE 158
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+ L+ VA + +L S IH D+ NVLL + VA + DFG+ + + +
Sbjct: 159 LRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
++ + + +MA E + + DV+++G++L E F+
Sbjct: 216 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
F++ IG+G FG V+K I + + V A K D+E + + I +
Sbjct: 9 FTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITV 58
Query: 768 ISCCSIGDFKALFKA--------LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
+S C + + + +EY+ GS L LD Q I+ ++
Sbjct: 59 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 116
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
L+YL+ S IH D+K +NVLL ++ L+DFG+ LT D + + T +M
Sbjct: 117 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWM 171
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
A E + + D+++ G+ +E G+ P +E+
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSI-RHRNII 765
+GRG FG V +A + VAVK+ + + ++ E +++ I H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYL---------YSSNYILDIFQRLNIMI-- 814
++ C+ + + +E+ G+L YL Y + F L +I
Sbjct: 97 NLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 815 --DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
VA +E+L S IH DL N+LL + V + DFG+ + + ++ V +
Sbjct: 154 SFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ +MA E + + DV++FGV+L E F+ G P
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
F++ IG+G FG V+K I + + V A K D+E + + I +
Sbjct: 9 FTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITV 58
Query: 768 ISCCSIGDFKALFKA--------LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
+S C + + + +EY+ GS L LD Q I+ ++
Sbjct: 59 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 116
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
L+YL+ S IH D+K +NVLL ++ L+DFG+ LT D + + T +M
Sbjct: 117 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 171
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
A E + + D+++ G+ +E G+ P +E+
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 708 FSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFN--------QQCGRAFKSFDVECEVMKS 758
+ ++IGRG V + G E AVK+ +Q ++ E +++
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 759 IR-HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVA 817
+ H +II +I F +F L + M G L YL + L + +IM
Sbjct: 156 VAGHPHIITLIDSYESSSF--MF--LVFDLMRKGELFDYL-TEKVALSEKETRSIM---R 207
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
S LE + F ++ ++H DLKP N+LL DNM LSDFG + L ++ TP G
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP---G 264
Query: 878 YMALE------------YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y+A E YG E D++ GV+L G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKE------VDLWACGVILFTLLAGSPP 304
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 701 LCQATDGFSENNLIGRGGFGSVYKAR--IQDGMEVAVKVFNQQCGRAFKSFDVECEV--- 755
LC+A + IG G +G V+KAR G VA+K Q G EV
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 756 --MKSIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKYL-------YSSNYILD 805
+++ H N++++ C++ K L E++ L YL + I D
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+ M + L++L+ S V+H DLKP N+L+ + L+DFG+ ++ + +
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ T T+ Y A E + +T D+++ G + E F +KP
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 701 LCQATDGFSENNLIGRGGFGSVYKAR--IQDGMEVAVKVFNQQCGRAFKSFDVECEV--- 755
LC+A + IG G +G V+KAR G VA+K Q G EV
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 756 --MKSIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKYL-------YSSNYILD 805
+++ H N++++ C++ K L E++ L YL + I D
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+ M + L++L+ S V+H DLKP N+L+ + L+DFG+ ++ + +
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ T T+ Y A E + +T D+++ G + E F +KP
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 701 LCQATDGFSENNLIGRGGFGSVYKAR--IQDGMEVAVKVFNQQCGRAFKSFDVECEV--- 755
LC+A + IG G +G V+KAR G VA+K Q G EV
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 756 --MKSIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKYL-------YSSNYILD 805
+++ H N++++ C++ K L E++ L YL + I D
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 806 IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQ 865
+ M + L++L+ S V+H DLKP N+L+ + L+DFG+ ++ + +
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 866 FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ T T+ Y A E + +T D+++ G + E F +KP
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + M VA+K N + F E M+ H +I+K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L + LD+ + +++AL YL S
Sbjct: 78 GVITENPVWIIMELCTL-----GELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 129
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ L DFG+++ + + + ++ I +MA E + R
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 232
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 233 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 50/186 (26%), Positives = 92/186 (49%), Gaps = 18/186 (9%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMK-SIRHRNIIK 766
F +++G G G++ + D +VAVK +C F D E ++++ S H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
C+ D + F+ +A+E +L++Y+ ++ + + ++ S L +L+
Sbjct: 83 YF--CTEKDRQ--FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH-- 135
Query: 827 YSTPVIHCDLKPSNVLLG-----DNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIGYMA 880
S ++H DLKP N+L+ + A +SDFG+ KL F ++ P T G++A
Sbjct: 136 -SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 881 LEYGSE 886
E SE
Sbjct: 195 PEMLSE 200
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 56.6 bits (135), Expect = 6e-08, Method: Composition-based stats.
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 22/220 (10%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFN-QQCGRAFKSFDVECEVMKSIRHRN 763
D + +IG G V A E VA+K N ++C + E + M H N
Sbjct: 10 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 764 IIKIISCCSIGD-----FKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+ + + D K L L+ + H + K + S +LD I+ +V
Sbjct: 70 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSG-VLDESTIATILREVLE 127
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL------TREDQFVTQTQT 872
LEYL+ IH D+K N+LLG++ ++DFG++ L TR T T
Sbjct: 128 GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 873 PATIGYMALEYGSEGR-VSTNGDVYNFGVMLMETFTGKKP 911
P +MA E + R D+++FG+ +E TG P
Sbjct: 185 PC---WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 56.6 bits (135), Expect = 6e-08, Method: Composition-based stats.
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 22/220 (10%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFN-QQCGRAFKSFDVECEVMKSIRHRN 763
D + +IG G V A E VA+K N ++C + E + M H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 764 IIKIISCCSIGD-----FKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+ + + D K L L+ + H + K + S +LD I+ +V
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSG-VLDESTIATILREVLE 132
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL------TREDQFVTQTQT 872
LEYL+ IH D+K N+LLG++ ++DFG++ L TR T T
Sbjct: 133 GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 873 PATIGYMALEYGSEGR-VSTNGDVYNFGVMLMETFTGKKP 911
P +MA E + R D+++FG+ +E TG P
Sbjct: 190 PC---WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 35/281 (12%)
Query: 714 IGRGGFGSV----YKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKII 768
IG G FG V Y + M VA+K N + F E M+ H +I+K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ + + L G L +L + LD+ + +++AL YL S
Sbjct: 458 GVITENPVWIIMELCTL-----GELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
+H D+ NVL+ L DFG+++ + + + ++ I +MA E + R
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 889 VSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSRED 947
++ DV+ FGV + E G KP + N ND I +I +G L
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKN---------ND----VIGRIENGERLP--- 612
Query: 948 IQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKI 988
C ++++ +C P +R E+ +L I
Sbjct: 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 68/283 (24%), Positives = 130/283 (45%), Gaps = 50/283 (17%)
Query: 733 VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI--IKIISCCS----IGDFKALFK----A 782
V KV ++ G + E+ +IR++ I ++++ C+ +G + A + +
Sbjct: 24 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 83
Query: 783 LALEYMPHGSLEKYLYSSNYILD-IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNV 841
+ +E+M GSL++ L + I + I +++I V L YL + ++H D+KPSN+
Sbjct: 84 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNI 139
Query: 842 LLGDNMVAHLSDFGITKLLTRE--DQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFG 899
L+ L DFG++ L E ++FV T YM+ E S D+++ G
Sbjct: 140 LVNSRGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPERLQGTHYSVQSDIWSMG 193
Query: 900 VMLMETFTGK--KPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCM 957
+ L+E G+ +P IF + D+++ + ++ S E FV K
Sbjct: 194 LSLVEMAVGRYPRPPMAIFE--------LLDYIVNEPPPKLPSAVFSLEFQDFVNK---- 241
Query: 958 SFVFNMAMECTVESPEKRINAKEI-VTRLLKIND---LDFNGY 996
C +++P +R + K++ V +K +D +DF G+
Sbjct: 242 ---------CLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGW 275
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V A G +VAVK + + + + E +M+ H N++ + S
Sbjct: 53 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +E++ G+L + + ++ Q + + V AL YL+ + VI
Sbjct: 113 VGD--ELW--VVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVI 163
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H D+K ++LL + LSDFG +++E + T +MA E S T
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 893 GDVYNFGVMLMETFTGKKPTNEIFNE 918
D+++ G+M++E G+ P FNE
Sbjct: 222 VDIWSLGIMVIEMIDGEPP---YFNE 244
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 56.2 bits (134), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 17/237 (7%)
Query: 708 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNI 764
FS + +IGRGGFG VY R D G A+K +++ + ++ + +M S+
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
I C S + L+ M G L +L +F ++ A + L
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLE 306
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYG 884
++ V++ DLKP+N+LL ++ +SD G+ +++ + T GYMA E
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVL 362
Query: 885 SEG-RVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTL-KHWVNDWLLISIMKIVD 939
+G ++ D ++ G ML + G P F + T KH ++ L +++ D
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPD 415
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 56.2 bits (134), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 17/237 (7%)
Query: 708 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNI 764
FS + +IGRGGFG VY R D G A+K +++ + ++ + +M S+
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
I C S + L+ M G L +L +F ++ A + L
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLE 305
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYG 884
++ V++ DLKP+N+LL ++ +SD G+ +++ + T GYMA E
Sbjct: 306 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVL 361
Query: 885 SEG-RVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTL-KHWVNDWLLISIMKIVD 939
+G ++ D ++ G ML + G P F + T KH ++ L +++ D
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPD 414
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEV--AVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
++ N IGRG +G V K +Q G + A K + F E E+MKS+ H NII
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSL-EKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
++ + D ++ L +E G L E+ ++ + R IM DV SA+ Y
Sbjct: 70 RLYE--TFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYC- 122
Query: 825 FGYSTPVIHCDLKPSNVL-LGDNMVAHLS--DFGITKLLTREDQFVTQTQTPATIGYMAL 881
+ V H DLKP N L L D+ + L DFG+ T+ TP + L
Sbjct: 123 --HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 882 E--YGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLK 923
E YG E D ++ GVM+ G P + + + LK
Sbjct: 181 EGLYGPE------CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLK 218
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 17/237 (7%)
Query: 708 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNI 764
FS + +IGRGGFG VY R D G A+K +++ + ++ + +M S+
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
I C S + L+ M G L +L +F ++ A + L
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLE 306
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYG 884
++ V++ DLKP+N+LL ++ +SD G+ +++ + T GYMA E
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVL 362
Query: 885 SEG-RVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTL-KHWVNDWLLISIMKIVD 939
+G ++ D ++ G ML + G P F + T KH ++ L +++ D
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPD 415
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 17/237 (7%)
Query: 708 FSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNI 764
FS + +IGRGGFG VY R D G A+K +++ + ++ + +M S+
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
I C S + L+ M G L +L +F ++ A + L
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLE 306
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYG 884
++ V++ DLKP+N+LL ++ +SD G+ +++ + T GYMA E
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVL 362
Query: 885 SEG-RVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTL-KHWVNDWLLISIMKIVD 939
+G ++ D ++ G ML + G P F + T KH ++ L +++ D
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPD 415
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEV--AVKVFNQQCGRAFKSFDVECEVMKSIRHRNII 765
++ N IGRG +G V K +Q G + A K + F E E+MKS+ H NII
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSL-EKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
++ + D ++ L +E G L E+ ++ + R IM DV SA+ Y
Sbjct: 87 RLYE--TFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYC- 139
Query: 825 FGYSTPVIHCDLKPSNVL-LGDNMVAHLS--DFGITKLLTREDQFVTQTQTPATIGYMAL 881
+ V H DLKP N L L D+ + L DFG+ T+ TP + L
Sbjct: 140 --HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 197
Query: 882 E--YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E YG E D ++ GVM+ G P
Sbjct: 198 EGLYGPE------CDEWSAGVMMYVLLCGYPP 223
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFNQ-----QCGRAFKSFDVECEVMKSIRHRNII 765
+IGRG FG V R + +V A+K+ ++ + AF F E ++M ++
Sbjct: 81 KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 138
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
++ C+ D K L+ + +EYMP G L + SNY + +V AL+ ++
Sbjct: 139 QLF--CAFQDDKYLY--MVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH- 191
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY-- 883
S +IH D+KP N+LL + L+DFG T + E V T Y++ E
Sbjct: 192 --SMGLIHRDVKPDNMLLDKHGHLKLADFG-TCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 884 --GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
G +G D ++ GV L E G P
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 41/231 (17%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDG-MEVAVKVFNQQCGRAFK-SFDVECEV 755
F NNL +G G FG V +A +D ++VAVK+ K + E ++
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 756 MKSI-RHRNIIKIISCCSIG----------------DFKALFKALALEYM--PHGSLEKY 796
M + +H NI+ ++ C+ G +F + LEY P + E+
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 797 LYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGI 856
L S + L+ VA + +L S IH D+ NVLL + VA + DFG+
Sbjct: 163 LSSRDL-------LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGL 212
Query: 857 TKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ + + ++ + + +MA E + + DV+++G++L E F+
Sbjct: 213 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQC-GRAFKSFDV-ECEVMKSIRHRNIIKIISCC 771
+G G +G VYKA+ G VA+K S + E ++K + H NI+ +I
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV- 87
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
I + L L E+M L+K L + L Q I I + L + + +
Sbjct: 88 -IHSERCL--TLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE--YGSEGRV 889
+H DLKP N+L+ + L+DFG+ + + + T T+ Y A + GS+ +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSK-KY 197
Query: 890 STNGDVYNFGVMLMETFTGK 909
ST+ D+++ G + E TGK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQC-GRAFKSFDV-ECEVMKSIRHRNIIKIISCC 771
+G G +G VYKA+ G VA+K S + E ++K + H NI+ +I
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV- 87
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
I + L L E+M L+K L + L Q I I + L + + +
Sbjct: 88 -IHSERCL--TLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE--YGSEGRV 889
+H DLKP N+L+ + L+DFG+ + + + T T+ Y A + GS+ +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSK-KY 197
Query: 890 STNGDVYNFGVMLMETFTGK 909
ST+ D+++ G + E TGK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 709 SENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
S+ ++G G FG V+K G+++A K+ + + + E VM + H N+I++
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 768 ISCC-SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
S D L +EY+ G L + +Y L + M + + +++
Sbjct: 152 YDAFESKNDI-----VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 827 YSTPVIHCDLKPSNVLLGDNMVAHLS--DFGITKLLTREDQFVTQTQTPATIGYMALEYG 884
Y ++H DLKP N+L + + DFG+ + ++ TP ++A E
Sbjct: 207 Y---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE---FLAPEVV 260
Query: 885 SEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ VS D+++ GV+ +G P
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSP 287
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
F++ + IG+G FG VYK EV A K D+E + + I +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVV----------AIKIIDLEEAEDEIEDIQQEITV 70
Query: 768 ISCCSIGDFKALFKA--------LALEYMPHGS----LEKYLYSSNYILDIFQRLNIMID 815
+S C F + + +EY+ GS L+ YI I + +
Sbjct: 71 LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------E 124
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
+ L+YL+ S IH D+K +NVLL + L+DFG+ LT D + + T
Sbjct: 125 ILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGT 179
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
+MA E + D+++ G+ +E G+ P +++
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
IG+G F V AR I G EVAVK+ + Q + + E + K + H NI+K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K L+ L EY G + YL + + R + SA++Y + +
Sbjct: 82 --IETEKTLY--LVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF--- 133
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE-YGSEGRV 889
++H DLK N+LL + ++DFG + T ++ P Y A E + +
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPP---YAAPELFQGKKYD 190
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
DV++ GV+L +G P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V AR + G +VAVK+ + + + + E +M+ +H N++++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+G+ L+ + +E++ G+L + S L+ Q + V AL YL+ + VI
Sbjct: 113 VGE--ELW--VLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVI 163
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H D+K ++LL + LSDFG ++++ + T +MA E S +T
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 893 GDVYNFGVMLMETFTGKKP 911
D+++ G+M++E G+ P
Sbjct: 222 VDIWSLGIMVIEMVDGEPP 240
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 36/300 (12%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVF-NQQCGRAFKSFDVECEVMKSIRHRNIIKIISC-- 770
IG+G +G V+ + + G +VAVKVF + F+ ++ V+ +RH NI+ I+
Sbjct: 45 IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAADI 101
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG-YST 829
G + L+ L +Y +GSL YL S+ LD L + S L +L+ +ST
Sbjct: 102 KGTGSWTQLY--LITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 830 ---PVI-HCDLKPSNVLLGDNMVAHLSDFGIT-KLLTREDQFVTQTQTP-ATIGYMALEY 883
P I H DLK N+L+ N ++D G+ K ++ ++ T T YM E
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 884 GSEG------RVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWV-------NDWL 930
E + D+Y+FG++L E + + I E H + D
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEV-ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 931 LISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLKIND 990
I +K + S +R + ++C+ + + EC +P R+ A + L K+++
Sbjct: 277 EIVCIKKLRPSFPNR-----WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
+D + +G+G F V + G+E A K+ N + R F+ + E + + ++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ + F L + + G L + + + + + + + LE
Sbjct: 88 PNIVRLHDSIQ----EESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 139
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
+ + +S ++H +LKP N+LL L+DFG+ + + + TP GY
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP---GY 196
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ E + S D++ GV+L G P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 54.3 bits (129), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 18/229 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVEC-----EVMKSI 759
D F ++G+G FG V AR+++ G AVKV + + DVEC ++
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--ILQDDDVECTMTEKRILSLA 80
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
R+ + + CC + F +E++ G L ++ S F A
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFF---VMEFVNGGDLMFHIQKSRR----FDEARARFYAAEI 133
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
+ L F + +I+ DLK NVLL L+DFG+ K VT T Y+
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYI 191
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVND 928
A E E D + GV+L E G P E NE + +ND
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILND 239
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 42/235 (17%)
Query: 708 FSENNL-----IGRGGFGSVYKARI-----QDG-MEVAVKVFNQQCGRAFK-SFDVECEV 755
F NNL +G G FG V +A +D ++VAVK+ K + E ++
Sbjct: 28 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 756 MKSI-RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLY---------------- 798
M + +H NI+ ++ C+ G + EY +G L +L
Sbjct: 88 MSHLGQHENIVNLLGACTHGGPVLVIT----EYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 799 ------SSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS 852
L++ L+ VA + +L S IH D+ NVLL + VA +
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIG 200
Query: 853 DFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
DFG+ + + + ++ + + +MA E + + DV+++G++L E F+
Sbjct: 201 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 712 NLIGRGGFGSVYKARIQDG--------MEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRN 763
++G+GG+G V++ R G M+V K + + E +++ ++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
I+ +I G L+ L LEY+ G L L ++ + +++ AL +L
Sbjct: 83 IVDLIYAFQTGG--KLY--LILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHL 137
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ +I+ DLKP N++L L+DFG+ K + D VT T TI YMA E
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC-GTIEYMAPEI 192
Query: 884 GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ D ++ G ++ + TG P
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 32/194 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV---------ECEV 755
D + IG G +G V AR + G +VA+K + +FDV E ++
Sbjct: 55 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKI 107
Query: 756 MKSIRHRNIIKIIS----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
+K +H NII I G+FK+++ L L L + ++SS L +
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM---ESDLHQIIHSSQ-PLTLEHVRY 163
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---TREDQFVT 868
+ + L+Y++ S VIH DLKPSN+L+ +N + DFG+ + L E Q+
Sbjct: 164 FLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 869 QTQTPATIGYMALE 882
T+ AT Y A E
Sbjct: 221 -TEYVATRWYRAPE 233
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 32/194 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV---------ECEV 755
D + IG G +G V AR + G +VA+K + +FDV E ++
Sbjct: 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKI 106
Query: 756 MKSIRHRNIIKIIS----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
+K +H NII I G+FK+++ L L L + ++SS L +
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM---ESDLHQIIHSSQ-PLTLEHVRY 162
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---TREDQFVT 868
+ + L+Y++ S VIH DLKPSN+L+ +N + DFG+ + L E Q+
Sbjct: 163 FLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 869 QTQTPATIGYMALE 882
T+ AT Y A E
Sbjct: 220 -TEYVATRWYRAPE 232
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 112
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 113 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 160
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T T+ Y A E G + ST D+++ G + E T +
Sbjct: 161 YTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 202
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 118
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 119 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 168
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 169 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 208
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 53.5 bits (127), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 111
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 112 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 161
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 162 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 53.5 bits (127), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 111
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 112 --------LLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 161
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 162 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 53.5 bits (127), Expect = 5e-07, Method: Composition-based stats.
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 715 GRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIG 774
RG FG V+KA++ + VAVK+F Q +++++ + E + ++H NI++ I G
Sbjct: 33 ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 775 DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF-------GY 827
+ L + GSL +L ++ ++ + +I +A L YL+ G+
Sbjct: 91 TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGIT-KLLTREDQFVTQTQTPATIGYMALEYGSE 886
+ H D+K NVLL +N+ A ++DFG+ K + T Q T YMA E E
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV-GTRRYMAPEV-LE 206
Query: 887 GRVSTNG------DVYNFGVMLME 904
G ++ D+Y G++L E
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWE 230
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 733 VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI--IKIISCCS----IGDFKALFK----A 782
V KV ++ G + E+ +IR++ I ++++ C+ +G + A + +
Sbjct: 31 VVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 90
Query: 783 LALEYMPHGSLEKYLYSSNYILD-IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNV 841
+ +E+M GSL++ L + I + I +++I V L YL + ++H D+KPSN+
Sbjct: 91 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSNI 146
Query: 842 LLGDNMVAHLSDFGITKLL--TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFG 899
L+ L DFG++ L + + FV T YMA E S D+++ G
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMAPERLQGTHYSVQSDIWSMG 200
Query: 900 VMLMETFTGKKP 911
+ L+E G+ P
Sbjct: 201 LSLVELAVGRYP 212
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRHRNIIKIIS 769
+G G FG V+ R + +G A+KV ++ K + E ++ + H II++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM-- 71
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
+ D + +F + ++Y+ G L L S + + +V ALEYL+ S
Sbjct: 72 WGTFQDAQQIF--MIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SK 125
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
+I+ DLKP N+LL N ++DFG K + D TP Y+A E S
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYXLCGTP---DYIAPEVVSTKPY 180
Query: 890 STNGDVYNFGVMLMETFTGKKP 911
+ + D ++FG+++ E G P
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTP 202
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 712 NLIGRGGFGSVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
LIG+G FG VY R EVA+++ + + K+F E + RH N++ +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
C A+ +L +L + + +LD+ + I ++ + YL ++
Sbjct: 97 ACMSPPHLAIITSLC----KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAK 149
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDF------GITKLLTREDQFVTQTQ-----TPATIGY 878
++H DLK NV DN ++DF G+ + RED+ Q P I
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 879 MALEYGSEG-RVSTNGDVYNFGVMLMETFTGKKP 911
++ + + S + DV+ G + E + P
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVA----VKVFNQQCGRAFKSFDVECEVMKSIRH 761
+ F + IG G +G VYKAR + EV +++ + G + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 762 RNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQR 809
NI+K++ D K A AL +P ++ YL+
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ---------- 111
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ 869
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 112 ---------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 160
Query: 870 TQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T T+ Y A E G + ST D+++ G + E T +
Sbjct: 161 THEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVA----VKVFNQQCGRAFKSFDVECEVMKSIRH 761
+ F + IG G +G VYKAR + EV +++ + G + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 762 RNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQR 809
NI+K++ D K A AL +P ++ YL+
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ 869
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 111 ---------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 159
Query: 870 TQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T T+ Y A E G + ST D+++ G + E T +
Sbjct: 160 THEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQC-GRAFKSFDVECEV--MKSIRHRNIIKIIS 769
+G G FG V A + +VA+K ++Q ++ VE E+ +K +RH +IIK+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 770 CCSI-GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+ D + +EY G L Y+ + + R + A+EY +
Sbjct: 77 VITTPTDI-----VMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---R 126
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY-GSEG 887
++H DLKP N+LL DN+ ++DFG++ ++T + T +P Y A E +
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVINGKL 183
Query: 888 RVSTNGDVYNFGVMLMETFTGKKPTNEIF 916
DV++ G++L G+ P ++ F
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 53/218 (24%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFD-------V 751
L++ + + + +G G F +VYKAR ++ ++ V + + G ++ D
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALR 61
Query: 752 ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
E ++++ + H NII ++ + G + +L ++M LE + ++ +L
Sbjct: 62 EIKLLQELSHPNIIGLLD--AFGHKSNI--SLVFDFM-ETDLEVIIKDNSLVLTPSHIKA 116
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED-----QF 866
M+ LEYL+ + ++H DLKP+N+LL +N V L+DFG+ K + Q
Sbjct: 117 YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQV 173
Query: 867 VTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLME 904
VT+ + + A YG D++ G +L E
Sbjct: 174 VTRWYRAPELLFGARMYG------VGVDMWAVGCILAE 205
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 52.8 bits (125), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V A ++ G VAVK + + + + E +M+ +H N++++ +
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +E++ G+L + + ++ Q + + V AL L+ + VI
Sbjct: 142 VGD--ELW--VVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVI 192
Query: 833 HCDLKPSNVLLGDNMVAHLSDFG----ITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
H D+K ++LL + LSDFG ++K + R V T +MA E S
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 246
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
D+++ G+M++E G+ P FNE
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEPP---YFNE 273
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 52.8 bits (125), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V A ++ G VAVK + + + + E +M+ +H N++++ +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +E++ G+L + + ++ Q + + V AL L+ + VI
Sbjct: 219 VGD--ELW--VVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVI 269
Query: 833 HCDLKPSNVLLGDNMVAHLSDFG----ITKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
H D+K ++LL + LSDFG ++K + R V T +MA E S
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISRLP 323
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNE 918
D+++ G+M++E G+ P FNE
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPP---YFNE 350
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 52.8 bits (125), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 44/244 (18%)
Query: 695 RFSYLELCQATDGFSEN----NLIGRGGFGSVYKARIQDGM--EVAVKVFNQQCGRAFKS 748
R + L +T GF EN ++GRG SV + I E AVK+ + G +F +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 749 FDV---------ECEVMKSIR-HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLY 798
+V E ++++ + H NII++ F F L + M G L YL
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF--FF--LVFDLMKKGELFDYLT 116
Query: 799 SSNYILDIFQR--LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGI 856
+ + R + +++V AL L ++H DLKP N+LL D+M L+DFG
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 857 TKLLTREDQFVTQTQTPATIGYMALE---------YGSEGRVSTNGDVYNFGVMLMETFT 907
+ L ++ + TP+ + +E YG E D+++ GV++
Sbjct: 171 SCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLA 224
Query: 908 GKKP 911
G P
Sbjct: 225 GSPP 228
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 52.8 bits (125), Expect = 9e-07, Method: Composition-based stats.
Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
+D + +G+G F V + G+E A K+ N + R F+ + E + + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ + F L + + G L + + + + + + + LE
Sbjct: 65 PNIVRLHDSIQ----EESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 116
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
+ + +S ++H +LKP N+LL L+DFG+ + + + TP GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP---GY 173
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ E + S D++ GV+L G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 52.8 bits (125), Expect = 9e-07, Method: Composition-based stats.
Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
+D + +G+G F V + G+E A K+ N + R F+ + E + + ++H
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ + F L + + G L + + + + + + + LE
Sbjct: 64 PNIVRLHDSIQ----EESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 115
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
+ + +S ++H +LKP N+LL L+DFG+ + + + TP GY
Sbjct: 116 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP---GY 172
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ E + S D++ GV+L G P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 52.8 bits (125), Expect = 9e-07, Method: Composition-based stats.
Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
+D + +G+G F V + G+E A K+ N + R F+ + E + + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ + F L + + G L + + + + + + + LE
Sbjct: 65 PNIVRLHDSIQ----EESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 116
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
+ + +S ++H +LKP N+LL L+DFG+ + + + TP GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP---GY 173
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ E + S D++ GV+L G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVA----VKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
IG G +G+V+KA+ ++ E+ V++ + G + C ++K ++H+NI+++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHD 68
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
+ K L L E+ L+KY S N LD + + + L+ L F +S
Sbjct: 69 V--LHSDKKL--TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFCHSR 120
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITK-----LLTREDQFVTQTQTPATIGYMALEYG 884
V+H DLKP N+L+ N L+DFG+ + + + VT P + + A Y
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY- 179
Query: 885 SEGRVSTNGDVYNFGVMLMETFTGKKP 911
ST+ D+++ G + E +P
Sbjct: 180 -----STSIDMWSAGCIFAELANAARP 201
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 700 ELCQATDGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFNQ-----QCGRAFKSFDVEC 753
+L + + +IGRG FG V R + +V A+K+ ++ + AF F E
Sbjct: 68 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEER 125
Query: 754 EVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNY-ILDIFQRLNI 812
++M ++++ + D + L+ + +EYMP G L + SNY + + + R
Sbjct: 126 DIMAFANSPWVVQLF--YAFQDDRYLY--MVMEYMPGGDLVNLM--SNYDVPEKWARF-Y 178
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ- 871
+V AL+ ++ S IH D+KP N+LL + L+DFG + +E T
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 872 -TPATIGYMALE-YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP I L+ G +G D ++ GV L E G P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 35/219 (15%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI- 764
D F + + +G G G V+K V ++ G + E+ +IR++ I
Sbjct: 68 DDFEKISELGAGNGGVVFK------------VSHKPSGLVMARKLIHLEIKPAIRNQIIR 115
Query: 765 -IKIISCCS----IGDFKALFK----ALALEYMPHGSLEKYLYSSNYILD-IFQRLNIMI 814
++++ C+ +G + A + ++ +E+M GSL++ L + I + I +++I
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 174
Query: 815 DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL--TREDQFVTQTQT 872
V L YL + ++H D+KPSN+L+ L DFG++ L + + FV
Sbjct: 175 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 226
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T YM+ E S D+++ G+ L+E G+ P
Sbjct: 227 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 700 ELCQATDGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFNQ-----QCGRAFKSFDVEC 753
+L + + +IGRG FG V R + +V A+K+ ++ + AF F E
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEER 120
Query: 754 EVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNY-ILDIFQRLNI 812
++M ++++ + D + L+ + +EYMP G L + SNY + + + R
Sbjct: 121 DIMAFANSPWVVQLF--YAFQDDRYLY--MVMEYMPGGDLVNLM--SNYDVPEKWARF-Y 173
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ- 871
+V AL+ ++ S IH D+KP N+LL + L+DFG + +E T
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 872 -TPATIGYMALE-YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP I L+ G +G D ++ GV L E G P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 72/313 (23%), Positives = 137/313 (43%), Gaps = 58/313 (18%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI- 764
D F + + +G G G V+K V ++ G + E+ +IR++ I
Sbjct: 6 DDFEKISELGAGNGGVVFK------------VSHKPSGLVMARKLIHLEIKPAIRNQIIR 53
Query: 765 -IKIISCCS----IGDFKALFK----ALALEYMPHGSLEKYLYSSNYILD-IFQRLNIMI 814
++++ C+ +G + A + ++ +E+M GSL++ L + I + I +++I
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 112
Query: 815 DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL--TREDQFVTQTQT 872
V L YL + ++H D+KPSN+L+ L DFG++ L + + FV
Sbjct: 113 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 164
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP-----TNEIFNEGMTLKHWVN 927
T YM+ E S D+++ G+ L+E G+ P E M + +
Sbjct: 165 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELL- 222
Query: 928 DWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEI-VTRLL 986
D+++ + + S E FV K C +++P +R + K++ V +
Sbjct: 223 DYIVNEPPPKLPSGVFSLEFQDFVNK-------------CLIKNPAERADLKQLMVHAFI 269
Query: 987 KIND---LDFNGY 996
K +D +DF G+
Sbjct: 270 KRSDAEEVDFAGW 282
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 42/281 (14%)
Query: 733 VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI--IKIISCCS----IGDFKALFK----A 782
V KV ++ G + E+ +IR++ I ++++ C+ +G + A + +
Sbjct: 40 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 99
Query: 783 LALEYMPHGSLEKYLYSSNYILD-IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNV 841
+ +E+M GSL++ L + I + I +++I V L YL + ++H D+KPSN+
Sbjct: 100 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNI 155
Query: 842 LLGDNMVAHLSDFGITKLL--TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFG 899
L+ L DFG++ L + + FV T YM+ E S D+++ G
Sbjct: 156 LVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMG 209
Query: 900 VMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSF 959
+ L+E G+ P G + D+++ + + S E FV K
Sbjct: 210 LSLVEMAVGRYPIGS--GSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK------ 261
Query: 960 VFNMAMECTVESPEKRINAKEI-VTRLLKIND---LDFNGY 996
C +++P +R + K++ V +K +D +DF G+
Sbjct: 262 -------CLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGW 295
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 52.4 bits (124), Expect = 1e-06, Method: Composition-based stats.
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 29/225 (12%)
Query: 715 GRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKS--IRHRNIIKIISCCS 772
RG FG V+KA++ + VAVK+F Q ++++S E E+ + ++H N+++ I+
Sbjct: 24 ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS---EREIFSTPGMKHENLLQFIAAEK 79
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF------- 825
G + L + GSL YL + I+ + ++ ++ L YL+
Sbjct: 80 RGSNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 826 -GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG---YMAL 881
G+ + H D K NVLL ++ A L+DFG L R + T +G YMA
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFG---LAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 882 EYGSEGRVSTNG------DVYNFGVMLMETFTGKKPTNEIFNEGM 920
E EG ++ D+Y G++L E + K + +E M
Sbjct: 195 EV-LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYM 238
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 700 ELCQATDGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFNQ-----QCGRAFKSFDVEC 753
+L + + +IGRG FG V R + +V A+K+ ++ + AF F E
Sbjct: 68 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEER 125
Query: 754 EVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNY-ILDIFQRLNI 812
++M ++++ + D + L+ + +EYMP G L + SNY + + + R
Sbjct: 126 DIMAFANSPWVVQLF--YAFQDDRYLY--MVMEYMPGGDLVNLM--SNYDVPEKWARF-Y 178
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ- 871
+V AL+ ++ S IH D+KP N+LL + L+DFG + +E T
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 872 -TPATIGYMALE-YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP I L+ G +G D ++ GV L E G P
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 701 LCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI 759
L A+D F E ++G+G FG V KAR D A+K + + E ++ S+
Sbjct: 2 LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASL 59
Query: 760 RHRNIIKIISC-----------CSIGDFKALFKALALEYMPHGSLEKYLYSSN--YILDI 806
H+ +++ + ++ LF + +EY +G+L ++S N D
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF--IQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 807 FQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF 866
+ RL I LE L + +S +IH DLKP N+ + ++ + DFG+ K + R
Sbjct: 118 YWRLFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 867 VT------------QTQTPATIGYMALEY-GSEGRVSTNGDVYNFGVMLME 904
+ T T Y+A E G + D+Y+ G++ E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +GSV Y AR++ +VAVK + Q A +++ E ++K ++H N+I +
Sbjct: 36 VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 768 IS----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
+ SI DF ++ L G+ + S + D ++ V L L
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTL----MGADLNNIVKSQALSD----EHVQFLVYQLLRGL 144
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ +S +IH DLKPSNV + ++ + DFG+ + + D+ +T GY+A +
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRW 193
Query: 884 GSEGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 64/244 (26%), Positives = 104/244 (42%), Gaps = 44/244 (18%)
Query: 695 RFSYLELCQATDGFSEN----NLIGRGGFGSVYKARIQDGM--EVAVKVFNQQCGRAFKS 748
R + L +T GF EN ++GRG SV + I E AVK+ + G +F +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 749 FDV---------ECEVMKSIR-HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLY 798
+V E ++++ + H NII++ F F L + M G L YL
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF--FF--LVFDLMKKGELFDYLT 116
Query: 799 SSNYILDIFQR--LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGI 856
+ + R + +++V AL L ++H DLKP N+LL D+M L+DFG
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 857 TKLLTREDQFVTQTQTPATIGYMALE---------YGSEGRVSTNGDVYNFGVMLMETFT 907
+ L ++ TP+ + +E YG E D+++ GV++
Sbjct: 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLA 224
Query: 908 GKKP 911
G P
Sbjct: 225 GSPP 228
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 712 NLIGRGGFGSVYKARIQDG--------MEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRN 763
++G+GG+G V++ R G M+V K + + E +++ ++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
I+ +I G L+ L LEY+ G L L ++ + +++ AL +L
Sbjct: 83 IVDLIYAFQTGG--KLY--LILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHL 137
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ +I+ DLKP N++L L+DFG+ K + D VT TI YMA E
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFC-GTIEYMAPEI 192
Query: 884 GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ D ++ G ++ + TG P
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQC-GRAFKSFDVECEV--MKSIRHRNIIKIIS 769
+G G FG V A G +VA+K+ N++ ++ +E E+ ++ +RH +IIK+
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
D + A + +++ S FQ+ + SA+EY +
Sbjct: 72 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 122
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
++H DLKP N+LL +++ ++DFG++ ++T + T +P Y A E S G++
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVIS-GKL 178
Query: 890 STNG--DVYNFGVMLMETFTGKKPTNE 914
DV++ GV+L + P ++
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDD 205
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQC-GRAFKSFDVECEV--MKSIRHRNIIKIIS 769
+G G FG V A G +VA+K+ N++ ++ +E E+ ++ +RH +IIK+
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
D + A + +++ S FQ+ + SA+EY +
Sbjct: 81 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 131
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
++H DLKP N+LL +++ ++DFG++ ++T + T +P Y A E S G++
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVIS-GKL 187
Query: 890 STNG--DVYNFGVMLMETFTGKKPTNE 914
DV++ GV+L + P ++
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDD 214
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 733 VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI--IKIISCCS----IGDFKALFK----A 782
V KV ++ G + E+ +IR++ I ++++ C+ +G + A + +
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 783 LALEYMPHGSLEKYLYSSNYILD-IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNV 841
+ +E+M GSL++ L + I + I +++I V L YL + ++H D+KPSN+
Sbjct: 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNI 136
Query: 842 LLGDNMVAHLSDFGITKLL--TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFG 899
L+ L DFG++ L + + FV T YM+ E S D+++ G
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMG 190
Query: 900 VMLMETFTGKKP 911
+ L+E G+ P
Sbjct: 191 LSLVEMAVGRYP 202
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQDG--MEVAVKVFNQQCGRAFKSFDVECEVMKSIR 760
Q TDG+ IG G + SV K I ME AVK+ ++ + ++ +++ +
Sbjct: 19 QFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQ 74
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H NII + G + + E M G L + + + + ++ + +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVT----ELMKGGELLDKILRQKFFSE-REASAVLFTITKTV 129
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL----GDNMVAHLSDFGITKLLTREDQFVTQTQTPA-T 875
EYL+ + V+H DLKPSN+L G+ + DFG K L E+ + TP T
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL---MTPCYT 183
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++A E D+++ GV+L TG P
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 52.0 bits (123), Expect = 2e-06, Method: Composition-based stats.
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 717 GGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGD 775
G FG VYKA+ ++ + A KV + + + + VE +++ S H NI+K++ +
Sbjct: 21 GDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 80
Query: 776 FKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCD 835
+ +E+ G+++ + L Q + AL YL+ +IH D
Sbjct: 81 NLWIL----IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 133
Query: 836 LKPSNVLLGDNMVAHLSDFGIT-----KLLTREDQFVTQTQTPATIG--YMALEYGSEGR 888
LK N+L + L+DFG++ + R D F+ TP + + E +
Sbjct: 134 LKAGNILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIG---TPYWMAPEVVMCETSKDRP 190
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEI 915
DV++ G+ L+E + P +E+
Sbjct: 191 YDYKADVWSLGITLIEMAEIEPPHHEL 217
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 733 VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI--IKIISCCS----IGDFKALFK----A 782
V KV ++ G + E+ +IR++ I ++++ C+ +G + A + +
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 783 LALEYMPHGSLEKYLYSSNYILD-IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNV 841
+ +E+M GSL++ L + I + I +++I V L YL + ++H D+KPSN+
Sbjct: 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNI 136
Query: 842 LLGDNMVAHLSDFGITKLL--TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFG 899
L+ L DFG++ L + + FV T YM+ E S D+++ G
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMG 190
Query: 900 VMLMETFTGKKP 911
+ L+E G+ P
Sbjct: 191 LSLVEMAVGRYP 202
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQC-GRAFKSFDVECEV--MKSIRHRNIIKIIS 769
+G G FG V A G +VA+K+ N++ ++ +E E+ ++ +RH +IIK+
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
D + A + +++ S FQ+ + SA+EY +
Sbjct: 76 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 126
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
++H DLKP N+LL +++ ++DFG++ ++T + T +P Y A E S G++
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVIS-GKL 182
Query: 890 STNG--DVYNFGVMLMETFTGKKPTNE 914
DV++ GV+L + P ++
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDD 209
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 714 IGRGGFGSVYK-ARIQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
IGRG +GSV K G +AVK V ++ + DV VM+S I++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 768 ISCCSIGDFKALFKA----LALEYMPHG--SLEKYLYSSNYILD--IFQRLNIMIDVASA 819
+ ALF+ + +E M KY+YS +LD I + + I +A+
Sbjct: 87 --------YGALFREGDCWICMELMSTSFDKFYKYVYS---VLDDVIPEEILGKITLATV 135
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
+ + +IH D+KPSN+LL + L DFGI+ L + +T+ YM
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYM 192
Query: 880 ALEY----GSEGRVSTNGDVYNFGVMLMETFTGKKPT---NEIFNE 918
A E S DV++ G+ L E TG+ P N +F++
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 45/229 (19%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVF---NQQCGRAFKSFDVECEVMKSIRHRN 763
F +GRGGFG V++A+ + D A+K N++ R + E + + + H
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 64
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSS-------------NYILDIFQR- 809
I++ F A + E + S + YLY N I +R
Sbjct: 65 IVRY--------FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 810 ----LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG-ITKLLTRED 864
L+I + +A A+E+L+ S ++H DLKPSN+ + V + DFG +T + E+
Sbjct: 117 RSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 865 QFVTQTQTPA---------TIGYMALEYGSEGRVSTNGDVYNFGVMLME 904
+ T PA T YM+ E S D+++ G++L E
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQC-GRAFKSFDVECEV--MKSIRHRNIIKIIS 769
+G G FG V A G +VA+K+ N++ ++ +E E+ ++ +RH +IIK+
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
D + A + +++ S FQ+ + SA+EY +
Sbjct: 82 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH---RH 132
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRV 889
++H DLKP N+LL +++ ++DFG++ ++T + T +P Y A E S G++
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSP---NYAAPEVIS-GKL 188
Query: 890 STNG--DVYNFGVMLMETFTGKKPTNE 914
DV++ GV+L + P ++
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDD 215
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 35/219 (15%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI- 764
D F + + +G G G V+K V ++ G + E+ +IR++ I
Sbjct: 33 DDFEKISELGAGNGGVVFK------------VSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 765 -IKIISCCS----IGDFKALFK----ALALEYMPHGSLEKYLYSSNYILD-IFQRLNIMI 814
++++ C+ +G + A + ++ +E+M GSL++ L + I + I +++I
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 139
Query: 815 DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL--TREDQFVTQTQT 872
V L YL + ++H D+KPSN+L+ L DFG++ L + + FV
Sbjct: 140 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 191
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T YM+ E S D+++ G+ L+E G+ P
Sbjct: 192 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ--------- 114
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 115 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 162
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 163 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 114
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 115 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 162
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 163 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 113
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 114 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 161
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 162 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 203
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 114
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 115 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 162
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 163 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 112
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 113 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 160
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 161 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 111
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 112 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 159
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 160 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 111
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 112 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 159
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 160 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 115
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 116 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 163
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 164 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 205
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 111
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 112 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 159
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 160 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 733 VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI--IKIISCCS----IGDFKALFK----A 782
V KV ++ G + E+ +IR++ I ++++ C+ +G + A + +
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 783 LALEYMPHGSLEKYLYSSNYILD-IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNV 841
+ +E+M GSL++ L + I + I +++I V L YL + ++H D+KPSN+
Sbjct: 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNI 136
Query: 842 LLGDNMVAHLSDFGITKLL--TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFG 899
L+ L DFG++ L + + FV T YM+ E S D+++ G
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMG 190
Query: 900 VMLMETFTGKKP 911
+ L+E G+ P
Sbjct: 191 LSLVEMAVGRYP 202
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 733 VAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI--IKIISCCS----IGDFKALFK----A 782
V KV ++ G + E+ +IR++ I ++++ C+ +G + A + +
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 783 LALEYMPHGSLEKYLYSSNYILD-IFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNV 841
+ +E+M GSL++ L + I + I +++I V L YL + ++H D+KPSN+
Sbjct: 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNI 136
Query: 842 LLGDNMVAHLSDFGITKLL--TREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFG 899
L+ L DFG++ L + + FV T YM+ E S D+++ G
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMG 190
Query: 900 VMLMETFTGKKP 911
+ L+E G+ P
Sbjct: 191 LSLVEMAVGRYP 202
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 110
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 111 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYX 160
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 161 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNIIKIISCCSIG------------DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ--------- 114
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 115 ----------LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--T 162
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 163 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 110
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 111 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYX 160
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 161 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 111
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 112 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 159
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 160 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNIIKIISCCSIG------------DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ--------- 112
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 113 ----------LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--T 160
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 161 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 31/297 (10%)
Query: 705 TDGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDV-ECEVMKSIRHR 762
+ F +L+G G +G V A + E VA+K F + E +++K +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII I + F+ + ++ + L + + + D Q + L
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF-----IYQTLRA 124
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED--------QFVTQTQTPA 874
+ + + VIH DLKPSN+L+ N + DFG+ +++ Q T+ A
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 875 TIGYMALEYG-SEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLIS 933
T Y A E + + S DV++ G +L E F ++P IF G +H L+
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP---IF-PGRDYRHQ-----LLL 234
Query: 934 IMKIVDGSLLSREDIQFVAKEQCMSFVFNMAM--ECTVESPEKRINAK--EIVTRLL 986
I I+ G+ S D++ + + ++ ++ M +E R+N K +++ R+L
Sbjct: 235 IFGII-GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML 290
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ--------- 114
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 115 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 162
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 163 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 113
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 114 ----------LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--T 161
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 162 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 113
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 114 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 161
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 162 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ--------- 112
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 113 ----------LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--T 160
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 161 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 202
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 112
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 113 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYX 162
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 163 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 202
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 714 IGRGGFGSVYK--ARIQDGMEVAVKVFNQQCGRAFKSFDV-ECEVMKSIRHRNIIKIISC 770
+G G + +VYK +++ D + VA+K + + E ++K ++H NI+ +
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
I K+L L EY+ L++YL I+++ N+ + + L L + +
Sbjct: 69 --IHTEKSL--TLVFEYLD-KDLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHRQK 120
Query: 831 VIHCDLKPSNVLLGDNMVAHLSDFGITK-----LLTREDQFVTQTQTPATIGYMALEYGS 885
V+H DLKP N+L+ + L+DFG+ + T +++ VT P I + +Y
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY-- 178
Query: 886 EGRVSTNGDVYNFGVMLMETFTGK 909
ST D++ G + E TG+
Sbjct: 179 ----STQIDMWGVGCIFYEMATGR 198
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 51.6 bits (122), Expect = 2e-06, Method: Composition-based stats.
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEV-----MK 757
AT + IG G +G+VYKAR G VA+K G EV ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 758 SIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKYL-------YSSNYILDIFQR 809
+ H N+++++ C+ K L E++ L YL + I D+ ++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ 869
L L F ++ ++H DLKP N+L+ L+DFG+ ++ + + +
Sbjct: 121 F---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MAL 168
Query: 870 TQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T+ Y A E + +T D+++ G + E F +KP
Sbjct: 169 APVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 702 CQATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVK---VFNQQCGRAFKSFDVECEVMK 757
C + + IG+G FG V+KAR + G +VA+K + N++ G + E ++++
Sbjct: 14 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 72
Query: 758 SIRHRNIIKIISCCSI-----GDFKALFKALALEYMPH---GSLEKYLYSSNYILDIFQR 809
++H N++ +I C KA L ++ H G L L + L +R
Sbjct: 73 LLKHENVVNLIEICRTKASPYNRCKASI-YLVFDFCEHDLAGLLSNVLVK--FTLSEIKR 129
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
+ M+ L LY+ + ++H D+K +NVL+ + V L+DFG+ +
Sbjct: 130 VMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 17/210 (8%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVK---VFNQQ--CGRAFKSFDVECEVMKSIRH 761
+++ IG G +G V A VA+K F Q C R + E +++ RH
Sbjct: 45 YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFRH 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
N+I I +A+ ++ + L K L S D +I + L
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSND-----HICYFLYQILR 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMA 880
L + +S V+H DLKPSN+L+ + DFG+ ++ E D T+ AT Y A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 881 LEYGSEGRVSTNG-DVYNFGVMLMETFTGK 909
E + T D+++ G +L E + +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 51.2 bits (121), Expect = 2e-06, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ----------- 110
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 111 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 160
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFT 907
T+ Y A E G + ST D+++ G + E T
Sbjct: 161 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVT 198
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ--------- 111
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 112 ----------LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--T 159
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 160 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNIIKIISCCSIG------------DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ--------- 114
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 115 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 162
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 163 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 111
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 112 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 161
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFT 907
T+ Y A E G + ST D+++ G + E T
Sbjct: 162 HEVVTLWYRAPEILLGXK-YYSTAVDIWSLGCIFAEMVT 199
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 118
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 119 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 168
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFT 907
T+ Y A E G + ST D+++ G + E T
Sbjct: 169 HEVVTLWYRAPEILLGXK-YYSTAVDIWSLGCIFAEMVT 206
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 704 ATDGFSENNLIGRGGFGSVYKARIQ-DGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIR 760
+ + F + IG G +G VYKAR + G VA+K + + + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNIIKIISCCSIG------------DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
H NI+K++ D K A AL +P ++ YL+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ--------- 113
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T
Sbjct: 114 ----------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 161
Query: 869 QTQTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
T+ Y A E G + ST D+++ G + E T +
Sbjct: 162 YXHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 203
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 31/297 (10%)
Query: 705 TDGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFKSFDV-ECEVMKSIRHR 762
+ F +L+G G +G V A + E VA+K F + E +++K +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NII I + F+ + ++ + L + + + D Q + L
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF-----IYQTLRA 124
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED--------QFVTQTQTPA 874
+ + + VIH DLKPSN+L+ N + DFG+ +++ Q T+ A
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 875 TIGYMALEYG-SEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLIS 933
T Y A E + + S DV++ G +L E F ++P IF G +H L+
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP---IF-PGRDYRHQ-----LLL 234
Query: 934 IMKIVDGSLLSREDIQFVAKEQCMSFVFNMAM--ECTVESPEKRINAK--EIVTRLL 986
I I+ G+ S D++ + + ++ ++ M +E R+N K +++ R+L
Sbjct: 235 IFGII-GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML 290
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 111
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 112 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 161
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFT 907
T+ Y A E G + ST D+++ G + E T
Sbjct: 162 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVT 199
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 115
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 116 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 165
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFT 907
T+ Y A E G + ST D+++ G + E T
Sbjct: 166 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVT 203
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 110
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 111 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 160
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFT 907
T+ Y A E G + ST D+++ G + E T
Sbjct: 161 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVT 198
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKV--FNQQCGRAFKSFDVECEVMKSIRHR 762
+ F + IG G +G VYKAR + G VA+K + + + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 763 NIIKIISCCSI------------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL 810
NI+K++ D K A AL +P ++ YL+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----------- 110
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT 870
L+ L F +S V+H DLKP N+L+ L+DFG+ + + T T
Sbjct: 111 --------LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT 160
Query: 871 QTPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFT 907
T+ Y A E G + ST D+++ G + E T
Sbjct: 161 HEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVT 198
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEV-----MK 757
AT + IG G +G+VYKAR G VA+K G EV ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 758 SIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKYL-------YSSNYILDIFQR 809
+ H N+++++ C+ K L E++ L YL + I D+ ++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ 869
L L F ++ ++H DLKP N+L+ L+DFG+ ++ + + +
Sbjct: 121 F---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MAL 168
Query: 870 TQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T+ Y A E + +T D+++ G + E F +KP
Sbjct: 169 DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 702 CQATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVK---VFNQQCGRAFKSFDVECEVMK 757
C + + IG+G FG V+KAR + G +VA+K + N++ G + E ++++
Sbjct: 14 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 72
Query: 758 SIRHRNIIKIISCCSI---------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
++H N++ +I C G +F E+ G L L + L +
Sbjct: 73 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC--EHDLAGLLSNVLVK--FTLSEIK 128
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
R+ M+ L LY+ + ++H D+K +NVL+ + V L+DFG+ +
Sbjct: 129 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 50.8 bits (120), Expect = 3e-06, Method: Composition-based stats.
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 32/208 (15%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVF-NQQCGRAFKSFDV-ECEVMKSIRHRNIIKIISC 770
IG G +G V+K R +D G VA+K F + K + E ++K ++H N++ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 771 CSIGDFKALFKA-LALEYMPHGSLEKYLYSSNYILDIFQR---LNIMIDVA-SALEYLYF 825
F+ + L EY H L + LD +QR +++ + L+ + F
Sbjct: 71 -----FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLT-----REDQFVTQTQTPATIGYMA 880
+ IH D+KP N+L+ + V L DFG +LLT +D+ T+ +
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 881 LEYGSEGRVSTNGDVYNFGVMLMETFTG 908
+YG DV+ G + E +G
Sbjct: 178 TQYGPP------VDVWAIGCVFAELLSG 199
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ +MA E + + DV++FGV+L E F+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ +MA E + + DV++FGV+L E F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ +MA E + + DV++FGV+L E F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
VA +E+L S IH DL N+LL + V + DFG+ + + ++ +V +
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFT 907
+ +MA E + + DV++FGV+L E F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 18/215 (8%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+GRG FG V++ Q G + AVK + RA + + C + S R I+ +
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGAVR 155
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
G + +F +E + GSL + + + + + + ALE L + +S ++
Sbjct: 156 EGPWVNIF----MELLEGGSLGQLVKEQGCLPED----RALYYLGQALEGLEYLHSRRIL 207
Query: 833 HCDLKPSNVLL-GDNMVAHLSDFGITKLLTRE---DQFVTQTQTPATIGYMALEYGSEGR 888
H D+K NVLL D A L DFG L + +T P T +MA E
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLK 923
DV++ M++ G P + F + LK
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+GRG +G V K R + G +AVK V +Q+ R D+ ++
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS------------MRT 106
Query: 768 ISCC-SIGDFKALFKA----LALEYMPHGSLEKYLYSSNYILDIFQRL------NIMIDV 816
+ C ++ + ALF+ + +E M SL+K+ ++D Q + I + +
Sbjct: 107 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSI 162
Query: 817 ASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
ALE+L+ S VIH D+KPSNVL+ + DFGI+ L V +T
Sbjct: 163 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAKTIDAGCK 217
Query: 877 GYMALEYG----SEGRVSTNGDVYNFGVMLME 904
YMA E ++ S D+++ G+ ++E
Sbjct: 218 PYMAPERINPELNQKGYSVKSDIWSLGITMIE 249
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 18/215 (8%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+GRG FG V++ Q G + AVK + RA + + C + S R I+ +
Sbjct: 82 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGAVR 136
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
G + +F +E + GSL + + + + + + ALE L + +S ++
Sbjct: 137 EGPWVNIF----MELLEGGSLGQLVKEQGCLPED----RALYYLGQALEGLEYLHSRRIL 188
Query: 833 HCDLKPSNVLL-GDNMVAHLSDFGITKLLTRE---DQFVTQTQTPATIGYMALEYGSEGR 888
H D+K NVLL D A L DFG L + +T P T +MA E
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLK 923
DV++ M++ G P + F + LK
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 50.4 bits (119), Expect = 4e-06, Method: Composition-based stats.
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEV-----MK 757
AT + IG G +G+VYKAR G VA+K G EV ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 758 SIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKYL-------YSSNYILDIFQR 809
+ H N+++++ C+ K L E++ L YL + I D+ ++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ 869
L L F ++ ++H DLKP N+L+ L+DFG+ ++ + + +
Sbjct: 121 F---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MAL 168
Query: 870 TQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T+ Y A E + +T D+++ G + E F +KP
Sbjct: 169 FPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 702 CQATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVK---VFNQQCGRAFKSFDVECEVMK 757
C + + IG+G FG V+KAR + G +VA+K + N++ G + E ++++
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 71
Query: 758 SIRHRNIIKIISCCSI---------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
++H N++ +I C G +F E+ G L L + L +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC--EHDLAGLLSNVLV--KFTLSEIK 127
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
R+ M+ L LY+ + ++H D+K +NVL+ + V L+DFG+ +
Sbjct: 128 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 704 ATDGFSENNLIGRGGFGSVYKAR-IQDGMEVA---VKVFNQQCGRAFKSFDVECEV---- 755
AT + IG G +G+VYKAR G VA V+V N G EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 756 -MKSIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKYL-------YSSNYILDI 806
+++ H N+++++ C+ K L E++ L YL + I D+
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 807 FQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF 866
++ L L F ++ ++H DLKP N+L+ L+DFG+ ++ + +
Sbjct: 126 MRQF---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--- 173
Query: 867 VTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ T T+ Y A E + +T D+++ G + E F +KP
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 217
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V A ++ G VAVK + + + + E +M+ +H N++++ +
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +E++ G+L + + ++ Q + + V AL L+ + VI
Sbjct: 97 VGD--ELW--VVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVI 147
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H D+K ++LL + LSDFG +++E + T +MA E S
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 893 GDVYNFGVMLMETFTGKKPTNEIFNE 918
D+++ G+M++E G+ P FNE
Sbjct: 206 VDIWSLGIMVIEMVDGEPP---YFNE 228
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V A ++ G VAVK + + + + E +M+ +H N++++ +
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +E++ G+L + + ++ Q + + V AL L+ + VI
Sbjct: 99 VGD--ELW--VVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVI 149
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H D+K ++LL + LSDFG +++E + T +MA E S
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 893 GDVYNFGVMLMETFTGKKPTNEIFNE 918
D+++ G+M++E G+ P FNE
Sbjct: 208 VDIWSLGIMVIEMVDGEPP---YFNE 230
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V A ++ G VAVK + + + + E +M+ +H N++++ +
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +E++ G+L + + ++ Q + + V AL L+ + VI
Sbjct: 88 VGD--ELW--VVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVI 138
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H D+K ++LL + LSDFG +++E + T +MA E S
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 893 GDVYNFGVMLMETFTGKKPTNEIFNE 918
D+++ G+M++E G+ P FNE
Sbjct: 197 VDIWSLGIMVIEMVDGEPP---YFNE 219
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
IG G G V A ++ G VAVK + + + + E +M+ +H N++++ +
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
+GD L+ + +E++ G+L + + ++ Q + + V AL L+ + VI
Sbjct: 92 VGD--ELW--VVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVI 142
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTN 892
H D+K ++LL + LSDFG +++E + T +MA E S
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 893 GDVYNFGVMLMETFTGKKPTNEIFNE 918
D+++ G+M++E G+ P FNE
Sbjct: 201 VDIWSLGIMVIEMVDGEPP---YFNE 223
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 720 GSVYKARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFK 777
G ++K R Q G ++ VKV + R + F+ EC ++ H N++ ++ C
Sbjct: 24 GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ--SPP 80
Query: 778 ALFKALALEYMPHGSLEKYLYS-SNYILDIFQRLNIMIDVASALEYLYFGYSTPVI--HC 834
A L + P+GSL L+ +N+++D Q + +D A +L+ P+I H
Sbjct: 81 APHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA 138
Query: 835 DLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGD 894
L +V + ++ A +S + Q + PA + AL+ E + D
Sbjct: 139 -LNSRSVXIDEDXTARISXADVKFSF----QSPGRXYAPAWVAPEALQKKPEDTNRRSAD 193
Query: 895 VYNFGVMLMETFTGKKPTNEIFN 917
++F V+L E T + P ++ N
Sbjct: 194 XWSFAVLLWELVTREVPFADLSN 216
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 702 CQATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVK---VFNQQCGRAFKSFDVECEVMK 757
C + + IG+G FG V+KAR + G +VA+K + N++ G + E ++++
Sbjct: 14 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 72
Query: 758 SIRHRNIIKIISCCSI---------GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
++H N++ +I C G +F E+ G L L + L +
Sbjct: 73 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC--EHDLAGLLSNVLVK--FTLSEIK 128
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
R+ M+ L LY+ + ++H D+K +NVL+ + V L+DFG+ +
Sbjct: 129 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 41/302 (13%)
Query: 705 TDGFSENNLIGRGGFGSVYKARIQDGMEVA----VKVFNQQCGRAFKSFDVECEVMKSIR 760
+ F +L+G G +G V A + E+ ++ F++ A ++ E +++K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLR-EIKILKHFK 67
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H NII I + F+ + ++ + L + + + D Q + L
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF-----IYQTL 122
Query: 821 EYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP------- 873
+ + + VIH DLKPSN+L+ N + DFG+ +++ D+ P
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII---DESAADNSEPTGQQSGM 179
Query: 874 ----ATIGYMALEYG-SEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVND 928
AT Y A E + + S DV++ G +L E F ++P IF G +H
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP---IF-PGRDYRHQ--- 231
Query: 929 WLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAM--ECTVESPEKRINAK--EIVTR 984
L+ I I+ G+ S D++ + + ++ ++ M +E R+N K +++ R
Sbjct: 232 --LLLIFGII-GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 985 LL 986
+L
Sbjct: 289 ML 290
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 39/213 (18%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +GSV Y AR++ +VAVK + Q A +++ E ++K ++H N+I +
Sbjct: 36 VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 768 IS----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
+ SI DF ++ L ++ K S+ ++ V L L
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDE--------HVQFLVYQLLRGL 144
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ +S +IH DLKPSNV + ++ + DFG+ + + D+ +T GY+A +
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRW 193
Query: 884 GSEGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 752 ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
E ++K + H N++K++ + L+ + E + G + + D Q
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLY--MVFELVNQGPVMEVPTLKPLSED--QARF 141
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT- 870
D+ +EYL++ +IH D+KPSN+L+G++ ++DFG++ D ++ T
Sbjct: 142 YFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 871 QTPATIGYMALEYGSEGRVSTNG---DVYNFGVMLMETFTGKKP 911
TPA +MA E SE R +G DV+ GV L G+ P
Sbjct: 199 GTPA---FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 704 ATDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDV-ECEVMKSIRH 761
++ F + +G G + +VYK G+ VA+K S + E +MK ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNY----------ILDIFQRLN 811
NI+++ + L E+M L+KY+ S ++ FQ
Sbjct: 63 ENIVRLYDVIHTENKLTL----VFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ--- 114
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL-TREDQFVTQT 870
L+ L F + ++H DLKP N+L+ L DFG+ + + F ++
Sbjct: 115 -----WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 871 QTPATIGYMALEYGSEGRV-STNGDVYNFGVMLMETFTGK 909
T+ Y A + R ST+ D+++ G +L E TGK
Sbjct: 170 ---VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 44/232 (18%)
Query: 707 GFSEN----NLIGRGGFGSVYKARIQDGM--EVAVKVFNQQCGRAFKSFDV--------- 751
GF EN ++GRG SV + I E AVK+ + G +F + +V
Sbjct: 1 GFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 59
Query: 752 ECEVMKSIR-HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQR- 809
E ++++ + H NII++ F F L + M G L YL + + R
Sbjct: 60 EVDILRKVSGHPNIIQLKDTYETNTF--FF--LVFDLMKKGELFDYLTEKVTLSEKETRK 115
Query: 810 -LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
+ +++V AL L ++H DLKP N+LL D+M L+DFG + L ++
Sbjct: 116 IMRALLEVICALHKL------NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 169
Query: 869 QTQTPATIGYMALE---------YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP+ + +E YG E D+++ GV++ G P
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 215
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 50.1 bits (118), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 714 IGRGGFGSVYKARIQDGMEVA----VKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
IG G +G+V+KA+ ++ E+ V++ + G + C ++K ++H+NI+++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHD 68
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
+ K L L E+ L+KY S N LD + + + L+ L F +S
Sbjct: 69 V--LHSDKKL--TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFCHSR 120
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGITK-----LLTREDQFVTQTQTPATIGYMALEYG 884
V+H DLKP N+L+ N L++FG+ + + + VT P + + A Y
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY- 179
Query: 885 SEGRVSTNGDVYNFGVMLMETFTGKKP 911
ST+ D+++ G + E +P
Sbjct: 180 -----STSIDMWSAGCIFAELANAGRP 201
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 50.1 bits (118), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 39/213 (18%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +GSV Y AR++ +VAVK + Q A +++ E ++K ++H N+I +
Sbjct: 28 VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 768 IS----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
+ SI DF ++ L ++ K S+ ++ V L L
Sbjct: 85 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDE--------HVQFLVYQLLRGL 136
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ +S +IH DLKPSNV + ++ + DFG+ + + D+ +T GY+A +
Sbjct: 137 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYVATRW 185
Query: 884 GSEGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E GK
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 50.1 bits (118), Expect = 7e-06, Method: Composition-based stats.
Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 833 HCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQT-QTPATIGYMALEYGSEGRVST 891
H D+KP N+L+ + A+L DFGI T D+ +TQ T T+ Y A E SE +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 892 NGDVYNFGVMLMETFTGKKP 911
D+Y +L E TG P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV--AVKVFNQQC---GRAFKSFDVECEVM-KSIRHRNII 765
+IG+G FG V AR EV AVKV ++ + K E V+ K+++H ++
Sbjct: 44 KVIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
+ D K F L+Y+ G L +L L+ R ++ASAL YL+
Sbjct: 103 GLHFSFQTAD-KLYF---VLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH- 156
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +++ DLKP N+LL L+DFG+ K + T + T Y+A E
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLH 212
Query: 886 EGRVSTNGDVYNFGVMLMETFTGKKP 911
+ D + G +L E G P
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPP 238
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 49.7 bits (117), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 32/248 (12%)
Query: 681 QPNDADMPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFN 739
+P D + +E W + +GRG FG V++ + Q G + AVK
Sbjct: 63 KPVDYEYREEVHW--------------MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 108
Query: 740 QQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYS 799
+ R + V C + S R I+ + G + +F +E + GSL + +
Sbjct: 109 LEVFRVEEL--VACAGLSSPR---IVPLYGAVREGPWVNIF----MELLEGGSLGQLIKQ 159
Query: 800 SNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLL-GDNMVAHLSDFGITK 858
+ + + ALE L + ++ ++H D+K NVLL D A L DFG
Sbjct: 160 ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 215
Query: 859 LLTRE---DQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEI 915
L + +T P T +MA E D+++ M++ G P +
Sbjct: 216 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 275
Query: 916 FNEGMTLK 923
F + LK
Sbjct: 276 FRGPLCLK 283
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 18/215 (8%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+GRG FG V++ + Q G + AVK + R + V C + S R I+ +
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 120
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
G + +F +E + GSL + + + + + ALE L + ++ ++
Sbjct: 121 EGPWVNIF----MELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 833 HCDLKPSNVLL-GDNMVAHLSDFGITKLLTRE---DQFVTQTQTPATIGYMALEYGSEGR 888
H D+K NVLL D A L DFG L + +T P T +MA E
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLK 923
D+++ M++ G P + F + LK
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267
>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr)
Rbc36 In Complex With H-Trisaccharide
Length = 229
Score = 49.7 bits (117), Expect = 9e-06, Method: Composition-based stats.
Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 39 SFCNWTGVTCDVHSHRVTALNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIF 98
S C+ +G T D S R H S+ IP+ + Q L+LH NQ + P
Sbjct: 15 SQCSCSGTTVDCRSKR-------HASVPAGIPT------NAQILYLHDNQITKLEPGVFD 61
Query: 99 NIHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIPSAL-SNCTYLRILRL 157
++ LK L G NQL G +P + +L L+L N +PSA+ +L+ L +
Sbjct: 62 SLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFM 119
Query: 158 SYNDFAGGIPKEIGNLTKLEELYLSFNGLQ----GAYD 191
N +P+ I LT L L L N L+ GA+D
Sbjct: 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Score = 32.7 bits (73), Expect = 1.1, Method: Composition-based stats.
Identities = 35/129 (27%), Positives = 53/129 (41%), Gaps = 9/129 (6%)
Query: 426 QVLYFPDN---KLEGSIPDEVCRLAKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXX 482
Q+LY DN KLE + D + L ++Y L +N+L G++P D
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELY---LGSNQL-GALPVGVFDSLTQLTVLDLGTN 98
Query: 483 XISVIPS-TFWNLKDILYLNLSSNSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGG 541
++V+PS F L + L + N LT LP I L L + N + A
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 542 IKDLQFLFL 550
+ L +L
Sbjct: 158 LSSLTHAYL 166
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 18/215 (8%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+GRG FG V++ + Q G + AVK + R + V C + S R I+ +
Sbjct: 80 LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 134
Query: 773 IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVI 832
G + +F +E + GSL + + + + + ALE L + ++ ++
Sbjct: 135 EGPWVNIF----MELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRIL 186
Query: 833 HCDLKPSNVLL-GDNMVAHLSDFGITKLLTRE---DQFVTQTQTPATIGYMALEYGSEGR 888
H D+K NVLL D A L DFG L + +T P T +MA E
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLK 923
D+++ M++ G P + F + LK
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRAFK-SFDVECEVMKSI-RHRNII 765
+G G FG V +A + M VAVK+ + + E +V+ + H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLY----------SSNYILDIFQRL----- 810
++ C+IG + EY +G L +L +S I++ +
Sbjct: 91 NLLGACTIGGPTLVIT----EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 811 --NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
+ VA + +L S IH DL N+LL + + DFG+ + + + +V
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 869 QTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVN 927
+ + +MA E + DV+++G+ L E F+ G P GM +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVDS--- 255
Query: 928 DWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLK 987
K++ +E + ++ E + ++++ C P KR K+IV + K
Sbjct: 256 -----KFYKMI------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 711 NNLIGRGGFGSVYKA-RIQDG-------MEVAVKVFNQQCGRAFKSFDVECEVMKSIRHR 762
N +G+G F ++K R + G EV +KV ++ +SF +M + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+++ C GD L + E++ GSL+ YL + ++I +L + +A+A+ +
Sbjct: 73 HLVLNYGVCVCGDENILVQ----EFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 823 LYFGYSTPVIHCDLKPSNVLL--------GDNMVAHLSDFGITKLLTREDQFVTQTQTPA 874
L +IH ++ N+LL G+ LSD GI+ + +D + Q + P
Sbjct: 129 L---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQERIP- 182
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
+ +E ++T D ++FG L E +G
Sbjct: 183 WVPPECIENPKNLNLAT--DKWSFGTTLWEICSG 214
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 49.3 bits (116), Expect = 1e-05, Method: Composition-based stats.
Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 17/119 (14%)
Query: 805 DIFQRLN------------IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS 852
D+F RL+ + ++A AL++L+ S +I+ DLKP N+LL + L+
Sbjct: 113 DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 169
Query: 853 DFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
DFG++K D T+ YMA E + + + D ++FGV++ E TG P
Sbjct: 170 DFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 49.3 bits (116), Expect = 1e-05, Method: Composition-based stats.
Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 17/119 (14%)
Query: 805 DIFQRLN------------IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS 852
D+F RL+ + ++A AL++L+ S +I+ DLKP N+LL + L+
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 168
Query: 853 DFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
DFG++K D T+ YMA E + + + D ++FGV++ E TG P
Sbjct: 169 DFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 49.3 bits (116), Expect = 1e-05, Method: Composition-based stats.
Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 17/119 (14%)
Query: 805 DIFQRLN------------IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS 852
D+F RL+ + ++A AL++L+ S +I+ DLKP N+LL + L+
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 168
Query: 853 DFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
DFG++K D T+ YMA E + + + D ++FGV++ E TG P
Sbjct: 169 DFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 706 DGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ---CGRAFKS-----FDVECEVM 756
D + + +G G G V A + +VA+K+ +++ G A ++ + E E++
Sbjct: 16 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSL------EKYLYSSNYILDIFQRL 810
K + H IIKI + D+ + LE M G L K L + L +Q L
Sbjct: 76 KKLNHPCIIKIKNFFDAEDY-----YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 130
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
A++YL+ +IH DLKP NVLL ++ + ++DFG +K+L
Sbjct: 131 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 180
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
T TP + L + D ++ GV+L +G P +E
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 706 DGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ---CGRAFKS-----FDVECEVM 756
D + + +G G G V A + +VA+K+ +++ G A ++ + E E++
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSL------EKYLYSSNYILDIFQRL 810
K + H IIKI + D+ + LE M G L K L + L +Q L
Sbjct: 70 KKLNHPCIIKIKNFFDAEDY-----YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
A++YL+ +IH DLKP NVLL ++ + ++DFG +K+L
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
T TP + L + D ++ GV+L +G P +E
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 706 DGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ---CGRAFKS-----FDVECEVM 756
D + + +G G G V A + +VA+K+ +++ G A ++ + E E++
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSL------EKYLYSSNYILDIFQRL 810
K + H IIKI + D+ + LE M G L K L + L +Q L
Sbjct: 70 KKLNHPCIIKIKNFFDAEDY-----YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
A++YL+ +IH DLKP NVLL ++ + ++DFG +K+L
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
T TP + L + D ++ GV+L +G P +E
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 701 LCQATDGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI 759
L A+D F E ++G+G FG V KAR D A+K + + E ++ S+
Sbjct: 2 LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASL 59
Query: 760 RHRNIIKIISC-----------CSIGDFKALFKALALEYMPHGSLEKYLYSSN--YILDI 806
H+ +++ + ++ LF + +EY + +L ++S N D
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF--IQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 807 FQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF 866
+ RL I LE L + +S +IH DLKP N+ + ++ + DFG+ K + R
Sbjct: 118 YWRLFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 867 VT------------QTQTPATIGYMALEY-GSEGRVSTNGDVYNFGVMLME 904
+ T T Y+A E G + D+Y+ G++ E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 706 DGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ---CGRAFKS-----FDVECEVM 756
D + + +G G G V A + +VA+K+ +++ G A ++ + E E++
Sbjct: 9 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSL------EKYLYSSNYILDIFQRL 810
K + H IIKI + D+ + LE M G L K L + L +Q L
Sbjct: 69 KKLNHPCIIKIKNFFDAEDY-----YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 123
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
A++YL+ +IH DLKP NVLL ++ + ++DFG +K+L
Sbjct: 124 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 173
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
T TP + L + D ++ GV+L +G P +E
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRAFK-SFDVECEVMKSI-RHRNII 765
+G G FG V +A + M VAVK+ + + E +V+ + H NI+
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLY----------SSNYILDIFQRL----- 810
++ C+IG + EY +G L +L +S I++ +
Sbjct: 114 NLLGACTIGGPTLVIT----EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 811 --NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
+ VA + +L S IH DL N+LL + + DFG+ + + + +V
Sbjct: 170 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 869 QTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVN 927
+ + +MA E + DV+++G+ L E F+ G P GM +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVDS--- 278
Query: 928 DWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLK 987
K++ +E + ++ E + ++++ C P KR K+IV + K
Sbjct: 279 -----KFYKMI------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 15/218 (6%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFDVECEVMK 757
L++ + F + ++G+G FG V+ A + + A+K + DVEC +++
Sbjct: 11 LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVE 68
Query: 758 ----SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIM 813
S+ + C+ + LF +EY+ G L Y S + D+ +
Sbjct: 69 KRVLSLAWEHPFLTHMFCTFQTKENLF--FVMEYLNGGDL-MYHIQSCHKFDLSRATFYA 125
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP 873
++ L++L+ S +++ DLK N+LL + ++DFG+ K D +
Sbjct: 126 AEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNEFC 180
Query: 874 ATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T Y+A E + + + D ++FGV+L E G+ P
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ + RH NII
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 89 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 143
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 706 DGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ---CGRAFKS-----FDVECEVM 756
D + + +G G G V A + +VA+++ +++ G A ++ + E E++
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSL------EKYLYSSNYILDIFQRL 810
K + H IIKI + D+ + LE M G L K L + L +Q L
Sbjct: 209 KKLNHPCIIKIKNFFDAEDY-----YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 263
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
A++YL+ +IH DLKP NVLL ++ + ++DFG +K+L
Sbjct: 264 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 313
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
T TP + L + D ++ GV+L +G P +E
Sbjct: 314 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + S D Q L + L L +
Sbjct: 89 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKSQKLTDDHVQFL-----IYQILRGLKY 140
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----------MTGYVATRWYR 189
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRAFK-SFDVECEVMKSI-RHRNII 765
+G G FG V +A + M VAVK+ + + E +V+ + H NI+
Sbjct: 49 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLY----------SSNYILDIFQRL----- 810
++ C+IG + EY +G L +L +S I++ +
Sbjct: 109 NLLGACTIGGPTLVIT----EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 811 --NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
+ VA + +L S IH DL N+LL + + DFG+ + + + +V
Sbjct: 165 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 869 QTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVN 927
+ + +MA E + DV+++G+ L E F+ G P GM +
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVDS--- 273
Query: 928 DWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLK 987
K++ +E + ++ E + ++++ C P KR K+IV + K
Sbjct: 274 -----KFYKMI------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 706 DGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ---CGRAFKS-----FDVECEVM 756
D + + +G G G V A + +VA+K+ +++ G A ++ + E E++
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSL------EKYLYSSNYILDIFQRL 810
K + H IIKI + D+ + LE M G L K L + L +Q L
Sbjct: 70 KKLNHPCIIKIKNFFDAEDY-----YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
A++YL+ +IH DLKP NVLL ++ + ++DFG +K+L
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
T TP + L + D ++ GV+L +G P +E
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 141
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ + RH NII
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 89 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 143
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 141
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 145
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 141
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRAFK-SFDVECEVMKSI-RHRNII 765
+G G FG V +A + M VAVK+ + + E +V+ + H NI+
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLY----------SSNYILDIFQRL----- 810
++ C+IG + EY +G L +L +S I++ +
Sbjct: 114 NLLGACTIGGPTLVIT----EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 811 --NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
+ VA + +L S IH DL N+LL + + DFG+ + + + +V
Sbjct: 170 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 869 QTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVN 927
+ + +MA E + DV+++G+ L E F+ G P GM +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVDS--- 278
Query: 928 DWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLK 987
K++ +E + ++ E + ++++ C P KR K+IV + K
Sbjct: 279 -----KFYKMI------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 714 IGRGGFGSVYKA------RIQDGMEVAVKVFNQQCGRAFK-SFDVECEVMKSI-RHRNII 765
+G G FG V +A + M VAVK+ + + E +V+ + H NI+
Sbjct: 47 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLY----------SSNYILDIFQRL----- 810
++ C+IG + EY +G L +L +S I++ +
Sbjct: 107 NLLGACTIGGPTLVIT----EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 811 --NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
+ VA + +L S IH DL N+LL + + DFG+ + + + +V
Sbjct: 163 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 869 QTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNEGMTLKHWVN 927
+ + +MA E + DV+++G+ L E F+ G P GM +
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVDS--- 271
Query: 928 DWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIVTRLLK 987
K++ +E + ++ E + ++++ C P KR K+IV + K
Sbjct: 272 -----KFYKMI------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 706 DGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ---CGRAFKS-----FDVECEVM 756
D + + +G G G V A + +VA+++ +++ G A ++ + E E++
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 757 KSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSL------EKYLYSSNYILDIFQRL 810
K + H IIKI + D+ + LE M G L K L + L +Q L
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY-----YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
A++YL+ +IH DLKP NVLL ++ + ++DFG +K+L
Sbjct: 250 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
T TP + L + D ++ GV+L +G P +E
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 703 QATDGFSENNLIGRGGFG-SVYKARIQDGMEVAVKVFN--QQCGRAFKSFDVECEVMKSI 759
Q+ + + IG G FG ++ +DG + +K N + + + E V+ ++
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIM---IDV 816
+H NI++ S + +L+ + ++Y G L K + + +L FQ I+ + +
Sbjct: 81 KHPNIVQYRE--SFEENGSLY--IVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQI 134
Query: 817 ASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
AL++++ ++H D+K N+ L + L DFGI ++L + A I
Sbjct: 135 CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR-----ACI 186
Query: 877 G---YMALEYGSEGRVSTNGDVYNFGVMLMETFTGK 909
G Y++ E + D++ G +L E T K
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 48.5 bits (114), Expect = 2e-05, Method: Composition-based stats.
Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 11/116 (9%)
Query: 805 DIFQRLNIMI-----DVASALEYLYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFG 855
D+F RL+ + DV L L G +S +I+ DLKP N+LL + L+DFG
Sbjct: 116 DLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 175
Query: 856 ITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++K ++ T+ YMA E + S + D +++GV++ E TG P
Sbjct: 176 LSKEAIDHEK--KAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 85 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 139
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
IG G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 35 IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 94 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 145
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----------MTGYVATRWYR 194
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 92 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 146
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+GRG +G V K R + G +AVK V +Q+ R D+ ++
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS------------MRT 62
Query: 768 ISCC-SIGDFKALFKA----LALEYMPHGSLEKYLYSSNYILDIFQRL------NIMIDV 816
+ C ++ + ALF+ + +E M SL+K+ ++D Q + I + +
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSI 118
Query: 817 ASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
ALE+L+ S VIH D+KPSNVL+ + DFGI+ L + V +
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCK 173
Query: 877 GYMALEYG----SEGRVSTNGDVYNFGVMLME 904
YMA E ++ S D+++ G+ ++E
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 92
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 93 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 147
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 148 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNR 231
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 83
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 84 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 138
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 139 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNR 222
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 145
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 39 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 94
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 95 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 149
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 150 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 141
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 88
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 89 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 143
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 106
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 161
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 162 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 85 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 139
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 705 TDGFSENNLIGRGGFGSVYKARIQDGME--VAVKVFNQQCGRAFKSFDVECEVMKSIRHR 762
+D F + +GRG VY+ + Q G + A+KV + + K E V+ + H
Sbjct: 52 SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHP 108
Query: 763 NIIKIISCCSIGDFKALFK-----ALALEYMPHGSL-----EKYLYSSNYILDIFQRLNI 812
NIIK+ K +F+ +L LE + G L EK YS D +++
Sbjct: 109 NIIKL---------KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI-- 157
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFVTQ 869
LE + + + ++H DLKP N+L + ++DFG++K++ + T
Sbjct: 158 -------LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 870 TQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP GY A E D+++ G++ G +P
Sbjct: 211 CGTP---GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 705 TDGFSENNLIGRGGFGS----VYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIR 760
+DG+ IG G + V+KA ME AVKV ++ + ++ +++ +
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEI---LLRYGQ 79
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H NII + D K ++ L E M G L + + + ++ + +
Sbjct: 80 HPNIITLKDVYD--DGKHVY--LVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTV 134
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL----GDNMVAHLSDFGITKLLTREDQFVTQTQTPA-T 875
EYL+ S V+H DLKPSN+L G+ + DFG K L E+ + TP T
Sbjct: 135 EYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL---MTPCYT 188
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++A E D+++ G++L G P
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-----LYQILRGLKYIH 145
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 141
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 48.1 bits (113), Expect = 2e-05, Method: Composition-based stats.
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
TD + IG+G F V + ++ G E A K+ N + R + + E + + ++H
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ S + F L + + G L + + + Y + + + LE
Sbjct: 63 SNIVRLHDSIS----EEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILE 114
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQ-FVTQTQTPATIG 877
+ + V+H DLKP N+LL L+DFG+ + + Q + TP G
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTP---G 171
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E + D++ GV+L G P
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 705 TDGFSENNLIGRGGFGS----VYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIR 760
+DG+ IG G + V+KA ME AVKV ++ + ++ +++ +
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI---LLRYGQ 79
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H NII + D K ++ L E M G L + + + ++ + +
Sbjct: 80 HPNIITLKDV--YDDGKHVY--LVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTV 134
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL----GDNMVAHLSDFGITKLLTREDQFVTQTQTPA-T 875
EYL+ S V+H DLKPSN+L G+ + DFG K L E+ + TP T
Sbjct: 135 EYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL---MTPCYT 188
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++A E D+++ G++L G P
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 705 TDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
TD + +G+G F V + +I G E A K+ N + R + + E + + ++H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ S + F L + + G L + + + Y + + + LE
Sbjct: 63 PNIVRLHDSIS----EEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILE 114
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQ-FVTQTQTPATIG 877
+ + ++H DLKP N+LL L+DFG+ + + Q + TP G
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP---G 171
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E + D++ GV+L G P
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 106
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 161
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 162 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 96 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----------MTG 188
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 711 NNLIGRGGFGSVYKA-RIQDG-------MEVAVKVFNQQCGRAFKSFDVECEVMKSIRHR 762
N +G+G F ++K R + G EV +KV ++ +SF +M + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
+++ C GD L + E++ GSL+ YL + ++I +L + +A A+ +
Sbjct: 73 HLVLNYGVCFCGDENILVQ----EFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHF 128
Query: 823 LYFGYSTPVIHCDLKPSNVLL--------GDNMVAHLSDFGITKLLTREDQFVTQTQTPA 874
L +IH ++ N+LL G+ LSD GI+ + +D + Q + P
Sbjct: 129 L---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQERIP- 182
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
+ +E ++T D ++FG L E +G
Sbjct: 183 WVPPECIENPKNLNLAT--DKWSFGTTLWEICSG 214
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 94 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 145
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----------MTGYVATRWYR 194
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 96 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----------MTG 188
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 96 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----------MTG 188
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVF--------NQQCGRAFKSFDVECEVMK 757
D F + ++GRGGFG V+ + M+ K++ + + ++ VE +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 758 SIRHRNIIKIISCCSIG-DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-- 814
+ R I+ + D L + M G + ++Y+ + FQ +
Sbjct: 241 KVHSRFIVSLAYAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 815 -DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT- 872
+ S LE+L+ +I+ DLKP NVLL D+ +SD G+ L QT+T
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-----AGQTKTK 347
Query: 873 --PATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T G+MA E G E S D + GV L E + P
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 100 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 151
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----------MTGYVATRWYR 200
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVF--------NQQCGRAFKSFDVECEVMK 757
D F + ++GRGGFG V+ + M+ K++ + + ++ VE +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 758 SIRHRNIIKIISCCSIG-DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-- 814
+ R I+ + D L + M G + ++Y+ + FQ +
Sbjct: 241 KVHSRFIVSLAYAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 815 -DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT- 872
+ S LE+L+ +I+ DLKP NVLL D+ +SD G+ L QT+T
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-----AGQTKTK 347
Query: 873 --PATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T G+MA E G E S D + GV L E + P
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 22/217 (10%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQC------GRAFKSFDVECEVMKS 758
D + +G G F V K R + G E A K ++ G + + + E +++
Sbjct: 12 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
IRH NII + I + K L LE + G L +L + + + + +
Sbjct: 72 IRHPNII---TLHDIFENKTDV-VLILELVSGGELFDFLAEKESLTED-EATQFLKQILD 126
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAH----LSDFGITKLLTREDQFVTQTQTPA 874
+ YL+ S + H DLKP N++L D V + L DFGI + ++F TP
Sbjct: 127 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 183
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ + Y G D+++ GV+ +G P
Sbjct: 184 FVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 217
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVF--------NQQCGRAFKSFDVECEVMK 757
D F + ++GRGGFG V+ + M+ K++ + + ++ VE +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 758 SIRHRNIIKIISCCSIG-DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-- 814
+ R I+ + D L + M G + ++Y+ + FQ +
Sbjct: 241 KVHSRFIVSLAYAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 815 -DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT- 872
+ S LE+L+ +I+ DLKP NVLL D+ +SD G+ L QT+T
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-----AGQTKTK 347
Query: 873 --PATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T G+MA E G E S D + GV L E + P
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 22/217 (10%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQC------GRAFKSFDVECEVMKS 758
D + +G G F V K R + G E A K ++ G + + + E +++
Sbjct: 26 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
IRH NII + I + K L LE + G L +L + + + + +
Sbjct: 86 IRHPNII---TLHDIFENKTDV-VLILELVSGGELFDFLAEKESLTED-EATQFLKQILD 140
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAH----LSDFGITKLLTREDQFVTQTQTPA 874
+ YL+ S + H DLKP N++L D V + L DFGI + ++F TP
Sbjct: 141 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 197
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ + Y G D+++ GV+ +G P
Sbjct: 198 FVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 231
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + + L+Y++
Sbjct: 85 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 138
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 185
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA++ F Q C R + E +++ RH NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 145
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 22/217 (10%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQC------GRAFKSFDVECEVMKS 758
D + +G G F V K R + G E A K ++ G + + + E +++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
IRH NII + I + K L LE + G L +L + + + + +
Sbjct: 65 IRHPNII---TLHDIFENKTDV-VLILELVSGGELFDFLAEKESLTED-EATQFLKQILD 119
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAH----LSDFGITKLLTREDQFVTQTQTPA 874
+ YL+ S + H DLKP N++L D V + L DFGI + ++F TP
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 176
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ + Y G D+++ GV+ +G P
Sbjct: 177 FVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 210
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 47.8 bits (112), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQDGM--EVAVKVFNQQCGRAFKSFDVECEVMKSIR 760
Q TDG+ IG G + SV K I E AVK+ ++ + ++ +++ +
Sbjct: 19 QFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQ 74
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASAL 820
H NII + G + + E G L + + + + ++ + +
Sbjct: 75 HPNIITLKDVYDDGKYVYV----VTELXKGGELLDKILRQKFFSE-REASAVLFTITKTV 129
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL----GDNMVAHLSDFGITKLLTREDQFVTQTQTPA-T 875
EYL+ + V+H DLKPSN+L G+ + DFG K L E+ + TP T
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLX---TPCYT 183
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++A E D+++ GV+L TG P
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 47.8 bits (112), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 94 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 186
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 86 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 129
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 178
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 96 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 188
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 86 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 129
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 178
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 99/221 (44%), Gaps = 21/221 (9%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFDVECEVMK 757
L++ + F + ++G+G FG V+ A + + A+K + DVEC +++
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVE 67
Query: 758 ----SIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIM 813
S+ + C+ + LF +EY+ G L Y S + D+ +
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLF--FVMEYLNGGDL-MYHIQSCHKFDLSRATFYA 124
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTP 873
++ L++L+ S +++ DLK N+LL + ++DFG+ K + + +T
Sbjct: 125 AEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTN 176
Query: 874 ATIG---YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
G Y+A E + + + D ++FGV+L E G+ P
Sbjct: 177 XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 91 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 183
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 95 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 146
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----------MTGYVATRWYR 195
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 94 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 186
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 29 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 88 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 131
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 132 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 180
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 712 NLIGRGGFGSVY--KARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
++G G F V+ K R+ G A+K + S + E V+K I+H NI+ +
Sbjct: 15 EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 770 CC-SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
S + + + ++ + LE+ +Y+ + Q+ V SA++YL+
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH---E 124
Query: 829 TPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
++H DLKP N+L +N ++DFG++K+ +Q + T GY+A E +
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLA 180
Query: 886 EGRVSTNGDVYNFGVMLMETFTGKKPTNE 914
+ S D ++ GV+ G P E
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYE 209
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 28 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + + L+Y++
Sbjct: 87 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 140
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 141 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 187
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVF--------NQQCGRAFKSFDVECEVMK 757
D F + ++GRGGFG V+ + M+ K++ + + ++ VE +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 758 SIRHRNIIKIISCCSIG-DFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-- 814
+ R I+ + D L + M G + ++Y+ + FQ +
Sbjct: 241 KVHSRFIVSLAYAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 815 -DVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT- 872
+ S LE+L+ +I+ DLKP NVLL D+ +SD G+ L QT+T
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-----AGQTKTK 347
Query: 873 --PATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T G+MA E G E S D + GV L E + P
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 91 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 142
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 191
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 91 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 142
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----------MTGYVATRWYR 191
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 49 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + + L+Y++
Sbjct: 108 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 161
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 162 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 208
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 46/211 (21%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV + ++ G+++AVK + Q A +++ E ++K ++H N+I ++
Sbjct: 59 VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + + L+Y++
Sbjct: 118 VFTPATSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 171
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 172 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 218
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 91 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 142
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 191
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 95 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 146
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 195
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 101 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 152
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 201
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 95 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 187
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVF-----NQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G G V+K R + G +AVK ++ R DV V+KS + I
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKS---HDCPYI 86
Query: 768 ISCCSIGDF---KALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
+ C G F +F A+ L L+K + I +R+ + VA Y
Sbjct: 87 VQC--FGTFITNTDVFIAMELMGTCAEKLKKRMQGP-----IPERILGKMTVAIVKALYY 139
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY- 883
VIH D+KPSN+LL + L DFGI+ L + + ++ YMA E
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERI 196
Query: 884 ----GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ DV++ G+ L+E TG+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 53/245 (21%), Positives = 104/245 (42%), Gaps = 37/245 (15%)
Query: 682 PNDADMPQEAT--WRRFSYLELCQATDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF 738
P + M QE +R+ + + + + + +G G +GSV A + G+ VAVK
Sbjct: 16 PRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 75
Query: 739 N---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS----CCSIGDFKALFKALALEYMPHG 791
+ Q A +++ E ++K ++H N+I ++ S+ +F ++ + ++
Sbjct: 76 SRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY---LVTHLMGA 131
Query: 792 SLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHL 851
L + D Q L + L L + +S +IH DLKPSN+ + ++ +
Sbjct: 132 DLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 186
Query: 852 SDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNG-------DVYNFGVMLME 904
DFG+ + E GY+A + + N D+++ G ++ E
Sbjct: 187 LDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 905 TFTGK 909
TG+
Sbjct: 236 LLTGR 240
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 101 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 152
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 201
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 101 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 152
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 201
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + + L+Y++
Sbjct: 112 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 165
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 166 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MXGYVATRWYR 212
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 47.4 bits (111), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 112 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 163
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 212
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 47.4 bits (111), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 100 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 151
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 200
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 47.0 bits (110), Expect = 5e-05, Method: Composition-based stats.
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQ-QCGRAFKSFDV-ECEVMKSIRHRNIIKIISC 770
IG G +G K R + DG + K + A K V E +++ ++H NI++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSN---YILDIFQRLNIMIDVASALEYLYF-- 825
I D + +EY G L + LD L +M + AL+ +
Sbjct: 73 -RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 826 --GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ-TQTPATIGYMALE 882
G++ V+H DLKP+NV L L DFG+ ++L ++ F + TP YM+ E
Sbjct: 132 DGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY---YMSPE 186
Query: 883 YGSEGRVSTNGDVYNFGVMLME 904
+ + D+++ G +L E
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYE 208
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 47.0 bits (110), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 145
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D + AT Y A E
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 47.0 bits (110), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKV---FNQQ--CGRAFKSFDVECEVMKSIRHRNII-- 765
IG G +G V A + + VA+K F Q C R + E +++ RH NII
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 766 -KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLY 824
II +I K ++ L L K + SN + F + + L+Y++
Sbjct: 92 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH 146
Query: 825 FGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEY 883
S V+H DLKPSN+LL + DFG+ ++ + D + AT Y A E
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 884 GSEGRVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 47.0 bits (110), Expect = 6e-05, Method: Composition-based stats.
Identities = 61/264 (23%), Positives = 99/264 (37%), Gaps = 45/264 (17%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
+GRG FG V++ + + F + G E ++ RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL------ 66
Query: 774 GDFKALFKALALEYMPHGSLEKYLYSSNYI--LDIFQRLN----------IMIDVASALE 821
+ S+E+ + +I LDIF+R+N I+ V E
Sbjct: 67 -------------HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS--DFGITKLLTREDQFVTQTQTPATIGYM 879
L F +S + H D++P N++ + + +FG + L D F P Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE---YY 170
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP----TNE-----IFNEGMTLKHWVNDWL 930
A E VST D+++ G ++ +G P TN+ I N T +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 931 LISIMKIVDGSLLSREDIQFVAKE 954
I M VD L+ + A E
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASE 254
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 47.0 bits (110), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 39/213 (18%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E T AT
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRW 187
Query: 878 YMALEYG-SEGRVSTNGDVYNFGVMLMETFTGK 909
Y A E + + D+++ G ++ E TG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 46.6 bits (109), Expect = 6e-05, Method: Composition-based stats.
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 35/242 (14%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVK--VFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
+G GGF V + DG A+K + ++Q R + E ++ + H NI+++++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHPNILRLVAY 94
Query: 771 CSIGDFKALFKA-LALEYMPHGSL----EKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
C + + A +A L L + G+L E+ N++ + Q L +++ + LE ++
Sbjct: 95 C-LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED-QILWLLLGICRGLEAIHA 152
Query: 826 -GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGIT-----------KLLTREDQFVTQTQTP 873
GY+ H DLKP+N+LLGD L D G + LT +D +
Sbjct: 153 KGYA----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR---- 204
Query: 874 ATIGYMALEY---GSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWL 930
TI Y A E S + DV++ G +L G+ P + +F +G ++ V + L
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 931 LI 932
I
Sbjct: 265 SI 266
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 46.6 bits (109), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 67/307 (21%), Positives = 126/307 (41%), Gaps = 58/307 (18%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIR----------HR 762
+G+G +G V+K+ + G VAVK + F +F + ++ R H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
NI+ +++ + + ++ L +YM L + ++ IL+ + ++ + ++Y
Sbjct: 70 NIVNLLNVLRADNDRDVY--LVFDYM-ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKY 124
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTR-------------------E 863
L+ G ++H D+KPSN+LL ++DFG+++ +
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 864 DQFVTQTQTPATIGYMALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTL 922
D T AT Y A E T G D+++ G +L E GK IF T+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP----IFPGSSTM 237
Query: 923 KHWVNDWLLISIMKIVDGSLLSREDIQFVAKEQCMSFVFNMAMECTVESPEKRINAKEIV 982
L I+ ++D S ED++ + + + ++ + + KR +
Sbjct: 238 NQ------LERIIGVID--FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289
Query: 983 TRLLKIN 989
LLKIN
Sbjct: 290 NLLLKIN 296
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 46.6 bits (109), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN-QQCGRAFKSFDV-ECEVMKSIRHRNIIKIISCC 771
IG G +G VYKA+ G A+K ++ S + E ++K ++H NI+K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
I K L L E++ L+K L L+ + ++ + + + Y + V
Sbjct: 69 -IHTKKRL--VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE--YGSEGRV 889
+H DLKP N+L+ ++DFG+ + + T T+ Y A + GS+ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEVVTLWYRAPDVLMGSK-KY 178
Query: 890 STNGDVYNFGVMLMETFTG 908
ST D+++ G + E G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 46.6 bits (109), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN-QQCGRAFKSFDV-ECEVMKSIRHRNIIKIISCC 771
IG G +G VYKA+ G A+K ++ S + E ++K ++H NI+K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
I K L L E++ L+K L L+ + ++ + + + Y + V
Sbjct: 69 -IHTKKRL--VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE--YGSEGRV 889
+H DLKP N+L+ ++DFG+ + + T T+ Y A + GS+ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEVVTLWYRAPDVLMGSK-KY 178
Query: 890 STNGDVYNFGVMLMETFTG 908
ST D+++ G + E G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 46.6 bits (109), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 54/247 (21%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG- 826
G+ + LF LEY G L F R+ I + +F
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 827 --------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
+ + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 46.6 bits (109), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + + D Q L + + L+Y++
Sbjct: 85 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCAKLTDDHVQFL--IYQILRGLKYIH- 138
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 185
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 46.2 bits (108), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 68/300 (22%), Positives = 121/300 (40%), Gaps = 48/300 (16%)
Query: 711 NNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIR-HRNIIKII 768
++ GGF VY+A+ + G E A+K ++ E MK + H NI++
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 769 SCCSIGDFKA---LFKALALEYMPHGSLEKYL--YSSNYILDIFQRLNIMIDVASALEYL 823
S SIG ++ + L L + G L ++L S L L I A++++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF-------------VTQT 870
+ P+IH DLK N+LL + L DFG ++ + +T+
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 871 QTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWL 930
TP ++ S + D++ G +L + P F +G L
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL-------- 259
Query: 931 LISIMKIVDGSL-LSREDIQFVAKEQCMSFVFNMAMECTVE-SPEKRINAKEIVTRLLKI 988
+IV+G + D Q+ VF+ + ++ +PE+R++ E+V +L +I
Sbjct: 260 -----RIVNGKYSIPPHDTQYT--------VFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 46.2 bits (108), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV----AVKVFNQ----QCGRAFKSFDVECEVMKSIRHRN 763
++G G +G V+ R G + A+KV + Q + + E +V++ IR
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-DVASALEY 822
+ + + K L L+Y+ G L +L + + I + ++ ALE+
Sbjct: 120 FLVTLHYAFQTETKL---HLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEH 174
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA-----TIG 877
L+ +I+ D+K N+LL N L+DFG++K +FV A TI
Sbjct: 175 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETERAYDFCGTIE 225
Query: 878 YMA--LEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
YMA + G + D ++ GV++ E TG P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 46.2 bits (108), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQ-QCGRAFKSFDV-ECEVMKSIRHRNIIK---- 766
IG G +G K R + DG + K + A K V E +++ ++H NI++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 767 -----------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMID 815
++ C GD ++ + G+ E+ ++L + +L + +
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASV--------ITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFV-TQTQTPA 874
G T V+H DLKP+NV L L DFG+ ++L + F T TP
Sbjct: 126 ECHRRS---DGGHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLME 904
YM+ E + + D+++ G +L E
Sbjct: 182 ---YMSPEQMNRMSYNEKSDIWSLGCLLYE 208
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 46.2 bits (108), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 54/247 (21%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG- 826
G+ + LF LEY G L F R+ I + +F
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 827 --------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
+ + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 712 NLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI-RHRNII---- 765
L+G G +G VYK R ++ G A+KV + G + E ++K HRNI
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
I G L+ L +E+ GS+ + N + + I L L
Sbjct: 89 AFIKKNPPGMDDQLW--LVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSH 144
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGIT----KLLTREDQFVTQTQTPATIG--YM 879
+ VIH D+K NVLL +N L DFG++ + + R + F+ TP + +
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG---TPYWMAPEVI 201
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A + + D+++ G+ +E G P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 46.2 bits (108), Expect = 9e-05, Method: Composition-based stats.
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 705 TDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRH 761
TD + +G+G F V + +I G E A K+ N + R + + E + + ++H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
NI+++ S + F L + + G L + + + Y + + + LE
Sbjct: 63 PNIVRLHDSIS----EEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILE 114
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQ-FVTQTQTPATIG 877
+ + ++H DLKP N+LL L+DFG+ + + Q + TP G
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP---G 171
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y++ E + D++ GV+L G P
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFN-QQCGRAFKSFDV-ECEVMKSIRHRNIIKIISCC 771
IG G +G VYKA+ G A+K ++ S + E ++K ++H NI+K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 772 SIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPV 831
I K L L E++ L+K L L+ + ++ + + + Y + V
Sbjct: 69 -IHTKKRL--VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 832 IHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE--YGSEGRV 889
+H DLKP N+L+ ++DFG+ + + T T+ Y A + GS+ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSK-KY 178
Query: 890 STNGDVYNFGVMLMETFTG 908
ST D+++ G + E G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + D+G+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F IG G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EYMP G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F IG G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EYMP G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 46.2 bits (108), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + + L+Y++
Sbjct: 85 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 138
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 185
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 46.2 bits (108), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 40 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 99 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 142
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 143 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 191
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 49 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + + L+Y++
Sbjct: 108 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 161
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 162 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 208
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 36 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 95 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 187
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 109 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 160
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + DFG+ + E GY+A +
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MTGYVATRWYR 209
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 19/224 (8%)
Query: 696 FSYLELC-QATDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDV 751
F + C + TD + +G+G F V + + E A K+ N + R + +
Sbjct: 20 FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 752 ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
E + + ++H NI+++ S + F L + + G L + + + Y + +
Sbjct: 80 EARICRLLKHPNIVRLHDSIS----EEGFHYLVFDLVTGGELFEDIVAREY----YSEAD 131
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQ-FV 867
+ LE + + ++H DLKP N+LL L+DFG+ + E Q +
Sbjct: 132 ASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP GY++ E + D++ GV+L G P
Sbjct: 192 GFAGTP---GYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 45.8 bits (107), Expect = 1e-04, Method: Composition-based stats.
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKS-FDVECEVMKSIRHRNII 765
F +G G F V A + G AVK ++ + +S + E V++ I+H NI+
Sbjct: 24 FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSL-----EKYLYSSNYILDIFQRLNIMIDVASAL 820
+ + L+ L ++ + G L EK Y+ + +++ L
Sbjct: 84 ALEDIYESPNH--LY--LVMQLVSGGELFDRIVEKGFYTEKDASTLIRQV---------L 130
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
+ +Y+ + ++H DLKP N+L + +SDFG++K+ + D T TP G
Sbjct: 131 DAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTP---G 187
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y+A E ++ S D ++ GV+ G P
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 34/210 (16%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQ-QCGRAFKSFDV-ECEVMKSIRHRNIIK---- 766
IG G +G K R + DG + K + A K V E +++ ++H NI++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 767 -----------IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMID 815
++ C GD ++ + G+ E+ ++L + +L + +
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASV--------ITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQ-TQTPA 874
G T V+H DLKP+NV L L DFG+ ++L + F TP
Sbjct: 126 ECHRRS---DGGHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY 181
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLME 904
YM+ E + + D+++ G +L E
Sbjct: 182 ---YMSPEQMNRMSYNEKSDIWSLGCLLYE 208
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 50/223 (22%), Positives = 98/223 (43%), Gaps = 16/223 (7%)
Query: 695 RFSYLELCQAT-DGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDV-- 751
++ +LE T + F + ++G+GGFG V +++ ++ ++ + +
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 752 --ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQ 808
E ++++ + R ++ + D AL L L M G L+ ++Y +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKD--AL--CLVLTLMNGGDLKFHIYHMGQAGFPEAR 287
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVT 868
+ ++ LE L+ +++ DLKP N+LL D+ +SD G+ + E Q +
Sbjct: 288 AVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIK 343
Query: 869 QTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T+GYMA E R + + D + G +L E G+ P
Sbjct: 344 GRV--GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 810 LNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFG-ITKLLTREDQFVT 868
L+I I +A A+E+L+ S ++H DLKPSN+ + V + DFG +T + E++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 869 QTQTPA---------TIGYMALEYGSEGRVSTNGDVYNFGVMLME 904
T PA T YM+ E S D+++ G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 714 IGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV-ECEVMKSIRHRNII---KII 768
IG G +G V A + + VA+K + + + + E +++ RH NII II
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
+I K ++ L L K + SN + F + + L+Y++ S
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----LYQILRGLKYIH---S 146
Query: 829 TPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE-DQFVTQTQTPATIGYMALEYGSEG 887
V+H DLKPSN+LL + DFG+ ++ + D T+ AT Y A E
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 888 RVSTNG-DVYNFGVMLMETFTGK 909
+ T D+++ G +L E + +
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 45.4 bits (106), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCS 772
+GRG F V + + G E A K ++ + D E++ I + K SC
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKR----RRGQDCRAEILHEIAVLELAK--SCPR 90
Query: 773 IGDFKALFK-----ALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
+ + +++ L LEY G E + + ++ +++ + LE +Y+ +
Sbjct: 91 VINLHEVYENTSEIILILEYAAGG--EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 828 STPVIHCDLKPSNVL------LGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
++H DLKP N+L LGD + DFG+++ + + TP Y+A
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIGHACELREIMGTPE---YLAP 202
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + ++T D++N G++ T P
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSP 232
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 45.4 bits (106), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + T+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 229
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 45.4 bits (106), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TPA + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPAFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 91/209 (43%), Gaps = 15/209 (7%)
Query: 708 FSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDV----ECEVMKSIRHRN 763
F + ++G+GGFG V +++ ++ ++ + + E ++++ + R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYI-LDIFQRLNIMIDVASALEY 822
++ + D AL L L M G L+ ++Y + + ++ LE
Sbjct: 246 VVSLAYAYETKD--AL--CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
L+ +++ DLKP N+LL D+ +SD G+ + E Q + T+GYMA E
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV--GTVGYMAPE 355
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
R + + D + G +L E G+ P
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + T+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 225
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 673 RNRKRGRQQPNDADMPQ-EATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKARIQDGM 731
+ RK+ A MP+ + W Q D + +LIG G +G V +A D +
Sbjct: 28 QQRKQHHSSKPTASMPRPHSDW---------QIPDRYEIRHLIGTGSYGHVCEA--YDKL 76
Query: 732 E---VAVK----VFNQ--QCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFKA 782
E VA+K VF C R + E ++ + H +++K++ D + +
Sbjct: 77 EKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 783 LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVL 842
+ + +K + Y+ + L+I + + L + + +S ++H DLKP+N L
Sbjct: 133 YVVLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL 188
Query: 843 LGDNMVAHLSDFGITKLL 860
+ + + DFG+ + +
Sbjct: 189 VNQDCSVKVCDFGLARTV 206
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + T+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 27 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 87 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 141
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + + T TP Y+A
Sbjct: 142 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPE---YLAP 193
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 223
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 45.1 bits (105), Expect = 2e-04, Method: Composition-based stats.
Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 714 IGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNIIKIISC 770
+G+G F V + ++ G E A K+ N + R + + E + + ++H NI+++
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
S + L + + G L + + + Y + + + LE + +
Sbjct: 90 IS----EEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMG 141
Query: 831 VIHCDLKPSNVLLGDNM---VAHLSDFGITKLLTREDQ-FVTQTQTPATIGYMALEYGSE 886
V+H DLKP N+LL + L+DFG+ + E Q + TP GY++ E +
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP---GYLSPEVLRK 198
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKP 911
D++ GV+L G P
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPP 223
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + + T TP Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPE---YLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 44.7 bits (104), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFN--QQCGRAFKS-FDVECEVMKSIRHRNIIKI 767
+IGRG FG V ++++ +V A+K+ N + RA + F E +V+ + + I +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYS-SNYILDIFQR-----LNIMIDVASALE 821
+ D L+ L ++Y G L L + + + R + I ID L
Sbjct: 140 HY--AFQDDNNLY--LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
Y +H D+KP N+L+ N L+DFG + L ED V + T Y++
Sbjct: 196 Y---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 882 EY-----GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E G +GR D ++ GV + E G+ P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 44.7 bits (104), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 44.7 bits (104), Expect = 3e-04, Method: Composition-based stats.
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVA-VKVFNQQCGRAFKS-FDVECEVMKSIRHRNIIKIISC 770
IGRG F +VYK + +EVA ++ +++ ++ + F E E +K ++H NI++
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 771 --CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI------DVASALEY 822
++ K + L E G+L+ YL F+ I + + L++
Sbjct: 94 WESTVKGKKCI--VLVTELXTSGTLKTYLKR-------FKVXKIKVLRSWCRQILKGLQF 144
Query: 823 LYFGYSTPVIHCDLKPSNVLL-GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG---Y 878
L+ + P+IH DLK N+ + G + D G+ L + F A IG +
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAK-----AVIGTPEF 196
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTNEIFN 917
A E E + + DVY FG +E T + P +E N
Sbjct: 197 XAPEXYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQN 234
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 44.7 bits (104), Expect = 3e-04, Method: Composition-based stats.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFK-SFDVECEVMKSIRHRN 763
D + +++G G F V A + + VA+K ++ + S + E V+ I+H N
Sbjct: 18 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSL-----EKYLYSSNYILDIFQRLNIMIDVAS 818
I+ + G L ++ + G L EK Y+ ++ V
Sbjct: 78 IVALDDIYESGGHLYLI----MQLVSGGELFDRIVEKGFYTER------DASRLIFQVLD 127
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVL---LGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
A++YL+ ++H DLKP N+L L ++ +SDFG++K+ ED + T
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
GY+A E ++ S D ++ GV+ G P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 44.7 bits (104), Expect = 3e-04, Method: Composition-based stats.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFK-SFDVECEVMKSIRHRN 763
D + +++G G F V A + + VA+K ++ + S + E V+ I+H N
Sbjct: 18 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSL-----EKYLYSSNYILDIFQRLNIMIDVAS 818
I+ + G L ++ + G L EK Y+ ++ V
Sbjct: 78 IVALDDIYESGGHLYLI----MQLVSGGELFDRIVEKGFYTER------DASRLIFQVLD 127
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVL---LGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
A++YL+ ++H DLKP N+L L ++ +SDFG++K+ ED + T
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
GY+A E ++ S D ++ GV+ G P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 44.7 bits (104), Expect = 3e-04, Method: Composition-based stats.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFK-SFDVECEVMKSIRHRN 763
D + +++G G F V A + + VA+K ++ + S + E V+ I+H N
Sbjct: 18 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSL-----EKYLYSSNYILDIFQRLNIMIDVAS 818
I+ + G L ++ + G L EK Y+ ++ V
Sbjct: 78 IVALDDIYESGGHLYLI----MQLVSGGELFDRIVEKGFYTER------DASRLIFQVLD 127
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVL---LGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
A++YL+ ++H DLKP N+L L ++ +SDFG++K+ ED + T
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
GY+A E ++ S D ++ GV+ G P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 44.7 bits (104), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 44.7 bits (104), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 44.7 bits (104), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQ------CGRAFKSFDVECEVMKSIRHRNIIK 766
+G G +G+V A + G +VA+K + RA++ E ++K +RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 767 IISCCS----IGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
++ + + DF + L + +M L K + D Q L V L+
Sbjct: 89 LLDVFTPDETLDDFTDFY--LVMPFM-GTDLGKLMKHEKLGEDRIQFL-----VYQMLKG 140
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE--DQFVTQ-TQTPATI-GY 878
L + ++ +IH DLKP N+ + ++ + DFG+ + E VT+ + P I +
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNW 200
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGK 909
M R + D+++ G ++ E TGK
Sbjct: 201 M--------RYTQTVDIWSVGCIMAEMITGK 223
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 85 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MAG 177
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
++A + + N D+++ G ++ E TG+
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 44.3 bits (103), Expect = 3e-04, Method: Composition-based stats.
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 31/222 (13%)
Query: 708 FSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIK 766
F E ++G+G FG V KAR D A+K + + E ++ S+ H+ +++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 767 IISC-----------CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMID 815
+ ++ LF + EY + +L ++S N + +
Sbjct: 67 YYAAWLERRNFVKPXTAVKKKSTLF--IQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 816 VASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFV-------- 867
+ AL Y++ S +IH +LKP N+ + ++ + DFG+ K + R +
Sbjct: 125 ILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 868 ----TQTQTPATIGYMALE-YGSEGRVSTNGDVYNFGVMLME 904
T T Y+A E G + D Y+ G++ E
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F IG G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVT 868
IM + SA+ +++ V+H DLKP N+L DN+ + DFG +L ++Q +
Sbjct: 111 IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL- 166
Query: 869 QTQTPA-TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+TP T+ Y A E ++ + D+++ GV+L +G+ P
Sbjct: 167 --KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 44.3 bits (103), Expect = 3e-04, Method: Composition-based stats.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQQCGRAFK-SFDVECEVMKSIRHRN 763
D + +++G G F V A + + VA+K ++ + S + E V+ I+H N
Sbjct: 18 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 77
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSL-----EKYLYSSNYILDIFQRLNIMIDVAS 818
I+ + G L ++ + G L EK Y+ ++ V
Sbjct: 78 IVALDDIYESGGHLYLI----MQLVSGGELFDRIVEKGFYTER------DASRLIFQVLD 127
Query: 819 ALEYLYFGYSTPVIHCDLKPSNVL---LGDNMVAHLSDFGITKLLTREDQFVTQTQTPAT 875
A++YL+ ++H DLKP N+L L ++ +SDFG++K+ ED + T
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 876 IGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
GY+A E ++ S D ++ GV+ G P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MAG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
++A + + N D+++ G ++ E TG+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + D G+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DFG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------MAG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
++A + + N D+++ G ++ E TG+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + FG+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 94 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 148
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 149 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 230
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 43.9 bits (102), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQ------CGRAFKSFDVECEVMKSIRHRNIIK 766
+G G +GSV A + G +VA+K ++ RA++ E ++K ++H N+I
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 105
Query: 767 IIS----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
++ S+ +F + L + +M L+K + F I V L+
Sbjct: 106 LLDVFTPASSLRNFYDFY--LVMPFM-QTDLQKIMGME------FSEEKIQYLVYQMLKG 156
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
L + +S V+H DLKP N+ + ++ + DFG+ + E T T Y A E
Sbjct: 157 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE 211
Query: 883 Y-GSEGRVSTNGDVYNFGVMLMETFTGK 909
S + D+++ G ++ E TGK
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGK 239
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 43.9 bits (102), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 21/212 (9%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI 764
D F +G G FG V + ++ G A+K+ ++Q K E+ ++ + I
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK------EIEHTLNEKRI 94
Query: 765 IKIISCCSIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
++ ++ + + FK + +EY P G + +L + R +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
EYL+ S +I+ DLKP N+++ ++DFG+ K + + T Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYL 205
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A E + D + GV++ E G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 43.9 bits (102), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + D G+ + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 43.9 bits (102), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 36/214 (16%)
Query: 713 LIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV--ECEVMKSIRHRNIIKIIS 769
++G+G FG V K + + E AVKV N+ + + + E E++K + H NI+K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD-IFQR--------LNIMIDVASAL 820
LE + LY+ + D I +R I+ V S +
Sbjct: 89 I--------------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
Y++ ++H DLKP N+LL + + DFG++ + + + T I
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
L G DV++ GV+L +G P
Sbjct: 192 PEVL----RGTYDEKCDVWSAGVILYILLSGTPP 221
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 43.9 bits (102), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 713 LIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV--ECEVMKSIRHRNIIKIIS 769
++G+G FG V K + + E AVKV N+ + + + E E++K + H NI+K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD-IFQRLNIMI-DVASALEYLYFG- 826
LE + LY+ + D I +R D A ++ ++ G
Sbjct: 89 I--------------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 827 ---YSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG--- 877
+ ++H DLKP N+LL + + DFG++ F T+ IG
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC------FQQNTKMKDRIGTAY 188
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y+A E G DV++ GV+L +G P
Sbjct: 189 YIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPP 221
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 43.9 bits (102), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 43.9 bits (102), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 36/214 (16%)
Query: 713 LIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFDV--ECEVMKSIRHRNIIKIIS 769
++G+G FG V K + + E AVKV N+ + + + E E++K + H NI+K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILD-IFQR--------LNIMIDVASAL 820
LE + LY+ + D I +R I+ V S +
Sbjct: 89 I--------------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 821 EYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
Y++ ++H DLKP N+LL + + DFG++ + + + T I
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 878 YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
L G DV++ GV+L +G P
Sbjct: 192 PEVL----RGTYDEKCDVWSAGVILYILLSGTPP 221
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 43.9 bits (102), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 43.9 bits (102), Expect = 5e-04, Method: Composition-based stats.
Identities = 36/134 (26%), Positives = 68/134 (50%), Gaps = 10/134 (7%)
Query: 711 NNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIR-HRNIIKII 768
+ L+G G + V A +Q+G E AVK+ +Q G + E E + + ++NI+++I
Sbjct: 18 SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 769 SCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
D + L E + GS+ ++ + + + ++ DVA+AL++L ++
Sbjct: 78 E--FFEDDTRFY--LVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFL---HT 129
Query: 829 TPVIHCDLKPSNVL 842
+ H DLKP N+L
Sbjct: 130 KGIAHRDLKPENIL 143
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 43.9 bits (102), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 43.9 bits (102), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQQ------CGRAFKSFDVECEVMKSIRHRNIIK 766
+G G +GSV A + G +VA+K ++ RA++ E ++K ++H N+I
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 767 IIS----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEY 822
++ S+ +F + L + +M L+K + F I V L+
Sbjct: 88 LLDVFTPASSLRNFYDFY--LVMPFM-QTDLQKIMGLK------FSEEKIQYLVYQMLKG 138
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
L + +S V+H DLKP N+ + ++ + DFG+ + E T T Y A E
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE 193
Query: 883 Y-GSEGRVSTNGDVYNFGVMLMETFTGK 909
S + D+++ G ++ E TGK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors A29
Length = 270
Score = 43.9 bits (102), Expect = 5e-04, Method: Composition-based stats.
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 7/150 (4%)
Query: 39 SFCNWTGVTCDVHSHRVTALNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIF 98
+ C G C ++++ +++ S L+ IPS + + + L L SN+ S S+P F
Sbjct: 3 ALCKKDGGVCSCNNNK-NSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLS-SLPSKAF 57
Query: 99 N-IHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYLRILRL 157
+ + L+LL DN+L +P I L E+L ++ N L LRL
Sbjct: 58 HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116
Query: 158 SYNDFAGGIPKEIGNLTKLEELYLSFNGLQ 187
N P+ +LTKL L L +N LQ
Sbjct: 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Score = 36.2 bits (82), Expect = 0.094, Method: Composition-based stats.
Identities = 48/201 (23%), Positives = 73/201 (36%), Gaps = 7/201 (3%)
Query: 354 IDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCNVSGSIPEEIGNLTNLIGFYLGGNNLNG 413
+D SS + I S N+ K D+ +S + LT L YL N L
Sbjct: 21 VDCSSKKLTAIPS-----NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ- 74
Query: 414 SIPITLGK-LQKLQVLYFPDNKLEGSIPDEVCRLAKVYQLDLSNNKLSGSIPACFGDXXX 472
++P + K L+ L+ L+ DNKL+ +L + +L L N+L P F
Sbjct: 75 TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK 134
Query: 473 XXXXXXXXXXXISVIPSTFWNLKDILYLNLSSNSLTGPLPLEIGNLKVLVKIDFSMNNFS 532
S+ F L + L L +N L L L + N
Sbjct: 135 LTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
Query: 533 GVIPNAIGGIKDLQFLFLEYN 553
V A ++ L+ L L+ N
Sbjct: 195 RVPEGAFDSLEKLKMLQLQEN 215
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 43.5 bits (101), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 43.5 bits (101), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 43.5 bits (101), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 36/244 (14%)
Query: 714 IGRGGFGSVYKARIQDGM-EVAVKVF-------------NQQCGRAFKSFDVECEVMKSI 759
+G G +G V + ++G E A+KV N+ + + E ++KS+
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H NIIK+ D K + L E+ G L + + + + D NIM + S
Sbjct: 104 DHPNIIKLFDV--FEDKKYFY--LVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSG 158
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDN---MVAHLSDFGITKLLTREDQFVTQTQTPATI 876
+ YL+ ++H D+KP N+LL + + + DFG++ +++ + + T I
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 877 GYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP-----TNEIFNEGMTLKHW--VNDW 929
L + + + DV++ GV++ G P +I + K++ NDW
Sbjct: 216 APEVL----KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 930 LLIS 933
IS
Sbjct: 272 KNIS 275
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 43.5 bits (101), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 43.5 bits (101), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 21/212 (9%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI 764
D F +G G FG V + ++ G A+K+ ++Q K E+ ++ + I
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK------EIEHTLNEKRI 94
Query: 765 IKIISCCSIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
++ ++ + + FK + +EY P G + +L + R +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
EYL+ S +I+ DLKP N+++ ++DFG+ K + + T Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYL 205
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A E + D + GV++ E G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 682 PNDADMPQEAT--WRRFSYLELCQATDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVF 738
P + M QE +R+ + + + + + +G G +GSV A + G VAVK
Sbjct: 16 PRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL 75
Query: 739 N---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS----CCSIGDFKALFKALALEYMPHG 791
+ Q A +++ E ++K ++H N+I ++ S+ +F ++ + ++
Sbjct: 76 SRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY---LVTHLMGA 131
Query: 792 SLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHL 851
L + D Q L + L L + +S +IH DLKPSN+ + ++ +
Sbjct: 132 DLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 186
Query: 852 SDFGITKLLTREDQFVTQTQTPATIGYMALEYG-SEGRVSTNGDVYNFGVMLMETFTGK 909
DFG+ + +D+ AT Y A E + + D+++ G ++ E TG+
Sbjct: 187 LDFGLAR--HTDDEMXGXV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 70 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 114
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 215
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 47/211 (22%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G+ VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 ----CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
S+ +F ++ + ++ L + D Q L + L L +
Sbjct: 89 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKY 140
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
+S +IH DLKPSN+ + ++ + D G+ + E GY+A +
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----------MTGYVATRWYR 189
Query: 886 EGRVSTNG-------DVYNFGVMLMETFTGK 909
+ N D+++ G ++ E TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 94 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 148
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 149 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 230
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 183
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 184 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 70 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 114
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 215
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 176
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 177 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 43.5 bits (101), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 176 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 43.5 bits (101), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 182
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 183 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 43.5 bits (101), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 43.5 bits (101), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EYSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 43.5 bits (101), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 705 TDGFSENNLIGRGGFGSVY--KARIQDGMEVAVKVFNQQCGRAF---KSFDVECEVMKSI 759
+D + ++G+G FG V K +I G E AVKV +++ + +S E +++K +
Sbjct: 31 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H NI+K+ + K F L E G L + S ++ I+ V S
Sbjct: 90 DHPNIMKLYE---FFEDKGYF-YLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSG 144
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
+ Y++ ++H DLKP N+LL + + DFG++ + + T I
Sbjct: 145 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 201
Query: 877 GYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTN 913
L G DV++ GV+L +G P N
Sbjct: 202 APEVL----HGTYDEKCDVWSTGVILYILLSGCPPFN 234
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 43.5 bits (101), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + + + K L LE + G L +L + +
Sbjct: 71 IQHPNVI---TLHEVYENKTDV-ILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 43.5 bits (101), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 181
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 182 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 43.1 bits (100), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 222 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 43.1 bits (100), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 178 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 43.1 bits (100), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 191
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 192 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 43.1 bits (100), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 227
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 228 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D+++ GV++ G P
Sbjct: 178 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EYSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 20/232 (8%)
Query: 687 MPQEATWRRFSYLELCQATDGFSENNLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRA 745
MP E + + L+ + TD F+ ++G+G FG V A + E+ A+K+ +
Sbjct: 1 MPSEDRKQPSNNLDRVKLTD-FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDV--V 57
Query: 746 FKSFDVECEVMKSI------RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYS 799
+ DVEC +++ + + ++ SC D L+ +EY+ G L ++
Sbjct: 58 IQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVD--RLY--FVMEYVNGGDLMYHIQQ 113
Query: 800 SNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKL 859
+ F+ + A L+F + +I+ DLK NV+L ++DFG+ K
Sbjct: 114 ----VGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 169
Query: 860 LTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ VT + T Y+A E + + D + +GV+L E G+ P
Sbjct: 170 HMMDG--VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 219
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 62 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 122 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 176
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 258
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 101 PFLVKL--EYSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 43.1 bits (100), Expect = 8e-04, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 43.1 bits (100), Expect = 8e-04, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 21/212 (9%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI 764
D F +G G FG V + ++ G A+K+ ++Q K ++ ++ + I
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK------QIEHTLNEKRI 95
Query: 765 IKIISCCSIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
++ ++ + + FK + +EY P G + +L + R +
Sbjct: 96 LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLT 154
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
EYL+ S +I+ DLKP N+++ ++DFG K + + T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYL 206
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A E + D + GV++ E G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 42.7 bits (99), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 50/110 (45%), Gaps = 12/110 (10%)
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
LE ++ + ++H DLKP+N L+ D M+ L DFGI + + V + + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 880 ALEYGSEGRVS-TNG----------DVYNFGVMLMETFTGKKPTNEIFNE 918
E + S NG DV++ G +L GK P +I N+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 52/237 (21%), Positives = 96/237 (40%), Gaps = 19/237 (8%)
Query: 683 NDADMPQEATWRRF--SYLELCQAT--DGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKV 737
ND D E W+++ +E+ Q + D + +G G FG V++ G K
Sbjct: 24 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83
Query: 738 FNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSIGDFKALFK-ALALEYMPHGSLEKY 796
N + E +M + H +I + F+ ++ L LE++ G L
Sbjct: 84 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMVLILEFLSGGELFDR 138
Query: 797 LYSSNYILDIFQRLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS--DF 854
+ + +Y + + +N M L++++ ++H D+KP N++ + + DF
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 195
Query: 855 GITKLLTREDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
G+ L D+ V T AT + A E V D++ GV+ +G P
Sbjct: 196 GLATKLN-PDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 36/224 (16%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVAS 818
I+H N+I + L LE + G L +L + +
Sbjct: 71 IQHPNVITLHEVYE----NKTDVILILELVAGGELFDFLAEKESLTE-----------EE 115
Query: 819 ALEYL-------YFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFV 867
A E+L Y+ +S + H DLKP N++L D V + DFG+ + ++F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP + + Y G D+++ GV+ +G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 705 TDGFSENNLIGRGGFGSVY--KARIQDGMEVAVKVFNQQCGRAF---KSFDVECEVMKSI 759
+D + ++G+G FG V K +I G E AVKV +++ + +S E +++K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H NI+K+ + K F L E G L + S ++ I+ V S
Sbjct: 84 DHPNIMKLYEFF---EDKGYF-YLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSG 138
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
+ Y++ ++H DLKP N+LL + + DFG++ F + I
Sbjct: 139 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKMKDKI 189
Query: 877 G---YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTN 913
G Y+A E G DV++ GV+L +G P N
Sbjct: 190 GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 228
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 51/219 (23%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFN---QQCGRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G G +GSV A + G VAVK + Q A +++ E ++K ++H N+I ++
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYIL-----DIFQRLNIMIDVASALEY 822
+ P SLE++ +Y +++ +I + + D L Y
Sbjct: 89 V----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 823 -----LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIG 877
L + +S +IH DLKPSN+ + ++ + DF + + E G
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----------MTG 181
Query: 878 YMALEYGSEGRVSTNG-------DVYNFGVMLMETFTGK 909
Y+A + + N D+++ G ++ E TG+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+++ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+++ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 705 TDGFSENNLIGRGGFGSVY--KARIQDGMEVAVKVFNQQCGRAF---KSFDVECEVMKSI 759
+D + ++G+G FG V K +I G E AVKV +++ + +S E +++K +
Sbjct: 48 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H NI+K+ + K F L E G L + S ++ I+ V S
Sbjct: 107 DHPNIMKLYEFF---EDKGYF-YLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSG 161
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
+ Y++ ++H DLKP N+LL + + DFG++ F + I
Sbjct: 162 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKMKDKI 212
Query: 877 G---YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTN 913
G Y+A E G DV++ GV+L +G P N
Sbjct: 213 GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 251
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 714 IGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISCCSI 773
IG G FG R + E+ + ++ + ++ E +S+RH NI++
Sbjct: 27 IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI-- 84
Query: 774 GDFKALFKALALEYMPHGSLEKYL-----YSSNYILDIFQRLNIMIDVASALEYLYFGYS 828
A+ +EY G L + + +S + FQ+L + A A++
Sbjct: 85 --LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ------- 135
Query: 829 TPVIHCDLKPSNVLLGDNMVAHL--SDFGITKLLTREDQFVTQTQTPATIGYMAL---EY 883
V H DLK N LL + L +DFG +K Q + TPA I L EY
Sbjct: 136 --VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEY 193
Query: 884 GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+G+V+ DV++ GV L G P
Sbjct: 194 --DGKVA---DVWSCGVTLYVMLVGAYP 216
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
+IGRG FG V ++++ + A+K+ N+ K + C R+++ C
Sbjct: 80 KVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKRAETAC----FREERDVLVNGDC 133
Query: 771 CSIGDFKALFKA-----LALEYMPHGSLEKYLYS-SNYILDIFQRLNI--MIDVASALEY 822
I F+ L ++Y G L L + + + R I M+ ++
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM--- 879
L++ +H D+KP NVLL N L+DFG + L +D V + T Y+
Sbjct: 194 LHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPE 246
Query: 880 ---ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A+E G G+ D ++ GV + E G+ P
Sbjct: 247 ILQAMEDGM-GKYGPECDWWSLGVCMYEMLYGETP 280
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 18/205 (8%)
Query: 714 IGRGGFGSVYK-ARIQDGMEVAVKVFNQQ--CGRAFKSFDVECEVMKSIRHRNIIKIISC 770
+G+G F V + ++ G E A + N + R + + E + + ++H NI+++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
S + L + + G L + + + Y + + + LE + +
Sbjct: 79 IS----EEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMG 130
Query: 831 VIHCDLKPSNVLLGDNM---VAHLSDFGITKLLTREDQ-FVTQTQTPATIGYMALEYGSE 886
V+H +LKP N+LL + L+DFG+ + E Q + TP GY++ E +
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP---GYLSPEVLRK 187
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKP 911
D++ GV+L G P
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPP 212
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 21/212 (9%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI 764
D F +G G FG V + ++ G A+K+ ++Q K ++ ++ + I
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK------QIEHTLNEKRI 95
Query: 765 IKIISCCSIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
++ ++ + + FK + +EY P G + +L + R +
Sbjct: 96 LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
EYL+ S +I+ DLKP N+++ ++DFG K + + T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYL 206
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A E + D + GV++ E G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFD---VECEVMKSIRHRN 763
F L+G+G FG V R + G A+K+ ++ A E V+++ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
+ + D + F +EY G L +L + R ++ SALEYL
Sbjct: 67 LTALKYAFQTHD-RLCF---VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL 121
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKL-LTREDQFVTQTQTPATIGYMALE 882
+ S V++ D+K N++L + ++DFG+ K ++ T TP + LE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
GR D + GV++ E G+ P
Sbjct: 179 DNDYGRAV---DWWGLGVVMYEMMCGRLP 204
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 705 TDGFSENNLIGRGGFGSVY--KARIQDGMEVAVKVFNQQCGRAF---KSFDVECEVMKSI 759
+D + ++G+G FG V K +I G E AVKV +++ + +S E +++K +
Sbjct: 49 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H NI+K+ + K F L E G L + S ++ I+ V S
Sbjct: 108 DHPNIMKLYEFF---EDKGYF-YLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSG 162
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
+ Y++ ++H DLKP N+LL + + DFG++ F + I
Sbjct: 163 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKMKDKI 213
Query: 877 G---YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTN 913
G Y+A E G DV++ GV+L +G P N
Sbjct: 214 GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 252
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 21/212 (9%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNI 764
D F +G G FG V + ++ G A+K+ ++Q K ++ ++ + I
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK------QIEHTLNEKRI 95
Query: 765 IKIISCCSIGDFKALFKA-----LALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
++ ++ + + FK + +EY P G + +L + R +
Sbjct: 96 LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM 879
EYL+ S +I+ DLKP N+++ ++DFG K + + T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYL 206
Query: 880 ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A E + D + GV++ E G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
+IGRG FG V ++++ + A+K+ N+ K + C R+++ C
Sbjct: 96 KVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKRAETAC----FREERDVLVNGDC 149
Query: 771 CSIGDFKALFKA-----LALEYMPHGSLEKYLYS-SNYILDIFQRLNI--MIDVASALEY 822
I F+ L ++Y G L L + + + R I M+ ++
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 823 LYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYM--- 879
L++ +H D+KP NVLL N L+DFG + L +D V + T Y+
Sbjct: 210 LHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPE 262
Query: 880 ---ALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
A+E G G+ D ++ GV + E G+ P
Sbjct: 263 ILQAMEDGM-GKYGPECDWWSLGVCMYEMLYGETP 296
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 39/175 (22%), Positives = 76/175 (43%), Gaps = 15/175 (8%)
Query: 696 FSYLELCQATDGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQ------QCGRAFKS 748
F ++ D + +LIGRG +G VY A ++ + VA+K N+ C R +
Sbjct: 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR- 74
Query: 749 FDVECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
E ++ ++ II++ D + + + L+K + ++ +
Sbjct: 75 ---EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE--- 128
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRE 863
+I + + L F + + +IH DLKP+N LL + + DFG+ + + E
Sbjct: 129 -EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 42.0 bits (97), Expect = 0.002, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
pdb|3RFS|B Chain B, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
Length = 272
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 51/185 (27%), Positives = 74/185 (40%), Gaps = 14/185 (7%)
Query: 59 NISHLSLSGTI---PSRLGNLSSLQSLFLHSNQFSGSIPFSIFN-IHTLKLLSFGDNQLS 114
N+ +L+L G S L L++L L L NQ S+P +F+ + LK L +NQL
Sbjct: 64 NVRYLALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ 122
Query: 115 GEIPTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYLRILRLSYNDFAGGIPKEIGNLT 174
+P + L LNL+ N T L L LSYN LT
Sbjct: 123 S-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLT 181
Query: 175 KLEELYLSFNGLQGAYDHGFLQIFVKNIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNK 234
+L++L L N L+ D G ++ N C P + L+ +NK
Sbjct: 182 QLKDLRLYQNQLKSVPD-GVFDRLTSLQYIWLHDNPWDCTCP-------GIRYLSEWINK 233
Query: 235 LVGVI 239
GV+
Sbjct: 234 HSGVV 238
Score = 30.8 bits (68), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 11/127 (8%)
Query: 489 STFWNLKDILYLNLSSNSLTGPLP----LEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKD 544
S L ++ YL L+ N L LP ++ NLK LV ++ N + + +
Sbjct: 79 SALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVE---NQLQSLPDGVFDKLTN 134
Query: 545 LQFLFLEYNILQGSIPDSFGDLMXXXXXXXXXXXXXGSIPVSL-EKLSYLKDLNLSFNKL 603
L +L L +N LQ S+P D + S+P + +KL+ LKDL L N+L
Sbjct: 135 LTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193
Query: 604 EGEIPKG 610
+ +P G
Sbjct: 194 KS-VPDG 199
Score = 30.8 bits (68), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 11/121 (9%)
Query: 494 LKDILYLNLSSNSLTGPLPLEIGNLKVLVKIDFSM--NNFSGVIPNAI-GGIKDLQFLFL 550
L ++ YL L N L +I LK L + + + N +PN + + +L+ L L
Sbjct: 62 LPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116
Query: 551 EYNILQGSIPDSFGDLMXXXXXXXXXXXXXGSIPVSL-EKLSYLKDLNLSFNKLEGEIPK 609
N LQ S+PD D + S+P + +KL+ L +L+LS+N+L+ +P+
Sbjct: 117 VENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPE 174
Query: 610 G 610
G
Sbjct: 175 G 175
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 42/227 (18%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ----CGRAFKSFDVECEV--MKS 758
D + +G G F V K R + G++ A K ++ R D+E EV +K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 759 IRHRNIIKIISCCS-------IGDFKA---LFKALALEYMPHGSLEKYLYSSNYILDIFQ 808
I+H N+I + IG+ A LF LA EK + + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLA---------EKESLTEEEATEFLK 121
Query: 809 RLNIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTRED 864
++ L +Y+ +S + H DLKP N++L D V + DFG+ + +
Sbjct: 122 QI---------LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 865 QFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+F TP + + Y G D+++ GV+ +G P
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLG---LEADMWSIGVITYILLSGASP 216
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 42.0 bits (97), Expect = 0.002, Method: Composition-based stats.
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 20/203 (9%)
Query: 708 FSENNLIGRGGFGSVYKARI-QDGMEVAVKVFNQQCGRAFKSF----DVECEVMKSIRHR 762
F + +G G +G V+K R +DG AVK R+ F D ++ + H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-------RSMSPFRGPKDRARKLAEVGSHE 111
Query: 763 NIIKIISCCSIGDFKALFKALALEYMPHG-SLEKYLYSSNYILDIFQRLNIMIDVASALE 821
+ + C + L L+ G SL+++ + L Q + D AL
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
+L+ S ++H D+KP+N+ LG L DFG+ L Q P YMA
Sbjct: 172 HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR---YMAP 225
Query: 882 EYGSEGRVSTNGDVYNFGVMLME 904
E +G T DV++ G+ ++E
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILE 247
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY P G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+++ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 712 NLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFD---VECEVMKSIRHRNIIKI 767
L+G+G FG V R + G A+K+ ++ A E V+++ RH + +
Sbjct: 14 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
D + F +EY G L +L + R ++ SALEYL+
Sbjct: 74 KYAFQTHD-RLCF---VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 125
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKL-LTREDQFVTQTQTPATIGYMALEYGSE 886
S V++ D+K N++L + ++DFG+ K ++ T TP + LE
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 185
Query: 887 GRVSTNGDVYNFGVMLMETFTGKKP 911
GR D + GV++ E G+ P
Sbjct: 186 GRAV---DWWGLGVVMYEMMCGRLP 207
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E + +++
Sbjct: 42 DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + LEY P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 16/237 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEV-AVKVFNQQC---GRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G+GGF ++ D EV A K+ + + +E + +S+ H++++
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
DF +F + LE SL + L+ L + + + +YL+
Sbjct: 85 FFEDNDF--VF--VVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RN 136
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
VIH DLK N+ L +++ + DFG+ TK+ ++ T TP Y+A E S+
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP---NYIAPEVLSKKG 193
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSR 945
S DV++ G ++ GK P + L+ N++ + + V SL+ +
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 42.0 bits (97), Expect = 0.002, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 42.0 bits (97), Expect = 0.002, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 16/237 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEV-AVKVFNQQC---GRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G+GGF ++ D EV A K+ + + +E + +S+ H++++
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
DF +F + LE SL + L+ L + + + +YL+
Sbjct: 85 FFEDNDF--VF--VVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RN 136
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
VIH DLK N+ L +++ + DFG+ TK+ ++ T TP Y+A E S+
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP---NYIAPEVLSKKG 193
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSR 945
S DV++ G ++ GK P + L+ N++ + + V SL+ +
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 9/163 (5%)
Query: 752 ECEVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
E ++++ +RH+N+I+++ + + ++ + +EY G E + Q
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMY--MVMEYCVCGMQEMLDSVPEKRFPVCQAHG 113
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL---TREDQFVT 868
+ LEYL+ S ++H D+KP N+LL +S G+ + L +D T
Sbjct: 114 YFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 869 QTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+PA + G + D+++ GV L TG P
Sbjct: 171 SQGSPA-FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 16/237 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEV-AVKVFNQQC---GRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G+GGF ++ D EV A K+ + + +E + +S+ H++++
Sbjct: 29 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
DF +F + LE SL + L+ L + + + +YL+
Sbjct: 89 FFEDNDF--VF--VVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RN 140
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
VIH DLK N+ L +++ + DFG+ TK+ ++ T TP Y+A E S+
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP---NYIAPEVLSKKG 197
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSR 945
S DV++ G ++ GK P + L+ N++ + + V SL+ +
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 254
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQDGME-VAVKVFNQ------QCGRAFKSFDVECEV 755
+ D + +LIGRG +G VY A ++ + VA+K N+ C R + E +
Sbjct: 25 KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR----EITI 80
Query: 756 MKSIRHRNIIKIISCCSIGD---FKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNI 812
+ ++ II++ D F L+ L + S K L+ + L I
Sbjct: 81 LNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA----DSDLKKLFKTPIFLTEQHVKTI 136
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL 860
+ ++ ++++ + +IH DLKP+N LL + + DFG+ + +
Sbjct: 137 LYNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTI 181
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 713 LIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFDVECEVMKSI------RHRNII 765
++G+G FG V + + E+ AVK+ + + DVEC +++ + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDV--VIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
++ SC D L+ +EY+ G L ++ + F+ + + A L+F
Sbjct: 406 QLHSCFQTMD--RLY--FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFF 457
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +I+ DLK NV+L ++DFG+ K + VT T Y+A E +
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPDYIAPEIIA 515
Query: 886 EGRVSTNGDVYNFGVMLMETFTGKKP 911
+ D + FGV+L E G+ P
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAP 541
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFK------SFDVECEVMKSIRHRNIIK 766
+G G F V K R + G+E A K ++ RA + + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ L LE + G L +L + L + + + + + YL+
Sbjct: 80 LHDVYE----NRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
+ + H DLKP N++L D + L DFG+ + +F TP + +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y G D+++ GV+ +G P
Sbjct: 192 YEPLG---LEADMWSIGVITYILLSGASP 217
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 713 LIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFDVECEVMKSI------RHRNII 765
++G+G FG V + + E+ AVK+ + + DVEC +++ + +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDV--VIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 766 KIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYF 825
++ SC D L+ +EY+ G L ++ + F+ + + A L+F
Sbjct: 85 QLHSCFQTMD--RLY--FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFF 136
Query: 826 GYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGS 885
S +I+ DLK NV+L ++DFG+ K + VT T Y+A E +
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPDYIAPEIIA 194
Query: 886 EGRVSTNGDVYNFGVMLMETFTGKKP 911
+ D + FGV+L E G+ P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFK------SFDVECEVMKSIRHRNIIK 766
+G G F V K R + G+E A K ++ RA + + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ L LE + G L +L + L + + + + + YL+
Sbjct: 80 LHDVYE----NRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
+ + H DLKP N++L D + L DFG+ + +F TP + +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y G D+++ GV+ +G P
Sbjct: 192 YEPLG---LEADMWSIGVITYILLSGASP 217
>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 520
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 5/139 (3%)
Query: 58 LNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFS--GSIPFSIFNIHTLKLLSFGDNQLSG 115
L+ S+ L+ T+ G+L+ L++L L NQ I + +L+ L N +S
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 116 EIPTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYLRILRLSYNDFAGGIPKEIGNLTK 175
+ CS SLN+S N+ I L +++L L N IPK++ L
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEA 445
Query: 176 LEELYLSFNGLQGAYDHGF 194
L+EL ++ N L+ D F
Sbjct: 446 LQELNVASNQLKSVPDGIF 464
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 41.6 bits (96), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFK------SFDVECEVMKSIRHRNIIK 766
+G G F V K R + G+E A K ++ RA + + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ L LE + G L +L + L + + + + + YL+
Sbjct: 80 LHDVYE----NRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
+ + H DLKP N++L D + L DFG+ + +F TP + +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y G D+++ GV+ +G P
Sbjct: 192 YEPLG---LEADMWSIGVITYILLSGASP 217
>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex
Length = 562
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 13/205 (6%)
Query: 37 SISFCNWTGVTCDVHSHRVTALNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFS 96
SIS + + C T LN + + ++ L LQ+L L N +
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVA 396
Query: 97 IF--NIHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYLRI 154
+ N+ +L+ L N L+ C+ LNLS NM G + L +++
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKV 454
Query: 155 LRLSYNDFAGGIPKEIGNLTKLEELYLSFNGLQGAYDHGFLQIFVKNIFVQFSHNFSKCE 214
L L +N+ IPK++ +L L+EL ++ N L+ D G ++ N C
Sbjct: 455 LDL-HNNRIMSIPKDVTHLQALQELNVASNQLKSVPD-GVFDRLTSLQYIWLHDNPWDCT 512
Query: 215 IPNEIGNLRNLEVLALGLNKLVGVI 239
P + L+ +NK GV+
Sbjct: 513 CP-------GIRYLSEWINKHSGVV 530
Score = 32.3 bits (72), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 64/269 (23%), Positives = 104/269 (38%), Gaps = 47/269 (17%)
Query: 55 VTALNISHLSLSGTIPSRLGNLS--SLQSLFLH--SNQ---FSGSIPFSIFNIHTLKLLS 107
V LNI +L+++ I S +L+SL + NQ FS +S+F +K+LS
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 108 FGDNQLSGEIPTNICSNLPF-FESLNLSKNMFHGGIPSALSNCTYLRILRLSYNDFAG-- 164
D + C P F LN ++N+F + S L+ L L N
Sbjct: 338 ISDTPFIHMV----CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF 393
Query: 165 GIPKEIGNLTKLEELYLSFNGLQG-AYDH--------------------GFLQIFVKNIF 203
+ N++ LE L +S N L AYD + +
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVK 453
Query: 204 VQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVGVIPAEIFN-MSTIQGVXXXXXXXXXX 262
V HN IP ++ +L+ L+ L + N+L V P +F+ ++++Q +
Sbjct: 454 VLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSV-PDGVFDRLTSLQYIWLHDN----- 507
Query: 263 XXXIPY-VRLPNLEELYLWGNHFSGSIPN 290
P+ P + L W N SG + N
Sbjct: 508 ----PWDCTCPGIRYLSEWINKHSGVVRN 532
Score = 31.6 bits (70), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 347 NCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCNVSGSIPEEIGNLTNLIGFYL 406
N LE +D+S NS++ ++ + S+ + ++S ++GS+ + ++ +
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCA-WAESILVLNLSSNMLTGSVFRCLPPKVKVLDLH- 458
Query: 407 GGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVC-RLAKVYQLDLSNNKLSGSIP 464
NN SIP + LQ LQ L N+L+ S+PD V RL + + L +N + P
Sbjct: 459 --NNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 705 TDGFSENNLIGRGGFGSVY--KARIQDGMEVAVKVFNQQCGRAF---KSFDVECEVMKSI 759
+D + ++G+G FG V K +I G E AVKV +++ + +S E +++K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 760 RHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASA 819
H NI K+ + K F L E G L + S F ++ +
Sbjct: 84 DHPNIXKLYEFF---EDKGYF-YLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQV 135
Query: 820 LEYLYFGYSTPVIHCDLKPSNVLL---GDNMVAHLSDFGITKLLTREDQFVTQTQTPATI 876
L + + + ++H DLKP N+LL + + DFG++ F + I
Sbjct: 136 LSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKXKDKI 189
Query: 877 G---YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKPTN 913
G Y+A E G DV++ GV+L +G P N
Sbjct: 190 GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 228
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY P G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+++ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFK------SFDVECEVMKSIRHRNIIK 766
+G G F V K R + G+E A K ++ RA + + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ L LE + G L +L + L + + + + + YL+
Sbjct: 80 LHDVYE----NRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
+ + H DLKP N++L D + L DFG+ + +F TP + +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y G D+++ GV+ +G P
Sbjct: 192 YEPLG---LEADMWSIGVITYILLSGASP 217
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 13 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 68
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 69 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 111
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 112 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 232 IDSAPLA 238
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 41.2 bits (95), Expect = 0.003, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
IM + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 175
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP Y+A E + + D+++ GV++ G P
Sbjct: 176 EPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFK------SFDVECEVMKSIRHRNIIK 766
+G G F V K R + G+E A K ++ RA + + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ L LE + G L +L + L + + + + + YL+
Sbjct: 80 LHDVYE----NRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
+ + H DLKP N++L D + L DFG+ + +F TP + +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y G D+++ GV+ +G P
Sbjct: 192 YEPLG---LEADMWSIGVITYILLSGASP 217
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 24/221 (10%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKS 758
L + +D + IG G FG R + E+ + ++ + ++ E +S
Sbjct: 11 LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 70
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYL-----YSSNYILDIFQRLNIM 813
+RH NI++ A+ +EY G L + + +S + FQ+L
Sbjct: 71 LRHPNIVRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--- 123
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS--DFGITKLLTREDQFVTQTQ 871
+ + + ++ V H DLK N LL + L DFG +K Q +
Sbjct: 124 ------ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 177
Query: 872 TPATIG-YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TPA I + L+ +G+V+ DV++ GV L G P
Sbjct: 178 TPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYP 215
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 700 ELCQATDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKV-----FNQQCGRAFKSFDVEC 753
ELC+ +IG+G F V + + G + AVK+ F G + + E
Sbjct: 27 ELCE---------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77
Query: 754 EVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIM 813
+ ++H +I++++ + + + YM + +++ ++ +I +R +
Sbjct: 78 SICHMLKHPHIVELLET---------YSSDGMLYM----VFEFMDGADLCFEIVKRADAG 124
Query: 814 IDVASA---------LEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLT 861
+ A LE L + + +IH D+KP NVLL ++ L DFG+ L
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184
Query: 862 REDQFVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP---TNEIFNE 918
E V + T +MA E DV+ GV+L +G P T E E
Sbjct: 185 -ESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242
Query: 919 GM 920
G+
Sbjct: 243 GI 244
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 40.8 bits (94), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKVVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ GV++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 40.8 bits (94), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKVVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ GV++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 40.8 bits (94), Expect = 0.004, Method: Composition-based stats.
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFD---VECEVMKSIRHRN 763
F L+G+G FG V R + G A+K+ ++ A E V+++ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
+ + D + F +EY G L +L + R ++ SALEYL
Sbjct: 67 LTALKYAFQTHD-RLCF---VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL 121
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKL-LTREDQFVTQTQTPATIGYMALE 882
+ S V++ D+K N++L + ++DFG+ K ++ T TP + LE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
GR D + GV++ E G+ P
Sbjct: 179 DNDYGRAV---DWWGLGVVMYEMMCGRLP 204
>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex
pdb|3T6Q|B Chain B, Crystal Structure Of Mouse Rp105MD-1 Complex
Length = 606
Score = 40.8 bits (94), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 43/136 (31%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 58 LNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSGEI 117
L +HLS +PS L LS+L+ L L +N+F S N +L LS N E+
Sbjct: 285 LTATHLS---ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 118 PTNICSNLPFFESLNLSKNMFHGGIPSA------LSNCTYLRILRLSYNDFAGGIPKEIG 171
T NL L+LS H I ++ L N ++L+ L LSYN+ +
Sbjct: 342 GTGCLENLENLRELDLS----HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 172 NLTKLEELYLSFNGLQ 187
+LE L L+F L+
Sbjct: 398 ECPQLELLDLAFTRLK 413
Score = 35.4 bits (80), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 49/170 (28%), Positives = 69/170 (40%), Gaps = 6/170 (3%)
Query: 45 GVTCDVHSHRVTALNISH--LSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHT 102
G C + + L++SH + S +L NLS LQSL L N+ +
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401
Query: 103 LKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYLRILRLSYNDF 162
L+LL +L + + NL + LNLS ++ L+ L L N F
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 163 -AGGIPK--EIGNLTKLEELYLSFNGLQGAYDHGFLQIFVKNIFVQFSHN 209
G I K + L +LE L LSF L H F + + N V SHN
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-HVDLSHN 510
>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex
pdb|2OMW|A Chain A, Crystal Structure Of Inla S192n Y369s/mec1 Complex
Length = 461
Score = 40.8 bits (94), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 14/130 (10%)
Query: 59 NISHLSLSGTIPSRLGNLSSLQSLF---LHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSG 115
N+ LSL+G +G L+SL +L L +NQ S P S + L L G NQ+S
Sbjct: 217 NLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 274
Query: 116 EIPTNICSNLPFFESLNLSKNMFHGGIP-SALSNCTYLRILRLSYNDFAGGIPKEIGNLT 174
P + L +L L++N P S L N TY L L +N+ + P + +LT
Sbjct: 275 ISP---LAGLTALTNLELNENQLEDISPISNLKNLTY---LTLYFNNISDISP--VSSLT 326
Query: 175 KLEELYLSFN 184
KL+ L+ S N
Sbjct: 327 KLQRLFFSNN 336
Score = 30.8 bits (68), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 69/287 (24%), Positives = 96/287 (33%), Gaps = 52/287 (18%)
Query: 267 PYVRLPNLEELYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXX 326
P L NL L L+ N + P + N + L+RLEL N+ S
Sbjct: 102 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI----------SALSG 149
Query: 327 XXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCN 386
N LE +D+SSN + I + NL + ++
Sbjct: 150 LTSLQQLNFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIA----TNNQ 205
Query: 387 VSGSIPEEIGNLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVCRL 446
+S P +G LTNL L GN L +G L L
Sbjct: 206 ISDITP--LGILTNLDELSLNGNQLKD-----IGTL---------------------ASL 237
Query: 447 AKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSSNS 506
+ LDL+NN++S P IS + L + L L+ N
Sbjct: 238 TNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG----LTALTNLELNENQ 293
Query: 507 LTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYN 553
L P I NLK L + NN S + P + + LQ LF N
Sbjct: 294 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNN 336
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 40.8 bits (94), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 14/208 (6%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFD---VECEVMKSIRHRN 763
F L+G+G FG V R + G A+K+ ++ A E V+++ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
+ + D + F +EY G L +L + R ++ SALEYL
Sbjct: 67 LTALKYAFQTHD-RLCF---VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL 121
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ S V++ D+K N++L + ++DFG+ K + T T Y+A E
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFCGTPEYLAPEV 176
Query: 884 GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ D + GV++ E G+ P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 14/208 (6%)
Query: 708 FSENNLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFD---VECEVMKSIRHRN 763
F L+G+G FG V R + G A+K+ ++ A E V+++ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 764 IIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYL 823
+ + D + F +EY G L +L + R ++ SALEYL
Sbjct: 67 LTALKYAFQTHD-RLCF---VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL 121
Query: 824 YFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEY 883
+ S V++ D+K N++L + ++DFG+ K + T T Y+A E
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFCGTPEYLAPEV 176
Query: 884 GSEGRVSTNGDVYNFGVMLMETFTGKKP 911
+ D + GV++ E G+ P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 40.4 bits (93), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 712 NLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFD---VECEVMKSIRHRNIIKI 767
L+G+G FG V R + G A+K+ ++ A E V+++ RH + +
Sbjct: 16 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
D + F +EY G L +L + R ++ SALEYL+
Sbjct: 76 KYAFQTHD-RLCF---VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 127
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEG 887
S V++ D+K N++L + ++DFG+ K + T T Y+A E +
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFCGTPEYLAPEVLEDN 185
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
D + GV++ E G+ P
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 40.4 bits (93), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 28 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 88 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 142
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ + ++DFG K + + T Y+A
Sbjct: 143 YLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 194
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 224
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 40.4 bits (93), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 712 NLIGRGGFGSVYKARIQ-DGMEVAVKVFNQQCGRAFKSFD---VECEVMKSIRHRNIIKI 767
L+G+G FG V R + G A+K+ ++ A E V+++ RH + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
D + F +EY G L +L + R ++ SALEYL+
Sbjct: 71 KYAFQTHD-RLCF---VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEG 887
S V++ D+K N++L + ++DFG+ K + T T Y+A E +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFCGTPEYLAPEVLEDN 180
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
D + GV++ E G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 40.4 bits (93), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 33/196 (16%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQ-----C---GRAFKSFDVEC 753
+ + +S + +G G FG V+ A ++ EV VK ++ C +E
Sbjct: 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 754 EVMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGS-LEKYLYSSNYILDIFQRLN- 811
++ + H NIIK++ I + + F+ L +E HGS L+ + + +D RL+
Sbjct: 81 AILSRVEHANIIKVLD---IFENQGFFQ-LVME--KHGSGLDLFAF-----IDRHPRLDE 129
Query: 812 -----IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQF 866
I + SA+ YL +IH D+K N+++ ++ L DFG L R F
Sbjct: 130 PLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF 186
Query: 867 VTQTQTPATIGYMALE 882
T TI Y A E
Sbjct: 187 YTFC---GTIEYCAPE 199
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 40.4 bits (93), Expect = 0.005, Method: Composition-based stats.
Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 16/117 (13%)
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFVT 868
IM D+ +A+++L+ S + H D+KP N+L + V L+DFG K T+
Sbjct: 114 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-----N 165
Query: 869 QTQTPA-TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP----TNEIFNEGM 920
QTP T Y+A E + + D+++ GV++ G P T + + GM
Sbjct: 166 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 222
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 40.4 bits (93), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 36 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 96 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 150
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 151 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 202
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 232
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 40.4 bits (93), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI---R 760
T F E IG G FGSV+K + DG A+K + + + EV +
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL---NIMIDVA 817
H ++++ S + D + EY GSL + + I+ F+ ++++ V
Sbjct: 66 HSHVVRYFSAWAEDDHMLIQN----EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLL 843
L Y++ S ++H D+KPSN+ +
Sbjct: 122 RGLRYIH---SMSLVHMDIKPSNIFI 144
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 40.4 bits (93), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFK------SFDVECEVMKSIRHRNIIK 766
+G G F V K R + G+E A K ++ RA + + E +++ + H NII
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFG 826
+ L LE + G L +L + L + + + + + YL+
Sbjct: 80 LHDVYE----NRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 827 YSTPVIHCDLKPSNVLLGDNMVA----HLSDFGITKLLTREDQFVTQTQTPATIGYMALE 882
+ + H DLKP N++L D + L DFG+ + +F TP + +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 883 YGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
Y G D+++ GV+ +G P
Sbjct: 192 YEPLG---LEADMWSIGVITYILLSGASP 217
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 62 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 122 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 176
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 258
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKAR-IQDGMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFD---VECEVMKSIRHRNIIKI 767
+IGRG + V R++ + A+KV ++ + D E V + + +
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
+ C + + F +EY+ G L ++ + + R +++ AL YL+
Sbjct: 75 LHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH--- 127
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEG 887
+I+ DLK NVLL L+D+G+ K R T + T Y+A E
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGE 185
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
+ D + GV++ E G+ P
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSP 209
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFD---VECEVMKSIRHRNIIKI 767
+IGRG + V R++ + A+KV ++ + D E V + + +
Sbjct: 11 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
+ C + + F +EY+ G L ++ + + R +++ AL YL+
Sbjct: 71 LHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH--- 123
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEG 887
+I+ DLK NVLL L+D+G+ K R T + T Y+A E
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGE 181
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
+ D + GV++ E G+ P
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSP 205
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI---R 760
T F E IG G FGSV+K + DG A+K + + + EV +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL---NIMIDVA 817
H ++++ S + D + EY GSL + + I+ F+ ++++ V
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQN----EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLL 843
L Y++ S ++H D+KPSN+ +
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFI 148
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI---R 760
T F E IG G FGSV+K + DG A+K + + + EV +
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL---NIMIDVA 817
H ++++ S + D + EY GSL + + I+ F+ ++++ V
Sbjct: 68 HSHVVRYFSAWAEDDHMLIQN----EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLL 843
L Y++ S ++H D+KPSN+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 40.0 bits (92), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 40.0 bits (92), Expect = 0.007, Method: Composition-based stats.
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 7/100 (7%)
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQ 871
M ++YL+ + VIH DLK N+ L D+M + DFG+ TK+ ++ T
Sbjct: 148 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCG 204
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP Y+A E + S D+++ G +L GK P
Sbjct: 205 TP---NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 40.0 bits (92), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 16/121 (13%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLG---DNMVAHLSDFGITKLLTREDQFV 867
IM D+ +A+++L+ S + H D+KP N+L + V L+DFG K T+
Sbjct: 132 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----- 183
Query: 868 TQTQTPA-TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP----TNEIFNEGMTL 922
QTP T Y+A E + + D+++ GV++ G P T + + GM
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
Query: 923 K 923
+
Sbjct: 244 R 244
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 40.0 bits (92), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 40.0 bits (92), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 40.0 bits (92), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 705 TDGFSENNLIGRGGFGSVYK-ARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKSI---R 760
T F E IG G FGSV+K + DG A+K + + + EV +
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 761 HRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRL---NIMIDVA 817
H ++++ S + D + EY GSL + + I+ F+ ++++ V
Sbjct: 68 HSHVVRYFSAWAEDDHMLIQN----EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLL 843
L Y++ S ++H D+KPSN+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 62 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 122 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 176
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T TP Y+A
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGATWTLCGTPE---YLAP 228
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 258
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 16/237 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEV-AVKVFNQQC---GRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G+GGF ++ D EV A K+ + + +E + +S+ H++++
Sbjct: 47 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
DF +F + LE SL + L+ L + + + +YL+
Sbjct: 107 FFEDNDF--VF--VVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RN 158
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
VIH DLK N+ L +++ + DFG+ TK+ ++ TP Y+A E S+
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP---NYIAPEVLSKKG 215
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSR 945
S DV++ G ++ GK P + L+ N++ + + V SL+ +
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 272
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFD---VECEVMKSIRHRNIIKI 767
+IGRG + V R++ + A+KV ++ + D E V + + +
Sbjct: 26 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
+ C + + F +EY+ G L ++ + + R +++ AL YL+
Sbjct: 86 LHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH--- 138
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEG 887
+I+ DLK NVLL L+D+G+ K R T + T Y+A E
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGE 196
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
+ D + GV++ E G+ P
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSP 220
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 16/237 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEV-AVKVFNQQC---GRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G+GGF ++ D EV A K+ + + +E + +S+ H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
DF +F + LE SL + L+ L + + + +YL+
Sbjct: 109 FFEDNDF--VF--VVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RN 160
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
VIH DLK N+ L +++ + DFG+ TK+ ++ TP Y+A E S+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP---NYIAPEVLSKKG 217
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSR 945
S DV++ G ++ GK P + L+ N++ + + V SL+ +
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex
Length = 466
Score = 39.7 bits (91), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 63/130 (48%), Gaps = 14/130 (10%)
Query: 59 NISHLSLSGTIPSRLGNLSSLQSLF---LHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSG 115
N+ LSL+G +G L+SL +L L +NQ S P S + L L G NQ+S
Sbjct: 221 NLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 278
Query: 116 EIPTNICSNLPFFESLNLSKNMFHGGIP-SALSNCTYLRILRLSYNDFAGGIPKEIGNLT 174
P + L +L L++N P S L N TY L L +N+ + P + +LT
Sbjct: 279 ISP---LAGLTALTNLELNENQLEDISPISNLKNLTY---LTLYFNNISDISP--VSSLT 330
Query: 175 KLEELYLSFN 184
KL+ L+ + N
Sbjct: 331 KLQRLFFANN 340
Score = 30.8 bits (68), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 69/287 (24%), Positives = 96/287 (33%), Gaps = 52/287 (18%)
Query: 267 PYVRLPNLEELYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXX 326
P L NL L L+ N + P + N + L+RLEL N+ S
Sbjct: 106 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI----------SALSG 153
Query: 327 XXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCN 386
N LE +D+SSN + I + NL + ++
Sbjct: 154 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIA----TNNQ 209
Query: 387 VSGSIPEEIGNLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVCRL 446
+S P +G LTNL L GN L +G L L
Sbjct: 210 ISDITP--LGILTNLDELSLNGNQLKD-----IGTL---------------------ASL 241
Query: 447 AKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSSNS 506
+ LDL+NN++S P IS + L + L L+ N
Sbjct: 242 TNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG----LTALTNLELNENQ 297
Query: 507 LTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYN 553
L P I NLK L + NN S + P + + LQ LF N
Sbjct: 298 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 340
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 39.7 bits (91), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 39.7 bits (91), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 42 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 102 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 156
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 39.7 bits (91), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 39.7 bits (91), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 39.7 bits (91), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 39.3 bits (90), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 42/239 (17%)
Query: 702 CQATDGFSENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQ------CGRAFKSFDVECE 754
+ D + +G G +G VYKA VA+K + G A + E
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVS 85
Query: 755 VMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI 814
++K ++HRNII++ S L EY L+KY+ + D+ R+ I
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLI----FEYA-ENDLKKYMDKNP---DVSMRV-IKS 136
Query: 815 DVASALEYLYFGYSTPVIHCDLKPSNVLL-----GDNMVAHLSDFGITK---LLTRE--D 864
+ + + F +S +H DLKP N+LL + V + DFG+ + + R+
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 865 QFVTQTQTPATIGYMALEYGSEGRVSTNGDVYN----FGVMLMET--FTGKKPTNEIFN 917
+ +T P I + Y ST+ D+++ + MLM+T F G +++F
Sbjct: 197 EIITLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 39.3 bits (90), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEV 186
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 187 -VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 39.3 bits (90), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 16/237 (6%)
Query: 714 IGRGGFGSVYKARIQDGMEV-AVKVFNQQC---GRAFKSFDVECEVMKSIRHRNIIKIIS 769
+G+GGF ++ D EV A K+ + + +E + +S+ H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 770 CCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYST 829
DF +F + LE SL + L+ L + + + +YL+
Sbjct: 83 FFEDNDF--VF--VVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RN 134
Query: 830 PVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQTPATIGYMALEYGSEGR 888
VIH DLK N+ L +++ + DFG+ TK+ ++ TP Y+A E S+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP---NYIAPEVLSKKG 191
Query: 889 VSTNGDVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKIVDGSLLSR 945
S DV++ G ++ GK P + L+ N++ + + V SL+ +
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248
>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|B Chain B, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|C Chain C, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|D Chain D, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
Length = 400
Score = 39.3 bits (90), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/104 (27%), Positives = 45/104 (43%), Gaps = 9/104 (8%)
Query: 811 NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD---NMVAHLSDFGITKLLTREDQFV 867
I + A++YL+ S + H D+KP N+L N + L+DFG K T +
Sbjct: 165 EIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 868 TQTQTPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T TP Y+A E + + D ++ GV+ G P
Sbjct: 222 TPCYTPY---YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPP 262
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 39.3 bits (90), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 703 QATDGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSI-- 759
+ D F + G+G FG+V + + GM VA+K Q + + E ++M+ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAV 75
Query: 760 -RHRNIIKIISC-CSIG--DFKALFKALALEYMP---HGSLEKYLYSSNYILDIFQRLNI 812
H NI+++ S ++G D + ++ + +EY+P H Y I ++
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-F 134
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD-NMVAHLSDFGITKLLTREDQFVTQTQ 871
+ + ++ L+ S V H D+KP NVL+ + + L DFG K L+ + V
Sbjct: 135 LFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI- 192
Query: 872 TPATIGYMALE--YGSEGRVSTNGDVYNFGVMLMETFTGK 909
+ Y A E +G++ +T D+++ G + E G+
Sbjct: 193 --CSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 39.3 bits (90), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 714 IGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDVECEVMKSIRHRNIIKII---- 768
+G GG G V+ A D VA+K ++ K E ++++ + H NI+K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 769 -SCCSIGDFKALFKALALEYMPHGSLEKYL---YSSNYILDIFQRLNIMIDVASALEYLY 824
S + D L Y+ +E L +L+ RL M + L+Y++
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKYIH 137
Query: 825 FGYSTPVIHCDLKPSNVLLG-DNMVAHLSDFGITKLL 860
S V+H DLKP+N+ + +++V + DFG+ +++
Sbjct: 138 ---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 38.9 bits (89), Expect = 0.013, Method: Composition-based stats.
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 704 ATDGFS---------ENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVEC 753
+TD FS + +++G G V + E AVK+ +Q G E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 754 EVMKSIR-HRNIIKIISCCSIGD-FKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
E++ + HRN++++I D F +F E M GS+ +++ + ++ +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVF-----EKMRGGSILSHIHKRRHFNELEASV- 115
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGD-NMVA--HLSDFGITKLLTREDQFVT 868
++ DVASAL++L+ + + H DLKP N+L N V+ + DFG+ + +
Sbjct: 116 VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGD-CS 171
Query: 869 QTQTP------ATIGYMALE----YGSEGRV-STNGDVYNFGVMLMETFTGKKP 911
TP + YMA E + E + D+++ GV+L +G P
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 38.9 bits (89), Expect = 0.013, Method: Composition-based stats.
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G G V A R+ + VAVK+ + + C K E + K + H N++K
Sbjct: 14 LGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 70 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 112
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 233 IDSAPLA 239
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 38.9 bits (89), Expect = 0.013, Method: Composition-based stats.
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 37/247 (14%)
Query: 714 IGRGGFGSVYKA--RIQDGMEVAVKVFNQQ----CGRAFKSFDVECEVMKSIRHRNIIKI 767
+G G +G V A R+ + VAVK+ + + C K E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINAMLNHENVVKF 70
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI-----DVASALEY 822
G+ + LF LEY G L F R+ I D
Sbjct: 71 YGHRREGNIQYLF----LEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQ 113
Query: 823 LYFG----YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGY 878
L G + + H D+KP N+LL + +SDFG+ + ++ + T+ Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 879 MALEYGSEGRVSTNG-DVYNFGVMLMETFTGKKPTNEIFNEGMTLKHWVNDWLLISIMKI 937
+A E DV++ G++L G+ P ++ + W ++ K
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 938 VDGSLLS 944
+D + L+
Sbjct: 234 IDSAPLA 240
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 38.9 bits (89), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 43/214 (20%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNIIK 766
IG G G V A G+ VAVK ++ RA++ E ++K + H+NII
Sbjct: 30 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIIS 85
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASALEY 822
+++ + P +LE++ +Y ++D + Q +++ +D + Y
Sbjct: 86 LLNV----------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD-HERMSY 128
Query: 823 LYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA 874
L + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMM-TPYVV 185
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 186 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 38.9 bits (89), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 60/251 (23%), Positives = 93/251 (37%), Gaps = 62/251 (24%)
Query: 714 IGRGGFGSVYKARIQDGMEV--AVKVFNQQCGRAFKSFDVE-----CEVMKSIRHRNIIK 766
IG+G +G V + I++ A+K+ N+ R DVE +MK + H NI +
Sbjct: 34 IGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 767 -------------IISCCSIGDF-------------KALFKALALEYMP---------HG 791
++ C G K + + P +G
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 792 SLEKYLYSSNYILDIFQRL----NIMIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDN- 846
S+ + S LD QR NIM + SAL YL+ + + H D+KP N L N
Sbjct: 153 SIHGFRES----LDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNK 205
Query: 847 -MVAHLSDFGITKLLTREDQ-----FVTQTQTPATIGYMALEYGSEGRVSTNGDVYNFGV 900
L DFG++K + + T+ TP + L +E D ++ GV
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES-YGPKCDAWSAGV 264
Query: 901 MLMETFTGKKP 911
+L G P
Sbjct: 265 LLHLLLMGAVP 275
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 38.9 bits (89), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 712 NLIGRGGFGSVYKARIQDGMEV-AVKVFNQQCGRAFKSFD---VECEVMKSIRHRNIIKI 767
+IGRG + V R++ + A++V ++ + D E V + + +
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 768 ISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGY 827
+ C + + F +EY+ G L ++ + + R +++ AL YL+
Sbjct: 118 LHSCFQTESRLFF---VIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH--- 170
Query: 828 STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMALEYGSEG 887
+I+ DLK NVLL L+D+G+ K R T + T Y+A E
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE 228
Query: 888 RVSTNGDVYNFGVMLMETFTGKKP 911
+ D + GV++ E G+ P
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSP 252
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 38.9 bits (89), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 43/214 (20%)
Query: 714 IGRGGFGSVYKA-RIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNIIK 766
IG G G V A G+ VAVK ++ RA++ E ++K + H+NII
Sbjct: 32 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIIS 87
Query: 767 IISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASALEY 822
+++ + P +LE++ +Y ++D + Q +++ +D + Y
Sbjct: 88 LLNV----------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD-HERMSY 130
Query: 823 LYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPA 874
L + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 131 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMM-TPYVV 187
Query: 875 TIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E + N D+++ G ++ E G
Sbjct: 188 TRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221
>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex
Length = 461
Score = 38.9 bits (89), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 42/126 (33%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 59 NISHLSLSGTIPSRLGNLSSLQSLF---LHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSG 115
N+ LSL+G +G L+SL +L L +NQ S P S + L L G NQ+S
Sbjct: 217 NLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 274
Query: 116 EIPTNICSNLPFFESLNLSKNMFHGGIP-SALSNCTYLRILRLSYNDFAGGIPKEIGNLT 174
P + L +L L++N P S L N TY L L +N+ + P + +LT
Sbjct: 275 ISP---LAGLTALTNLELNENQLEDISPISNLKNLTY---LTLYFNNISDISP--VSSLT 326
Query: 175 KLEELY 180
KL+ L+
Sbjct: 327 KLQRLF 332
Score = 30.0 bits (66), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 68/283 (24%), Positives = 95/283 (33%), Gaps = 52/283 (18%)
Query: 267 PYVRLPNLEELYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXX 326
P L NL L L+ N + P + N + L+RLEL N+ S
Sbjct: 102 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI----------SALSG 149
Query: 327 XXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCN 386
N LE +D+SSN + I + NL + ++
Sbjct: 150 LTSLQQLNFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIA----TNNQ 205
Query: 387 VSGSIPEEIGNLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVCRL 446
+S P +G LTNL L GN L +G L L
Sbjct: 206 ISDITP--LGILTNLDELSLNGNQLKD-----IGTL---------------------ASL 237
Query: 447 AKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSSNS 506
+ LDL+NN++S P IS + L + L L+ N
Sbjct: 238 TNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG----LTALTNLELNENQ 293
Query: 507 LTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLF 549
L P I NLK L + NN S + P + + LQ LF
Sbjct: 294 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 332
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 38.9 bits (89), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 38.9 bits (89), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 712 NLIGRGGFGSVYKARIQDGMEVAVK-VFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
++G G G+V G VAVK + C A + E S H N+I+
Sbjct: 39 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVIRYY-- 93
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN---IMIDVASALEYLYFGY 827
CS + L+ AL L + L + S+ L + + N ++ +AS + +L+
Sbjct: 94 CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 150
Query: 828 STPVIHCDLKPSNVLL-------------GDNMVAHLSDFGITKLL-TREDQFVTQTQTP 873
S +IH DLKP N+L+ +N+ +SDFG+ K L + + F P
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 874 A-TIGYMA---LEYGSEGRVSTNGDVYNFGVMLMETFT-GKKP 911
+ T G+ A LE ++ R++ + D+++ G + + GK P
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 38.9 bits (89), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 23/213 (10%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQ---TPATIGY 878
YL+ S +I+ DLKP N+L+ ++DFG K + + T PA I
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAII-- 210
Query: 879 MALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
L G V D + GV++ E G P
Sbjct: 211 --LSKGYNKAV----DWWALGVLIYEMAAGYPP 237
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 38.9 bits (89), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ + +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV 186
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGK 909
T Y A E N D+++ G ++ E K
Sbjct: 187 -VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 38.9 bits (89), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 31/230 (13%)
Query: 712 NLIGRGGFGSVYKARIQDGMEVAVK-VFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
++G G G+V G VAVK + C A + E S H N+I+
Sbjct: 39 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVIRYY-- 93
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN---IMIDVASALEYLYFGY 827
CS + L+ AL L + L + S+ L + + N ++ +AS + +L+
Sbjct: 94 CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 150
Query: 828 STPVIHCDLKPSNVLL-------------GDNMVAHLSDFGITKLL-TREDQFVTQTQTP 873
S +IH DLKP N+L+ +N+ +SDFG+ K L + + F P
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 874 A-TIGYMA---LEYGSEGRVSTNGDVYNFGVMLMETFT-GKKPTNEIFNE 918
+ T G+ A LE ++ R++ + D+++ G + + GK P + ++
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 260
>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human)
Recognition Complex
pdb|1O6T|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|B Chain B, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
Length = 466
Score = 38.5 bits (88), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 42/126 (33%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 59 NISHLSLSGTIPSRLGNLSSLQSLF---LHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSG 115
N+ LSL+G +G L+SL +L L +NQ S P S + L L G NQ+S
Sbjct: 222 NLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 279
Query: 116 EIPTNICSNLPFFESLNLSKNMFHGGIP-SALSNCTYLRILRLSYNDFAGGIPKEIGNLT 174
P + L +L L++N P S L N TY L L +N+ + P + +LT
Sbjct: 280 ISP---LAGLTALTNLELNENQLEDISPISNLKNLTY---LTLYFNNISDISP--VSSLT 331
Query: 175 KLEELY 180
KL+ L+
Sbjct: 332 KLQRLF 337
Score = 30.0 bits (66), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 68/283 (24%), Positives = 95/283 (33%), Gaps = 52/283 (18%)
Query: 267 PYVRLPNLEELYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXX 326
P L NL L L+ N + P + N + L+RLEL N+ S
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI----------SALSG 154
Query: 327 XXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCN 386
N LE +D+SSN + I + NL + ++
Sbjct: 155 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIA----TNNQ 210
Query: 387 VSGSIPEEIGNLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVCRL 446
+S P +G LTNL L GN L +G L L
Sbjct: 211 ISDITP--LGILTNLDELSLNGNQLKD-----IGTL---------------------ASL 242
Query: 447 AKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSSNS 506
+ LDL+NN++S P IS + L + L L+ N
Sbjct: 243 TNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG----LTALTNLELNENQ 298
Query: 507 LTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLF 549
L P I NLK L + NN S + P + + LQ LF
Sbjct: 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 38.5 bits (88), Expect = 0.017, Method: Composition-based stats.
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 33/163 (20%)
Query: 714 IGRGGFGSVYKAR-IQDGMEVAVK-----VFNQQCGRAFKSFDVECEVMKSIRHRNIIKI 767
+GRG +G V K R + G AVK V +Q+ R D+ +
Sbjct: 42 LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDIS------------XRT 89
Query: 768 ISC-CSIGDFKALFK---ALALEYMPHGSLEKYLYSSNYILDIFQRL------NIMIDVA 817
+ C ++ + ALF+ + SL+K+ ++D Q + I + +
Sbjct: 90 VDCPFTVTFYGALFREGDVWICXELXDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIV 146
Query: 818 SALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLL 860
ALE+L+ S VIH D+KPSNVL+ DFGI+ L
Sbjct: 147 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL 187
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 38.5 bits (88), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKVVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 38.5 bits (88), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+++ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ E G P
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 38.5 bits (88), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 89/227 (39%), Gaps = 28/227 (12%)
Query: 700 ELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVK-VFNQQC-GRAFK--SFDVECE- 754
EL ++ I G +G+V +G+ VA+K VFN GR S C+
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 755 VMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI 814
V++ IR N + + D F+ A+ + YL + D+ Q ++
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKL-------YLVTELMRTDLAQVIHDQR 128
Query: 815 DVASALEYLYFGY----------STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED 864
V S YF Y V+H DL P N+LL DN + DF L RED
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN----LARED 184
Query: 865 QF-VTQTQTPATIGYMALEYGSEGRVSTN-GDVYNFGVMLMETFTGK 909
+T Y A E + + T D+++ G ++ E F K
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 38.5 bits (88), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 89/227 (39%), Gaps = 28/227 (12%)
Query: 700 ELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVK-VFNQQC-GRAFK--SFDVECE- 754
EL ++ I G +G+V +G+ VA+K VFN GR S C+
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 755 VMKSIRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMI 814
V++ IR N + + D F+ A+ + YL + D+ Q ++
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKL-------YLVTELMRTDLAQVIHDQR 128
Query: 815 DVASALEYLYFGY----------STPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTRED 864
V S YF Y V+H DL P N+LL DN + DF L RED
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN----LARED 184
Query: 865 QF-VTQTQTPATIGYMALEYGSEGRVSTN-GDVYNFGVMLMETFTGK 909
+T Y A E + + T D+++ G ++ E F K
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 38.5 bits (88), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKVVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567
pdb|4HNI|B Chain B, Crystal Structure Of Ck1e In Complex With Pf4800567
pdb|4HOK|A Chain A, Crystal Structure Of Apo Ck1e
pdb|4HOK|C Chain C, Crystal Structure Of Apo Ck1e
pdb|4HOK|E Chain E, Crystal Structure Of Apo Ck1e
pdb|4HOK|G Chain G, Crystal Structure Of Apo Ck1e
pdb|4HOK|I Chain I, Crystal Structure Of Apo Ck1e
pdb|4HOK|K Chain K, Crystal Structure Of Apo Ck1e
pdb|4HOK|M Chain M, Crystal Structure Of Apo Ck1e
pdb|4HOK|O Chain O, Crystal Structure Of Apo Ck1e
pdb|4HOK|Q Chain Q, Crystal Structure Of Apo Ck1e
pdb|4HOK|S Chain S, Crystal Structure Of Apo Ck1e
pdb|4HOK|U Chain U, Crystal Structure Of Apo Ck1e
pdb|4HOK|W Chain W, Crystal Structure Of Apo Ck1e
Length = 296
Score = 38.5 bits (88), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 34/215 (15%)
Query: 714 IGRGGFGSVY-KARIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSIRHR-NIIKIISC 770
IG G FG +Y A I G EVA+K+ +C + +E + K ++ I I C
Sbjct: 17 IGSGSFGDIYLGANIASGEEVAIKL---ECVKTKHPQLHIESKFYKMMQGGVGIPSIKWC 73
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
+ GD+ + L SLE + + L + + S +EY++ S
Sbjct: 74 GAEGDYNVMVMELL-----GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKN 125
Query: 831 VIHCDLKPSNVLLG---DNMVAHLSDFGITK----------LLTREDQFVTQTQTPATIG 877
IH D+KP N L+G + ++ DFG+ K + RE++ +T T A+I
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 878 -YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ +E S D+ + G +LM G P
Sbjct: 186 THLGIE------QSRRDDLESLGYVLMYFNLGSLP 214
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 38.5 bits (88), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 38.5 bits (88), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex
pdb|3B2D|B Chain B, Crystal Structure Of Human Rp105MD-1 Complex
Length = 603
Score = 38.5 bits (88), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 51/184 (27%), Positives = 73/184 (39%), Gaps = 6/184 (3%)
Query: 45 GVTCDVHSHRVTALNISH--LSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHT 102
GV C + L++SH + S +L NLS LQ+L L N+ G +
Sbjct: 339 GVGCLEKLGNLQTLDLSHNDIEASDCCSLQLKNLSHLQTLNLSHNEPLGLQSQAFKECPQ 398
Query: 103 LKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIPSALSNCTYLRILRLSYNDF 162
L+LL +L P + NL F + LNL+ L+ LR L L N F
Sbjct: 399 LELLDLAFTRLHINAPQSPFQNLHFLQVLNLTYCFLDTSNQHLLAGLPVLRHLNLKGNHF 458
Query: 163 AGGIPKE---IGNLTKLEELYLSFNGLQGAYDHGFLQIFVKNIFVQFSHNFSKCEIPNEI 219
G + + + LE L LS GL F K V SHN C+ + +
Sbjct: 459 QDGTITKTNLLQTVGSLEVLILSSCGLLSIDQQAF-HSLGKMSHVDLSHNSLTCDSIDSL 517
Query: 220 GNLR 223
+L+
Sbjct: 518 SHLK 521
Score = 30.0 bits (66), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 58/136 (42%), Gaps = 3/136 (2%)
Query: 54 RVTALNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHTLKLLSFGDNQL 113
++ L+++ L G +PS + L+ L+ L L N F S N +L L N
Sbjct: 276 QLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHFDQLCQISAANFPSLTHLYIRGNVK 334
Query: 114 SGEIPTNICSNLPFFESLNLSKNMFHGGIPSALS--NCTYLRILRLSYNDFAGGIPKEIG 171
+ L ++L+LS N +L N ++L+ L LS+N+ G +
Sbjct: 335 KLHLGVGCLEKLGNLQTLDLSHNDIEASDCCSLQLKNLSHLQTLNLSHNEPLGLQSQAFK 394
Query: 172 NLTKLEELYLSFNGLQ 187
+LE L L+F L
Sbjct: 395 ECPQLELLDLAFTRLH 410
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 38.1 bits (87), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 38.1 bits (87), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 35/227 (15%)
Query: 712 NLIGRGGFGSVYKARIQDGMEVAVK-VFNQQCGRAFKSFDVECEVMKSIRHRNIIKIISC 770
++G G G+V G VAVK + C A + E S H N+I+
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVIRYY-- 75
Query: 771 CSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN---IMIDVASALEYLYFGY 827
CS + L+ AL L + L + S+ L + + N ++ +AS + +L+
Sbjct: 76 CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 828 STPVIHCDLKPSNVLL-------------GDNMVAHLSDFGITKLL-TREDQFVTQTQTP 873
S +IH DLKP N+L+ +N+ +SDFG+ K L + + F T P
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 874 A-TIGYMALEYGSEG-------RVSTNGDVYNFGVMLMETFT-GKKP 911
+ T G+ A E E R++ + D+++ G + + GK P
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 38.1 bits (87), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQTPATIGYMAL 881
YL+ S +I+ DLKP N+L+ ++DFG K + + T Y+A
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 882 EYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
E + D + GV++ + G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAGYPP 237
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 38.1 bits (87), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 24/221 (10%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKS 758
L + +D + IG G FG R + E+ + ++ + ++ E +S
Sbjct: 12 LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYL-----YSSNYILDIFQRLNIM 813
+RH NI++ A+ +EY G L + + +S + FQ+L
Sbjct: 72 LRHPNIVRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--- 124
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS--DFGITKLLTREDQFVTQTQ 871
+ + + ++ V H DLK N LL + L FG +K Q +
Sbjct: 125 ------ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVG 178
Query: 872 TPATIG-YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TPA I + L+ +G+V+ DV++ GV L G P
Sbjct: 179 TPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYP 216
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 38.1 bits (87), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 47/216 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 33 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 86
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 87 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 129
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM-TPY 186
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTG 908
T Y A E N D+++ G ++ E G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 38.1 bits (87), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 37/157 (23%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 706 DGFSENNLIGRGGFGSVYKARIQD-GMEVAVKVFNQQCGRAFKSFDV---ECEVMKSIRH 761
D F +G G FG V + ++ G A+K+ ++Q K + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 762 RNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALE 821
++K+ S D L+ + +EY+ G + +L + R + E
Sbjct: 101 PFLVKL--EFSFKDNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 822 YLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
YL+ S +I+ DLKP N+L+ ++DFG K
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 38.1 bits (87), Expect = 0.027, Method: Composition-based stats.
Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
M ++YL+ + VIH DLK N+ L D+M + DFG+ + + + +
Sbjct: 148 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDL 202
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T Y+A E + S D+++ G +L GK P
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 38.1 bits (87), Expect = 0.027, Method: Composition-based stats.
Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
M ++YL+ + VIH DLK N+ L D+M + DFG+ + + + +
Sbjct: 132 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDL 186
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
T Y+A E + S D+++ G +L GK P
Sbjct: 187 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 38.1 bits (87), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 47/217 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 86 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ + +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV 186
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGK 909
T Y A E N D+++ G ++ E K
Sbjct: 187 -VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 37.7 bits (86), Expect = 0.029, Method: Composition-based stats.
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 7/100 (7%)
Query: 813 MIDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLSDFGI-TKLLTREDQFVTQTQ 871
M ++YL+ + VIH DLK N+ L D+M + DFG+ TK+ ++
Sbjct: 148 MRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCG 204
Query: 872 TPATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TP Y+A E + S D+++ G +L GK P
Sbjct: 205 TP---NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist
Antibody
pdb|3KJ4|D Chain D, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist
Antibody
Length = 286
Score = 37.7 bits (86), Expect = 0.031, Method: Composition-based stats.
Identities = 46/166 (27%), Positives = 65/166 (39%), Gaps = 5/166 (3%)
Query: 77 SSLQSLFLHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKN 136
+S Q +FLH N+ S S + L +L N L+G I + L E L+LS N
Sbjct: 31 ASSQRIFLHGNRISYVPAASFQSCRNLTILWLHSNALAG-IDAAAFTGLTLLEQLDLSDN 89
Query: 137 -MFHGGIPSALSNCTYLRILRLSYNDFAGGIPKEIGNLTKLEELYLSFNGLQGAYDHGFL 195
P+ +L L L P L L+ LYL N LQ D+ F
Sbjct: 90 AQLRVVDPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQALPDNTFR 149
Query: 196 QIFVKNIFVQFSHNFSKCEIP-NEIGNLRNLEVLALGLNKLVGVIP 240
+ N+ F H +P + L +L+ L L N + V P
Sbjct: 150 DL--GNLTHLFLHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHP 193
Score = 35.8 bits (81), Expect = 0.13, Method: Composition-based stats.
Identities = 50/198 (25%), Positives = 71/198 (35%), Gaps = 12/198 (6%)
Query: 405 YLGGNNLNGSIPITLGKLQKLQVLYFPDNKLEGSIPDEVCRLAKVYQLDLSNN-KLSGSI 463
+L GN ++ + + L +L+ N L G L + QLDLS+N +L
Sbjct: 37 FLHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVD 96
Query: 464 PACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSSNSLTGPLP----LEIGNLK 519
P F + P F L + YL L N+L LP ++GNL
Sbjct: 97 PTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQA-LPDNTFRDLGNLT 155
Query: 520 VLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYNILQGSIPDSF---GDLMXXXXXXXXX 576
L N V +A G+ L L L N + P +F G LM
Sbjct: 156 HLF---LHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNL 212
Query: 577 XXXXGSIPVSLEKLSYLK 594
+ V L L YL+
Sbjct: 213 SMLPAEVLVPLRSLQYLR 230
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 37.4 bits (85), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 24/221 (10%)
Query: 699 LELCQATDGFSENNLIGRGGFGSVYKARIQDGMEVAVKVFNQQCGRAFKSFDVECEVMKS 758
L + +D + IG G FG R + E+ + ++ + ++ E +S
Sbjct: 12 LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 759 IRHRNIIKIISCCSIGDFKALFKALALEYMPHGSLEKYL-----YSSNYILDIFQRLNIM 813
+RH NI++ A+ +EY G L + + +S + FQ+L
Sbjct: 72 LRHPNIVRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--- 124
Query: 814 IDVASALEYLYFGYSTPVIHCDLKPSNVLLGDNMVAHLS--DFGITKLLTREDQFVTQTQ 871
+ + + ++ V H DLK N LL + L FG +K Q
Sbjct: 125 ------ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVG 178
Query: 872 TPATIG-YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
TPA I + L+ +G+V+ DV++ GV L G P
Sbjct: 179 TPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYP 216
>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex
Length = 462
Score = 37.4 bits (85), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 63/230 (27%), Positives = 90/230 (39%), Gaps = 42/230 (18%)
Query: 40 FCNWTGVT------CDVHSHR-VTALNISHLSLSGTIP--SRLGNLSSLQSLFLHSNQFS 90
N TG+T D+ + +T LN LS S TI S L L+SLQ L SNQ +
Sbjct: 106 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELS-SNTISDISALSGLTSLQQLSFSSNQVT 164
Query: 91 GSIPFSIFNIHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIP------- 143
P + N+ TL+ L N++S ++ + L ESL + N P
Sbjct: 165 DLKPLA--NLTTLERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGILTNL 219
Query: 144 -------------SALSNCTYLRILRLSYNDFAGGIPKEIGNLTKLEELYLSFNGLQGAY 190
L++ T L L L+ N + P + LTKL EL L N +
Sbjct: 220 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 277
Query: 191 DHGFLQIFVKNIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVGVIP 240
L N ++ E + I NL+NL L L N + + P
Sbjct: 278 PLAGLTALTN-----LELNENQLEDISPISNLKNLTYLTLYFNNISDISP 322
Score = 34.3 bits (77), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 72/289 (24%), Positives = 105/289 (36%), Gaps = 55/289 (19%)
Query: 267 PYVRLPNLEELYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXX 326
P L NL L L+ N + P + N + L+RLEL N+ S
Sbjct: 102 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--------------- 144
Query: 327 XXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCN 386
L+ + SSN + + K + NL+ +L+ D+S
Sbjct: 145 ----------------SALSGLTSLQQLSFSSNQVTDL---KPLANLT-TLERLDISSNK 184
Query: 387 VSGSIPEEIGNLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLE--GSIPDEVC 444
VS + LTNL N ++ P LG L L L N+L+ G++
Sbjct: 185 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL----A 236
Query: 445 RLAKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSS 504
L + LDL+NN++S P IS + L + L L+
Sbjct: 237 SLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG----LTALTNLELNE 292
Query: 505 NSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYN 553
N L P I NLK L + NN S + P + + LQ LF N
Sbjct: 293 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNN 337
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 37.4 bits (85), Expect = 0.040, Method: Composition-based stats.
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 21/151 (13%)
Query: 704 ATDGFS---------ENNLIGRGGFGSVYKA-RIQDGMEVAVKVFNQQCGRAFKSFDVEC 753
+TD FS + +++G G V + E AVK+ +Q G E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 754 EVMKSIR-HRNIIKIISCCSIGD-FKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLN 811
E++ + HRN++++I D F +F E M GS+ +++ + ++ +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVF-----EKMRGGSILSHIHKRRHFNELEASV- 115
Query: 812 IMIDVASALEYLYFGYSTPVIHCDLKPSNVL 842
++ DVASAL++L+ + + H DLKP N+L
Sbjct: 116 VVQDVASALDFLH---NKGIAHRDLKPENIL 143
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 37.4 bits (85), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 44/166 (26%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A + VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKXVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P +LE++ +Y ++D + Q + + +D +
Sbjct: 86 ISLLNV----------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
YL + +S +IH DLKPSN+++ + + DFG+ +
Sbjct: 129 SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174
>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing
Residues 1-317 Complex With Bound Tungstate
pdb|1CKJ|B Chain B, Casein Kinase I Delta Truncation Mutant Containing
Residues 1-317 Complex With Bound Tungstate
pdb|1CKI|A Chain A, Recombinant Casein Kinase I Delta Truncation Mutant
Containing Residues 1-317
pdb|1CKI|B Chain B, Recombinant Casein Kinase I Delta Truncation Mutant
Containing Residues 1-317
Length = 317
Score = 37.4 bits (85), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 34/215 (15%)
Query: 714 IGRGGFGSVY-KARIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG +Y I G EVA+K+ +C + +E ++ K ++ I I C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 772 SI-GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
GD+ + L SLE + + L + + S +EY++ S
Sbjct: 72 GAEGDYNVMVMELL-----GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKN 123
Query: 831 VIHCDLKPSNVLLG---DNMVAHLSDFGITK----------LLTREDQFVTQTQTPATIG 877
IH D+KP N L+G + ++ DFG+ K + RE++ +T T A+I
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 878 -YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ +E S D+ + G +LM G P
Sbjct: 184 THLGIE------QSRRDDLESLGYVLMYFNLGSLP 212
>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|B Chain B, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|C Chain C, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|D Chain D, Crystal Structure Of Apo Human Ck1d
pdb|3UYT|A Chain A, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|B Chain B, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|C Chain C, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|D Chain D, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UZP|A Chain A, Crystal Structure Of Ck1d With Pf670462 From P21 Crystal
Form
pdb|3UZP|B Chain B, Crystal Structure Of Ck1d With Pf670462 From P21 Crystal
Form
pdb|4HNF|A Chain A, Crystal Structure Of Ck1d In Complex With Pf4800567
pdb|4HNF|B Chain B, Crystal Structure Of Ck1d In Complex With Pf4800567
pdb|4HGT|A Chain A, Crystal Structure Of Ck1d With Compound 13
pdb|4HGT|B Chain B, Crystal Structure Of Ck1d With Compound 13
Length = 296
Score = 37.4 bits (85), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 34/215 (15%)
Query: 714 IGRGGFGSVY-KARIQDGMEVAVKVFNQQCGRA-FKSFDVECEVMKSIRHRNIIKIISCC 771
IG G FG +Y I G EVA+K+ +C + +E ++ K ++ I I C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 772 SI-GDFKALFKALALEYMPHGSLEKYLYSSNYILDIFQRLNIMIDVASALEYLYFGYSTP 830
GD+ + L SLE + + L + + S +EY++ S
Sbjct: 74 GAEGDYNVMVMELL-----GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKN 125
Query: 831 VIHCDLKPSNVLLG---DNMVAHLSDFGITK----------LLTREDQFVTQTQTPATIG 877
IH D+KP N L+G + ++ DFG+ K + RE++ +T T A+I
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 878 -YMALEYGSEGRVSTNGDVYNFGVMLMETFTGKKP 911
++ +E S D+ + G +LM G P
Sbjct: 186 THLGIE------QSRRDDLESLGYVLMYFNLGSLP 214
>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX
Length = 462
Score = 37.0 bits (84), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 63/230 (27%), Positives = 90/230 (39%), Gaps = 42/230 (18%)
Query: 40 FCNWTGVT------CDVHSHR-VTALNISHLSLSGTIP--SRLGNLSSLQSLFLHSNQFS 90
N TG+T D+ + +T LN LS S TI S L L+SLQ L SNQ +
Sbjct: 106 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELS-SNTISDISALSGLTSLQQLSFSSNQVT 164
Query: 91 GSIPFSIFNIHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIP------- 143
P + N+ TL+ L N++S ++ + L ESL + N P
Sbjct: 165 DLKPLA--NLTTLERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGILTNL 219
Query: 144 -------------SALSNCTYLRILRLSYNDFAGGIPKEIGNLTKLEELYLSFNGLQGAY 190
L++ T L L L+ N + P + LTKL EL L N +
Sbjct: 220 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 277
Query: 191 DHGFLQIFVKNIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVGVIP 240
L N ++ E + I NL+NL L L N + + P
Sbjct: 278 PLAGLTALTN-----LELNENQLEDISPISNLKNLTYLTLYFNNISDISP 322
Score = 33.1 bits (74), Expect = 0.79, Method: Compositional matrix adjust.
Identities = 71/285 (24%), Positives = 104/285 (36%), Gaps = 55/285 (19%)
Query: 267 PYVRLPNLEELYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXX 326
P L NL L L+ N + P + N + L+RLEL N+ S
Sbjct: 102 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--------------- 144
Query: 327 XXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCN 386
L+ + SSN + + K + NL+ +L+ D+S
Sbjct: 145 ----------------SALSGLTSLQQLSFSSNQVTDL---KPLANLT-TLERLDISSNK 184
Query: 387 VSGSIPEEIGNLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLE--GSIPDEVC 444
VS + LTNL N ++ P LG L L L N+L+ G++
Sbjct: 185 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL----A 236
Query: 445 RLAKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSS 504
L + LDL+NN++S P IS + L + L L+
Sbjct: 237 SLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG----LTALTNLELNE 292
Query: 505 NSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLF 549
N L P I NLK L + NN S + P + + LQ LF
Sbjct: 293 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 333
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 37.0 bits (84), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 44/166 (26%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A + VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKXVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P +LE++ +Y ++D + Q + + +D +
Sbjct: 86 ISLLNV----------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
YL + +S +IH DLKPSN+++ + + DFG+ +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174
>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|E Chain E, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|I Chain I, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|M Chain M, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|B Chain B, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|F Chain F, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|J Chain J, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|N Chain N, Crystal Structure Of The Rp105MD-1 Complex
Length = 612
Score = 37.0 bits (84), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 54 RVTALNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHTLKLLSFGDNQL 113
RV L+++ L+G +PS + ++SL+ L L++N F + + +L+ L N
Sbjct: 278 RVQELDLTAAHLNG-LPSGIEGMNSLKKLVLNANSFDQLCQINAASFPSLRDLYIKGNMR 336
Query: 114 SGEIPTNICSNLPFFESLNLSKNMFHGGIPSA------LSNCTYLRILRLSYNDFAGGIP 167
++ T L + L+LS H I ++ L N +L+ L LSYN+ G
Sbjct: 337 KLDLGTRCLEKLENLQKLDLS----HSDIEASDCCNLQLKNLRHLQYLNLSYNEPLGLED 392
Query: 168 KEIGNLTKLEELYLSFNGLQGAYDHGFLQ 196
+ +LE L ++F L H Q
Sbjct: 393 QAFKECPQLELLDVAFTHLHVKAPHSPFQ 421
Score = 32.0 bits (71), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 33/117 (28%), Positives = 51/117 (43%), Gaps = 4/117 (3%)
Query: 348 CKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCNVSGSIPEEIGNLTNLIGFYLG 407
C LE +D++ + NL H L++ ++S C + S + L +L L
Sbjct: 398 CPQLELLDVAFTHLHVKAPHSPFQNL-HLLRVLNLSHCLLDTSNQHLLAGLQDLRHLNLQ 456
Query: 408 GNNL-NGSIPIT--LGKLQKLQVLYFPDNKLEGSIPDEVCRLAKVYQLDLSNNKLSG 461
GN+ +GSI T L + L++L L L V LDLS+N L+G
Sbjct: 457 GNSFQDGSISKTNLLQMVGSLEILILSSCNLLSIDQQAFHGLRNVNHLDLSHNSLTG 513
>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit
Length = 192
Score = 37.0 bits (84), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 31/116 (26%), Positives = 43/116 (37%)
Query: 516 GNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLFLEYNILQGSIPDSFGDLMXXXXXXXX 575
G L LVK++ N +G+ PNA G +Q L L N ++ F L
Sbjct: 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110
Query: 576 XXXXXGSIPVSLEKLSYLKDLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP 631
+P S E L+ L LNL+ N +S G CG+P
Sbjct: 111 DNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166
Score = 32.3 bits (72), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 1/85 (1%)
Query: 54 RVTALNISHLSLSGTIPSRLGNLSSLQSLFLHSNQFSGSIPFSIFNIHTLKLLSFGDNQL 113
+ L + L+G P+ S +Q L L N+ +H LK L+ DNQ+
Sbjct: 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI 114
Query: 114 SGEIPTNICSNLPFFESLNLSKNMF 138
S +P + +L SLNL+ N F
Sbjct: 115 SCVMPGSF-EHLNSLTSLNLASNPF 138
Score = 30.4 bits (67), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 1/89 (1%)
Query: 74 GNLSSLQSLFLHSNQFSGSIPFSIFNIHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNL 133
G L L L L NQ +G P + ++ L G+N++ EI + L ++LNL
Sbjct: 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109
Query: 134 SKNMFHGGIPSALSNCTYLRILRLSYNDF 162
N +P + + L L L+ N F
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASNPF 138
>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX
Length = 462
Score = 37.0 bits (84), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 63/230 (27%), Positives = 90/230 (39%), Gaps = 42/230 (18%)
Query: 40 FCNWTGVT------CDVHSHR-VTALNISHLSLSGTIP--SRLGNLSSLQSLFLHSNQFS 90
N TG+T D+ + +T LN LS S TI S L L+SLQ L SNQ +
Sbjct: 106 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELS-SNTISDISALSGLTSLQQLNFSSNQVT 164
Query: 91 GSIPFSIFNIHTLKLLSFGDNQLSGEIPTNICSNLPFFESLNLSKNMFHGGIP------- 143
P + N+ TL+ L N++S ++ + L ESL + N P
Sbjct: 165 DLKPLA--NLTTLERLDISSNKVSD---ISVLAKLTNLESLIATNNQISDITPLGILTNL 219
Query: 144 -------------SALSNCTYLRILRLSYNDFAGGIPKEIGNLTKLEELYLSFNGLQGAY 190
L++ T L L L+ N + P + LTKL EL L N +
Sbjct: 220 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 277
Query: 191 DHGFLQIFVKNIFVQFSHNFSKCEIPNEIGNLRNLEVLALGLNKLVGVIP 240
L N ++ E + I NL+NL L L N + + P
Sbjct: 278 PLAGLTALTN-----LELNENQLEDISPISNLKNLTYLTLYFNNISDISP 322
Score = 33.9 bits (76), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 71/285 (24%), Positives = 105/285 (36%), Gaps = 55/285 (19%)
Query: 267 PYVRLPNLEELYLWGNHFSGSIPNFIFNASKLSRLELQKNSFSGFIPSTFXXXXXXXXXX 326
P L NL L L+ N + P + N + L+RLEL N+ S
Sbjct: 102 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--------------- 144
Query: 327 XXXXXXXXXXXXXXXXXXXXNCKYLEFIDLSSNSIDGILSRKSVGNLSHSLKIFDMSDCN 386
L+ ++ SSN + + K + NL+ +L+ D+S
Sbjct: 145 ----------------SALSGLTSLQQLNFSSNQVTDL---KPLANLT-TLERLDISSNK 184
Query: 387 VSGSIPEEIGNLTNLIGFYLGGNNLNGSIPITLGKLQKLQVLYFPDNKLE--GSIPDEVC 444
VS + LTNL N ++ P LG L L L N+L+ G++
Sbjct: 185 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL----A 236
Query: 445 RLAKVYQLDLSNNKLSGSIPACFGDXXXXXXXXXXXXXXISVIPSTFWNLKDILYLNLSS 504
L + LDL+NN++S P IS + L + L L+
Sbjct: 237 SLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG----LTALTNLELNE 292
Query: 505 NSLTGPLPLEIGNLKVLVKIDFSMNNFSGVIPNAIGGIKDLQFLF 549
N L P I NLK L + NN S + P + + LQ LF
Sbjct: 293 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 333
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 37.0 bits (84), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 44/166 (26%)
Query: 714 IGRGGFG---SVYKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G + Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 34 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 87
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 88 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 130
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
YL + +S +IH DLKPSN+++ + + DFG+ +
Sbjct: 131 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 176
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 37.0 bits (84), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 47/217 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A + VA+K ++ RA++ E +MK + H+NI
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 78
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P +LE++ +Y ++D + Q + + +D +
Sbjct: 79 ISLLNV----------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERM 121
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 122 SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMM-TPY 178
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGK 909
T Y A E N D+++ G ++ E K
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 37.0 bits (84), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 44/166 (26%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A + VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P +LE++ +Y ++D + Q + + +D +
Sbjct: 86 ISLLNV----------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
YL + +S +IH DLKPSN+++ + + DFG+ +
Sbjct: 129 SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 36.6 bits (83), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 44/166 (26%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 37 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 90
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 91 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 133
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
YL + +S +IH DLKPSN+++ + + DFG+ +
Sbjct: 134 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 179
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 36.6 bits (83), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 44/166 (26%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A ++ VA+K ++ RA++ E +MK + H+NI
Sbjct: 26 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 79
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P SLE++ +Y ++D + Q + + +D +
Sbjct: 80 IGLLNV----------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERM 122
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITK 858
YL + +S +IH DLKPSN+++ + + DFG+ +
Sbjct: 123 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 36.6 bits (83), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 47/217 (21%)
Query: 714 IGRGGFGSV---YKARIQDGMEVAVKVFNQ------QCGRAFKSFDVECEVMKSIRHRNI 764
IG G G V Y A + VA+K ++ RA++ E +MK + H+NI
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKXVNHKNI 85
Query: 765 IKIISCCSIGDFKALFKALALEYMPHGSLEKY--LYSSNYILD--IFQRLNIMIDVASAL 820
I +++ + P +LE++ +Y ++D + Q + + +D +
Sbjct: 86 ISLLNV----------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERM 128
Query: 821 EYLYFG--------YSTPVIHCDLKPSNVLLGDNMVAHLSDFGITKLLTREDQFVTQTQT 872
YL + +S +IH DLKPSN+++ + + DFG+ + T F+ T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMM-TPY 185
Query: 873 PATIGYMALEYGSEGRVSTNGDVYNFGVMLMETFTGK 909
T Y A E N D+++ G ++ E K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.139 0.413
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 27,636,648
Number of Sequences: 62578
Number of extensions: 1140230
Number of successful extensions: 4866
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 672
Number of HSP's successfully gapped in prelim test: 503
Number of HSP's that attempted gapping in prelim test: 2482
Number of HSP's gapped (non-prelim): 1606
length of query: 1002
length of database: 14,973,337
effective HSP length: 108
effective length of query: 894
effective length of database: 8,214,913
effective search space: 7344132222
effective search space used: 7344132222
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 56 (26.2 bits)